INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18330, 'Ginkonoro plus 30 capsules', 'جينكونورو بلس 30 كبسولة', '260', '240', 'Multivitamins', 'Citicoline 300 mg+ginkgo biloba 50 mg+magnesium+vitamin b6+vitamin b1', 'Egy minds', 'Capsule', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 2522, '2025-08-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18331, 'Enrich syrup 100 ml', 'انريتش شراب 100 مل', '34', '21.75', 'Anemia.iron supplement', 'Ferric hydroxide polymaltose', 'Marcyrl co.', 'Syrup', 'شراب', '100 ml', '1', NULL, NULL, '6223003579630', NULL, 2432, '2024-10-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03AB04', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18332, 'Aaa', 'ششش', '22', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 743, '2023-08-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18333, 'Skynor 20 cap', 'سكاينور 20 كبسولة', '150', NULL, 'Multivitamins', 'Ferrous bisglycinate 150mg+lactoferrin 100 mg+vit c 110 mg+folic acid 400mg+vit b1+vit b6+vit b12+vit e+molybdenum', 'Eveno pharm', 'Cap', 'كبسولة', NULL, '2', NULL, NULL, NULL, NULL, 674, '2023-08-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18335, 'Entecavir 0.25mg/5ml oral soln. 210 ml', 'انتيكافير 0.25 مجم / 5 مل عن طريق الفم 210 مل', '450', NULL, 'Antiviral.nucleoside', 'Entecavir', 'Global napi pharmaceuticals > penta pharma-egypt', 'Sol', 'محلول', '0.25mg', '1', 'مضاد فيروسات -- لعلاج التهاب الكبد الوبائي المزمن من النوع B', 'about entecavir nucleoside analog reverse transcriptase inhibitor oral antiviral drug used in the treatment of hepatitis b infection. mechanism of action of entecavir by competing with the natural substrate deoxyguanosine triphosphate entecavir functional', NULL, NULL, 863, '2022-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS).

Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005.', '["J05AF10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18336, 'Entecavir 0.5 mg 10 tab', 'انتيكافير 0.5مجم 10 اقراص', '300', NULL, 'Antiviral.nucleoside', 'Entecavir', 'Penta pharma-egypt', 'Tab', 'أقراص', '0.5 mg', '1', 'مضاد فيروسات -- لعلاج التهاب الكبد الوبائي المزمن من النوع ب', NULL, NULL, NULL, 6618, '2023-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS).

Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005.', '["J05AF10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18337, 'Entecavir 1 mg 10 tab.', 'انتاكافير 1مجم 10 اقراص', '450', NULL, 'Antiviral.nucleoside', 'Entecavir', 'Penta pharma-egypt', 'Tab', 'أقراص', '1 mg', '1', 'يستخدم لعلاج التهاب الكبد الفيروسي B', 'about entecavir nucleoside analog reverse transcriptase inhibitor oral antiviral drug used in the treatment of hepatitis b infection. mechanism of action of entecavir by competing with the natural substrate deoxyguanosine triphosphate entecavir functional', NULL, NULL, 2420, '2022-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Entecavir is an oral antiviral drug used in the treatment of hepatitis B infection. It is marketed under the trade name Baraclude (BMS).

Entecavir is a guanine analogue that inhibits all three steps in the viral replication process, and the manufacturer claims that it is more efficacious than previous agents used to treat hepatitis B (lamivudine and adefovir). It was approved by the U.S. Food and Drug Administration (FDA) in March 2005.', '["J05AF10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18338, 'Enterogermina 2 billion/5ml oral susp. 10 mini bottles', 'انتيروجيرمينا 2 بليون/5مل معلق فموي 10 زجاجات صغيرة الحجم', '180', '150', 'Antidiarrhoeal', 'Bacillus clausii spores', 'Sanofi', 'Susp', 'معلق', '5ml', '10', 'علاج الاسهال -- تنظيم حركة المعدة و الامعاء', 'what is enterogermina? enterogermina is a probiotic which is useful for the management of imbalance of intestinal bacterial flora due to diverse causes. enterogermina is used to effectively manage diarrhoea and for treating the alterations of the intestin', '3582910075455', NULL, 3648, '2025-06-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18339, 'Enterolok 10 f.c.tab.', 'انتيرولوك 10 اقراص', '19', NULL, 'Antibiotic quinolone with antiprotozoal', 'Norfloxacin+tinidazole', 'Hochster pharmaceutical industries', 'Tab', 'أقراص', NULL, '1', NULL, 'enterolok tablets is a combination of norfloxacin an anti microbial agent ( quinolone group ) and effective anti anerobic bactericidal agent (tinidazole). this combination shows a great efficacy and control against gastrointestinal infections due to susce', NULL, NULL, 1404, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18340, 'Enteromycin dry 60 ml syrup', 'انتيرومايسين شراب جاف 60 مل', '5', NULL, 'Antidiarrheal', 'Alumina gel+clioquinol+streptomycin', 'El nile.', 'Syrup', 'شراب', '60 ml', '1', 'علاج حمى الأرانب -- الحفاظ على صحة الجهاز الهضمي -- لعلاج الإسهال الناتج عن عدوى بكتيرية', NULL, NULL, NULL, 1144, '2023-04-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18341, 'Aaa', 'ششش', '8', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 740, '2023-05-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18342, 'Enteroquin comp. pd. for oral susp. 60 ml', 'انتروكين كومب باودر لعمل معلق 60 مل', '5', NULL, 'Antidiarrheal', 'Homatropine methylbromide+iodoquinol+kaolin+phthalyl sulphathiazole+sulphadimidine+vitamin b1+b6+b12', 'Arab drug company.', 'Susp', 'معلق', '60 ml', '1', NULL, NULL, '6221060000760', NULL, 998, '2023-05-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18343, 'Entocid 20*10 tab.', 'انتوسيد 20*10 قرص', '300', '127.5', 'Antidiarrheal', 'Diiodohydroxyquinoline+phthalylsulfathiazol+streptomycin', 'Cid', 'Tab', 'أقراص', NULL, '20', NULL, NULL, '6221043011035', NULL, 1175, '2024-11-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18345, 'Aaa', 'ششش', '12', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 654, '2022-10-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18346, 'Aaa', 'ششش', '5', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 772, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18347, 'Entophar 500 mg 5 vag. ovules', 'انتوفار 500 مجم 5 بويضات مهبلية', '9', '4.25', 'Antiprotozoal.nitroimidazole', 'Metronidazole', 'Pharopharma', 'Unknown', 'غير محدد', '500 mg', '1', NULL, 'about metronidazolesa nitroimidazole antibiotic anti-infective antiprotozoal amebicide.smechanism of action of metronidazolesmetronidazole is nitro imidazoles which have broad spectrum cidal activity against protozoa and some anaerobic bacteria. its selec', '6221094503169', NULL, 1091, '2025-08-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Metronidazole is a commonly used antibiotic, belonging to the nitroimidazole class of antibiotics.[L3754] It is frequently used to treat gastrointestinal infections as well as trichomoniasis and giardiasis, and amebiasis which are parasitic infections.[A181036,A181039] Metronidazole has been used as an antibiotic for several decades[L7429], with added antiparasitic properties that set it apart from many other antibacterial drugs, allowing it to treat a wide variety of infections. It is available in capsule form, tablet form, and topical form, and suppository preparations for the treatment of various infections.', '["A02BD11", "P01AB52", "D06BX01", "A02BD03", "J01XD01", "J01RA04", "A02BD01", "J01RA14", "A02BD15", "J01RA03", "A01AB17", "G01AF20", "J01RA10", "A02BD02", "A02BD13", "G01AF01", "P01AB51", "A02BD08", "P01AB01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18348, 'Entresto 100 mg (49/51 mg) 28 f.c. tabs.', 'انترستو 100مجم 28 قرص', '1,700', '1369', 'Angiotensin receptor blockers & neprilysin inhibitors', 'Sacubitril+valsartan', 'Novartis', 'Tab', 'أقراص', '100 mg', '2', 'علاج ارتفاع ضغط الدم -- علاج الفشل القلبي', NULL, '300780777209', '01076134210066551727093010TJLU2 2110712547671476', 11757, '2024-09-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18349, 'Entresto 200 mg (97/103 mg) 56 f.c. tabs.', 'انترستو 200مجم 56 قرص', '3,559', '2738', 'Angiotensin receptor blockers & neprilysin inhibitors', 'Sacubitril+valsartan', 'Novartis', 'Tab', 'أقراص', '200 mg', '4', 'علاج ارتفاع ضغط الدم', NULL, '300780696203', NULL, 4994, '2024-07-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18350, 'Entresto 50 mg (24/26 mg) 28 f.c. tabs.', 'انترستو 50مجم 28 قرص', '1,700', '1369', 'Angiotensin receptor blockers & neprilysin inhibitors', 'Sacubitril+valsartan', 'Novartis', 'Tab', 'أقراص', '50 mg', '2', 'علاج ارتفاع ضغط الدم', NULL, '300780659208', NULL, 14571, '2024-07-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18351, 'Entyvio 300 mg vial for inf.', 'انتيفيو 300مجم فيال للاطفال', '48,824', '36600', 'Ulcerative colitis', 'Vedolizumab', 'Takeda > pharma overseas', 'Vial', 'فيال', '300 mg', '1', NULL, 'indications: entyvio (vedolizumab) is indicated for adult patients with moderately to severely active ulcerative colitis (uc) or crohns disease (cd) who have had an inadequate response with were intolerant to or demonstrated dependence on corticosteroids', NULL, NULL, 2617, '2024-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Vedolizumab is a recombinant humanized IgG1 monoclonal antibody directed against the human lymphocyte α4β7 integrin, a key mediator of gastrointestinal inflammation. It is used in the treatment of moderate to severe active ulcerative colitis and Crohn''s disease for patients who have had an inadequate response with, lost response to, or were intolerant to inhibitors of tumor necrosis factor-alpha (TNF-alpha) or other conventional therapies. By blocking its primary target, α4β7 integrin, vedolizumab reduces inflammation in the gut. Vedolizumab is administered by IV infusion over a period of 30 minutes; after the first dose, it is given again at two and six weeks and then every 8 weeks thereafter.', '["L04AA33"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18352, 'Epanutin 100mg 50 caps', 'ايبانوتين 100مجم 50 كبسولة', '14', NULL, 'Anti-epileptic.hydantoin', 'Phenytoin', 'El nile. > pfizer', 'Cap', 'كبسولة', '100mg', '5', NULL, NULL, NULL, NULL, 3916, '2022-07-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Phenytoin is classified as a hydantoin derivative and despite its narrow therapeutic index, it is one of the most commonly used anticonvulsants.[A33595,A188832,A189219] Since it''s introduction about 80 years ago, phenytoin has not only been established as an effective anti-epileptic, but has also been investigated for several other indications such as bipolar disorder, retina protection, and wound healing.[A188826,A188832]

Clinicians are advised to initiate therapeutic drug monitoring in patients who require phenytoin since even small deviations from the recommended therapeutic range can lead to suboptimal treatment, or adverse effects.[A189219,A35884] Both parenteral and oral formulations of phenytoin are available on the market.[A189219]', '["N03AB02", "N03AB52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18353, 'Epcidin s.r. 6 mg 10 caps.', 'ابسيدين اس ار 6 مجم 10 كبسولات', '8', NULL, 'Cns.analgesic.skeletal muscle relaxant.alpha2 agonist', 'Tizanidine', 'Epci', 'Cap', 'كبسولة', '6 mg', '1', 'مسكن وباسط للعضلات ومضاد للالتهابات', 'about tizanidine a centrally acting a-2 adrenergic agonist centrally acting muscle relaxant (short-acting). mechanism of action of tizanidine this drug is a centrally acting alpha2 agonist at alpha2-adrenergic receptor sites and presumably reduces spastic', NULL, NULL, 1058, '2022-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Tizanidine is a fast-acting drug used for the management of muscle spasm, which may result from the effects of multiple sclerosis, stroke, an acquired brain injury, or a spinal cord injury [T574].  It may also be caused by musculoskeletal injury [A177583].  Regardless of the cause, muscle spasticity can be an extremely painful and debilitating condition. 

Initially approved by the FDA in 1996, tizanidine is an Alpha-2 adrenergic receptor agonist reducing spasticity by the presynaptic inhibition of excitatory neurotransmitters that cause firing of neurons promoting muscle spasm [FDA label].', '["M03BX02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18355, 'Epcifam 20mg 10 orally disentigrating tabs.', 'ابسيفام 20 مجم 10 اقراص', '7', NULL, 'Peptic ulcer.anti-histamine.h2 antagonist', 'Famotidine', 'Epci', 'Tab', 'أقراص', '20mg', '1', NULL, 'about famotidine guanidine:thiazole derivative a histamine h2-receptor antagonist anti-secretory antiulcer. mechanism of action of famotidine famotidine is a h2 (histamine) receptor antagonist. histamine is the most potent stimulus of acid secretion and a', NULL, NULL, 946, '2022-07-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Famotidine is a competitive histamine-2 (H2) receptor antagonist that works to inhibit gastric acid secretion. It is commonly used in gastrointestinal conditions related to acid secretion, such as gastric ulcers and gastroesophageal reflux disease (GERD), in adults and children.[L11166] Compared to other H2receptor antagonists, famotidine displays high selectivity towards this receptor; in a study consisting of healthy volunteers and patients with acid hypersecretory disease, famotidine was about 20 to 50 times more potent at inhibiting gastric acid secretion than [cimetidine] and eight times more potent than [ranitidine] on a weight basis.[A189462] Famotidine is used in various over-the-counter and off-label uses.[L11166] While oral formulations of famotidine are more commonly used, the intravenous solution of the drug is available for use in hospital settings.[L11142]', '["A02BA03", "A02BA53"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18356, 'Epcifam plus 10 chewable tab.', 'ابسيفام بلس 10 اقراص مضغ', '7', NULL, 'Antacid', 'Aluminium hydroxide+famotidine+magnesium hydroxide', 'Epci', 'Tab', 'أقراص', NULL, '1', NULL, 'about aluminium hydroxide antacid antidote protectant( topical) in hyperacidity; hyperphosphatemia. mechanism of action of aluminium hydroxide it neutralizes and reduces stomach acid relieving heartburn (acid reflux gerd) and indigestion. this results inc', NULL, NULL, 969, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18357, 'Epciflurifen 8.75 mg 20 lozenges', 'ابسيفلوريفين 8.75 مجم 20 قرص استحلاب', '14', NULL, 'Nsaid.propionic acid derivatives', 'Flurbiprofen', 'Epci', 'Lozenges', 'استحلاب', '8.75 mg', '2', NULL, 'about flurbiprofen nsaid oral phenylalkanoic acid derivative analgesic and anti-inflammatory anti arthritic. mechanism of action of flurbiprofen it reduces prostaglandin synthesis by inhibiting cyclo oxygenase enzymes both cox1 and cox2.in higher doses it', NULL, NULL, 771, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis. Flurbiprofen is structurally and pharmacologically related to fenoprofen, ibuprofen, and ketoprofen.', '["M02AA19", "M01AE09", "R02AX01", "S01BC04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18358, 'Epcimox 125mg 8 oral dis. tab.', 'ابسيموكس 125 مجم 8 اقراص', '3', NULL, 'Penicillins.monocomponent', 'Amoxicillin', 'Epci', 'Tab', 'أقراص', '125mg', '1', NULL, '(indications): is a penicillin-like beta-lactam antibiotic. it is used to treat bacterial infections caused by susceptible microorganisms. it prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia bronchitis', NULL, NULL, 991, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Amoxicillin, or BRL-2333, is a penicillin G derivative first described in the literature in 1972.[A190648] Amoxicillin has similar activity to [penicillin] and [ampicillin], but leads to higher serum concentrations than ampicillin.[A190648]

Amoxicillin was granted FDA approval on 18 January 1974.[L11644]', '["A02BD12", "J01CR50", "A02BD14", "A02BD04", "A02BD07", "A02BD13", "A02BD10", "A02BD05", "A02BD03", "A02BD01", "A02BD15", "A02BD06", "J01CA04", "A02BD16", "A02BD11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18359, 'Epcimox 250mg 8 oral dis. tab.', 'ايبسيموكس 250 مجم 8 أقراص', '5', NULL, 'Penicillins.monocomponent', 'Amoxicillin', 'Epci', 'Tab', 'أقراص', '250mg', '1', NULL, '(indications): is a penicillin-like beta-lactam antibiotic. it is used to treat bacterial infections caused by susceptible microorganisms. it prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia bronchitis', NULL, NULL, 925, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Amoxicillin, or BRL-2333, is a penicillin G derivative first described in the literature in 1972.[A190648] Amoxicillin has similar activity to [penicillin] and [ampicillin], but leads to higher serum concentrations than ampicillin.[A190648]

Amoxicillin was granted FDA approval on 18 January 1974.[L11644]', '["A02BD12", "J01CR50", "A02BD14", "A02BD04", "A02BD07", "A02BD13", "A02BD10", "A02BD05", "A02BD03", "A02BD01", "A02BD15", "A02BD06", "J01CA04", "A02BD16", "A02BD11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18360, 'Epcura mr 4mg 10 tab.', 'ايبكيورا ام ار 4 مجم 10 قرص', '10', NULL, 'Antihypertensive.selective alpha 1 receptor blockers', 'Doxazosin', 'Epci', 'Tab', 'أقراص', '4mg', '1', NULL, 'about doxazosin alpha-1 adrenergic antagonist quinazoline derivative antihypertensive. mechanism of action of doxazosin the drug exerts its antihypertensive action by acting as a selective alpha-1 antagonist. it dilates both arteries and veins thus it red', NULL, NULL, 886, '2022-08-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Doxazosin is an alpha-1 antagonist used for the treatment of benign prostatic hypertrophy (BPH) symptoms and hypertension. Other members of this drug class include [Prazosin], [Terazosin], [Tamsulosin], and [Alfuzosin].[A180661]  Because of its long-lasting effects, doxazosin can be administered once a day.[A180649] It is marketed by Pfizer and was initially approved by the FDA in 1990.[L7285]', '["C02CA04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18361, 'Ephedrine-cid 30mg/ml 100 amp.', 'افيديرين سيد 30 مجم/مل 100 امبولة', '700', '400', 'Sympathomimetic', 'Ephedrine', 'Cid', 'Amp', 'أمبول', '30mg', '100', 'علاج ارتفاع ضغط الدم -- موسع للشعب الهوائية -- علاج الازمات التنفسية و القلبية', NULL, NULL, NULL, 1200, '2024-11-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ephedrine was first described in western literature in 1888, as a naturally occurring component of the ephedra plant, along with [pseudoephedrine].[A193698] Ephedrine acts as both a direct and indirect sympathomimetic. It is an alpha- and beta-adrenergic receptor agonist; however, it also causes the indirect release of norepinephrine from sympathetic neurons, inhibiting norepinephrine reuptake and displacing more norepinephrine from storage vesicles.[A193650,L12972] Ephedrine is used for its vasoconstrictive, positive chronotropic, and positive inotropic effects.[L12972] Ephedrine and [phenylephrine] are still used to treat hypotension, but their use in other indications has decreased due to the development of more selective adrenergic agonists.[A193701,A193704,L12975] Ephedrine was granted a type 7 FDA Approval on 29 April 2016.[L12975]', '["S01FB02", "R01AB05", "C01CA26", "R03CA02", "A08AA56", "R01AA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18362, 'Ephedrine sulphate-misr 25mg/ml 100 amp.', 'ايفيدرين سلفات 25 مجم / مل 100 امبول', '600', '400', 'Sympathomimetic', 'Ephedrine', 'Misr', 'Amp', 'أمبول', '25mg', '100', NULL, NULL, NULL, NULL, 2710, '2024-11-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ephedrine was first described in western literature in 1888, as a naturally occurring component of the ephedra plant, along with [pseudoephedrine].[A193698] Ephedrine acts as both a direct and indirect sympathomimetic. It is an alpha- and beta-adrenergic receptor agonist; however, it also causes the indirect release of norepinephrine from sympathetic neurons, inhibiting norepinephrine reuptake and displacing more norepinephrine from storage vesicles.[A193650,L12972] Ephedrine is used for its vasoconstrictive, positive chronotropic, and positive inotropic effects.[L12972] Ephedrine and [phenylephrine] are still used to treat hypotension, but their use in other indications has decreased due to the development of more selective adrenergic agonists.[A193701,A193704,L12975] Ephedrine was granted a type 7 FDA Approval on 29 April 2016.[L12975]', '["S01FB02", "R01AB05", "C01CA26", "R03CA02", "A08AA56", "R01AA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18363, 'Aaa', 'ششش', '398', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 665, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18364, 'Epiao 10000i.u./ml vial', 'ابياو 10000 وحدة دولية/مل فيال', '210', NULL, 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Shenyang sunshine pharmaceutical co. > egyptian pharmex', 'Vial', 'فيال', NULL, '1', NULL, 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', NULL, NULL, 729, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18365, 'Aaa', 'ششش', '53', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 629, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18366, 'Epiao 4000i.u./ml vial', 'ابياو 4000 وحدة دولية/مل فيال', '155', '118', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Shenyang sunshine pharmaceutical co. > egyptian pharmex', 'Vial', 'فيال', NULL, '1', 'يستخدم لعلاج الأنميا الناتجة عن (عملية زرع الكلى أو بعض الأدوية اللي تستخدم في علاج مرض الإيدز).', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '6909389581053', NULL, 4391, '2024-11-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18367, 'Epicare hand sanitizer topical solution 125 ml', 'ابيكير محلول موضعي مطهر لليدين 125 مل', '30', NULL, 'Antiseptic', 'Alcohol 80%', 'Eipico', 'Solution', 'محلول', '125 ml', '1', NULL, 'alcohol antiseptic non-sterile solution', NULL, NULL, 934, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18368, 'Aaa', 'ششش', '36', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 770, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18369, 'Epicephin 1gm i.v. vial', 'ابيسيفين 1جم فيال وريد', '60', '45', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Eipico', 'Vial', 'فيال', '1gm', '1', NULL, NULL, '6221032312181', NULL, 1757, '2024-09-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18370, 'Epicephin 2gm i.v. vial', 'ابيسيفين 2 جم فيال وريد', '77', '55', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Eipico', 'Vial', 'فيال', '2gm', '1', NULL, NULL, '6221032314109', NULL, 2858, '2024-08-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18371, 'Epicephin 250mg i.m. vial', 'ابيسيفين 250مجم فيال عضل', '22', '7', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Eipico', 'Vial', 'فيال', '250mg', '1', NULL, NULL, '6221032319500', NULL, 789, '2024-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18372, 'Epicephin 250mg i.v. vial', 'ابيسيفين 250مجم فيال وريد', '22', '7', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Eipico', 'Vial', 'فيال', '250mg', '1', NULL, NULL, '6221032318701', NULL, 918, '2024-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18373, 'Epicephin 500mg i.v. vial', 'ابيسيفين 500مجم فيال وريد', '47', '33', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Eipico', 'Vial', 'فيال', '500mg', '1', NULL, NULL, '6221032335814', NULL, 1070, '2024-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18376, 'Epicocillin 125mg/5ml 100ml susp.', 'ابيكوسيللين 125مجم/5مل معلق 100 مل', '7', NULL, 'Penicillins.monocomponent', 'Ampicillin', 'Eipico', 'Susp', 'معلق', '125mg', '1', NULL, 'description : semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic . indication : for treatment of infection (respiratory gi uti and meningitis) due to e. coli p. mirabilis enterococci shigella s. typhosa an', '6221032150509', NULL, 958, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.', '["J01CR50", "J01CA51", "J01CA01", "S01AA19"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18377, 'Aaa', 'ششش', '5', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 769, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18378, 'Epicocillin 250mg 12 caps.', 'ابيكوسيللين 250مجم 12 كبسولة', '7', NULL, 'Penicillins.monocomponent', 'Ampicillin', 'Eipico', 'Cap', 'كبسولة', '250mg', '2', NULL, 'description : semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic . indication : for treatment of infection (respiratory gi uti and meningitis) due to e. coli p. mirabilis enterococci shigella s. typhosa an', '6221032130556', NULL, 887, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.', '["J01CR50", "J01CA51", "J01CA01", "S01AA19"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18379, 'Aaa', 'ششش', '4', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 677, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18380, 'Epicocillin 250mg/5ml 100ml susp.', 'ابيكوسيللين 250 مجم/5 مل معلق 100 مل', '9', NULL, 'Penicillins.monocomponent', 'Ampicillin', 'Eipico', 'Susp', 'معلق', '250mg', '1', NULL, 'description : semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic . indication : for treatment of infection (respiratory gi uti and meningitis) due to e. coli p. mirabilis enterococci shigella s. typhosa an', '6221032150707', NULL, 729, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.', '["J01CR50", "J01CA51", "J01CA01", "S01AA19"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18381, 'Epicocillin 250mg/5ml susp. 60 ml', 'ابيكوسيللين 250مجم/5مل معلق 60 مل', '7', NULL, 'Penicillins.monocomponent', 'Ampicillin', 'Eipico', 'Susp', 'معلق', '250mg', '1', NULL, NULL, NULL, NULL, 998, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.', '["J01CR50", "J01CA51", "J01CA01", "S01AA19"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18383, 'Aaa', 'ششش', '5', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 878, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18384, 'Epicoflocin 200 mg 10 f.c.tab.', 'ابيكوفلوسين 200 مجم 10 قرص', '28', '18', 'Antibiotic.quinolone', 'Ofloxacin', 'Eipico', 'Tab', 'أقراص', '200 mg', '1', 'مضاد حيوى واسع المدى يستخدم فى علاج العديد من الالتهابات', NULL, '6221032298997', NULL, 972, '2025-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.', '["J01MA01", "J01RA09", "S01AE01", "S02AA16"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18385, 'Aaa', 'ششش', '12', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', 'للحموضة', NULL, NULL, NULL, 794, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18386, 'Epicopentin 600mg 30 f.c. tab.', 'ابيكوبنتين 600 مجم 30 قرص', '138', '102', 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Eipico', 'Tab', 'أقراص', '600mg', '3', NULL, NULL, '6221032101662', NULL, 2052, '2025-05-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid ([GABA]) that was first approved for use in the United States in 1993.[L8717] It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures[A186277,A186143] - today it is also widely used to treat neuropathic pain.[A14097,A186179] Gabapentin has some stark advantages as compared with other anti-epileptics, such as a relatively benign adverse effect profile, wide therapeutic index, and lack of appreciable metabolism making it unlikely to participate in pharmacokinetic drug interactions.[A186143,A185981,L8717]. It is structurally and functionally related to another GABA derivative, [pregabalin].', '["N03AX12"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18387, 'Epicopentin 800 mg 30 f.c. tabs.', 'ابيكوبنتين 800 مجم 30 اقراص', '110', '28', 'Anti-epileptic.gaba analogs', 'Gabapentin', 'Eipico', 'Tab', 'أقراص', '800 mg', '3', 'دواء مضاد للصرع ، ويسمى أيضًا مضاد الاختلاج. وهو يؤثر على المواد الكيميائية والأعصاب في الجسم التي تسبب التشنجات وبعض أنواع الألم', NULL, '6221032101679', NULL, 4304, '2024-11-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid ([GABA]) that was first approved for use in the United States in 1993.[L8717] It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures[A186277,A186143] - today it is also widely used to treat neuropathic pain.[A14097,A186179] Gabapentin has some stark advantages as compared with other anti-epileptics, such as a relatively benign adverse effect profile, wide therapeutic index, and lack of appreciable metabolism making it unlikely to participate in pharmacokinetic drug interactions.[A186143,A185981,L8717]. It is structurally and functionally related to another GABA derivative, [pregabalin].', '["N03AX12"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18390, 'Epicopred 20 mg 20 orodispersible tabs.', 'ابيكوبريد 20مجم 20 قرص ذائب بالفم', '104', '72', 'Glucocorticoid', 'Prednisolone', 'Eipico', 'Tab', 'أقراص', '20 mg', '2', 'مضاد التهاب كورتيزوني', 'about prednisolone systemic synthetic glucocorticoid immunosuppressant. mechanism of action of prednisolone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes a structural change in steroid re', '6221032119667', NULL, 30769, '2024-08-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Prednisolone is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463]

Prednisolone was granted FDA approval on 21 June 1955.[L9431]', '["D07AA03", "S01CA02", "D07XA02", "A01AC54", "R01AD02", "S01BB02", "R01AD52", "S01CB02", "V03AB05", "S03BA02", "D07BA01", "D07CA03", "S01BA04", "S02BA03", "A07EA01", "H02AB06", "S02CA01", "C05AA04", "S03CA02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18391, 'Epicopred 5 mg 30 orodispersible tabs.', 'ابيكوبريد 5مجم 30 قرص', '69', '48', 'Glucocorticoid', 'Prednisolone', 'Eipico', 'Tab', 'أقراص', '5 mg', '3', 'مضاد عام للالتهابات والحساسية', 'about prednisolone systemic synthetic glucocorticoid immunosuppressant. mechanism of action of prednisolone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes a structural change in steroid re', '6221032119551', NULL, 33486, '2024-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Prednisolone is a glucocorticoid similar to [cortisol] used for its anti-inflammatory, immunosuppressive, anti-neoplastic, and vasoconstrictive effects.[A187463]

Prednisolone was granted FDA approval on 21 June 1955.[L9431]', '["D07AA03", "S01CA02", "D07XA02", "A01AC54", "R01AD02", "S01BB02", "R01AD52", "S01CB02", "V03AB05", "S03BA02", "D07BA01", "D07CA03", "S01BA04", "S02BA03", "A07EA01", "H02AB06", "S02CA01", "C05AA04", "S03CA02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18392, 'Aaa', 'ششش', '21', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 610, '2022-09-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18393, 'Aaa', 'ششش', '14', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 858, '2022-09-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18394, 'Epicotil 20mg i.m./i.v. 3 vial', 'ابيكوتيل 20مجم 3 فيال', '48', '28.5', 'Nsaid.oxicam', 'Tenoxicam', 'Eipico', 'Vial', 'فيال', '20mg', '3', NULL, 'mechanism of action of tenoxicam the anti-inflammatory effects of tenoxicam may result from the inhibition of the enzyme cyclooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis (prostaglandins sensitize pain receptors their inhi', '6221032311115', NULL, 3552, '2024-12-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M01AC02', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18397, 'Epident tooth paste 50 gm', 'ابيدنت معجون اسنان 50 جم', '5', NULL, 'Oral care', 'Salvadora persica powder(miswak)+veltol plus+propylene glycol+sodium phosphate(monobasic & di-basic)', 'Eipico', 'Unknown', 'غير محدد', '50 gm', '1', NULL, '-kills harmful germs -protect from tooth decay -strengthens the gum', '6221032242211', NULL, 785, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18398, 'Epi-derm silicone gel sheet 14.5*12 cm', 'ابيدرم لزقة سيليكون جيل 14.5 سم * 12 سم', '923', NULL, 'Scar therapy', NULL, 'Biodermis corp. > united health care', 'Gel', 'جل', NULL, '1', 'لزقة لازالة ومعالجة الندبات', '100% silicone sheet for scars', NULL, NULL, 1029, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18399, 'Epiderm soothing cream 50 gm', 'ابيدرم كريم ملطف 50 جرام', '70', '55', 'Soothing topical', 'Panthenol+olive oil+chamomile+zinc oxide+petrolatum+sunflower oil+glycerin+beeswax', 'Egyptian company for cosmetics > kmt pharma', 'Cream', 'كريم', '50 gm', '1', 'كريم ملطف للجلد', 'skin soothing cream.', '6224011031097', NULL, 10822, '2024-05-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18400, 'Aaa', 'ششش', '6', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 675, '2022-07-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18402, 'Aaa', 'ششش', '23', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 737, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18403, 'Aaa', 'ششش', '6', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 656, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18405, 'Aaa', 'ششش', '9', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 763, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18406, 'Epifenac 100mg 5 rectal supp.', 'ابيفيناك 100 مجم 5 اقماع', '21', '13.5', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Supp', 'لبوس', '100mg', '1', NULL, 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032117779', NULL, 877, '2025-05-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18407, 'Epifenac 100mg s.r. 10 caps.', 'ابيفيناك 100 مجم اس ار 10 كبسولات', '33', '22', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Cap', 'كبسولة', '100mg', '1', NULL, 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032117779', NULL, 1418, '2024-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18408, 'Epifenac 12.5mg 5 supp.', 'ابيفيناك 12.5 مجم 5 اقماع', '15', '9', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Supp', 'لبوس', '12.5mg', '1', NULL, 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032250346', NULL, 1127, '2025-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18409, 'Aaa', 'ششش', '12', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 745, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18410, 'Epifenac 25mg 5 supp.', 'ابيفيناك 25 مجم 5 اقماع', '15', '9', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Supp', 'لبوس', '25mg', '1', NULL, 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032250322', NULL, 874, '2025-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18411, 'Epifenac 50 mg 5 supp.', 'ابيفيناك 50 مجم 5 اقماع', '9', NULL, 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Supp', 'لبوس', '50 mg', '1', NULL, 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032250902', NULL, 923, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18412, 'Aaa', 'ششش', '14', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 688, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18413, 'Epifenac 75mg s.r. 10 tabs.', 'ابيفيناك 75 مجم اس ار 10 اقراص', '29', '19', 'Nsaid.acetic acid derivatives', 'Diclofenac sodium', 'Eipico', 'Tab', 'أقراص', '75mg', '1', NULL, 'description a non-steroidal anti-inflammatory agent (nsaid) with antipyretic and analgesic actions. it is primarily available as the sodium salt. indication : for the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthr', '6221032117786', NULL, 1142, '2025-02-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Diclofenac is a phenylacetic acid derivative and non-steroidal anti-inflammatory drug (NSAID).[label] NSAIDs inhibit cyclooxygenase (COX)-1 and-2 which are the enzyme responsible for producing prostaglandins (PGs). PGs contribute to inflammation and pain signalling. Diclofenac, like other NSAIDs, is often used as first line therapy for acute and chronic pain and inflammation from a variety of causes. Diclofenac was the product of rational drug design based on the structures of [phenylbutazone], [mefenamic acid], and [indomethacin].[A180796] The addition of two chlorine groups in the ortho position of the phenyl ring locks the ring in maximal torsion which appears to be related to increased potency. It is often used in combination with [misoprostol] to prevent NSAID-induced gastric ulcers. Diclofenac was first approved by the FDA in July 1988 under the trade name Voltaren, marketed by Novartis (previously Ciba-Geigy).[L7360]', '["S01CC01", "S01BC03", "M01AB55", "M02AA15", "M01AB05", "D11AX18"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18414, 'Aaa', 'ششش', '18', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 809, '2022-08-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18415, 'Aaa', 'ششش', '145', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 727, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18416, 'Epigent 20mg/2ml i.v./i.m. 3 amp.', 'ابيجينت 20مجم/2مل 3 امبولات', '24', '10.5', 'Aminoglycoside antibiotic', 'Gentamicin', 'Eipico', 'Amp', 'أمبول', '20mg', '3', NULL, NULL, '6221032320469', NULL, 919, '2024-12-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Gentamicin is a bactericidal aminoglycoside that was discovered and isolated from _Micromonospora purpurea_ in 1963.[A234349] It is one of the most frequently prescribed aminoglycosides due to its spectrum of activity, low cost, and availability.[A234339,A234354] Gentamicin is effective against both gram-positive and gram-negative organisms but is particularly useful for the treatment of severe gram-negative infections including those caused by _Pseudomonas aeruginosa_.[A233325,A234359,A234364] There is the added benefit of synergy when gentamicin is co-administered with other antibacterials such as beta-lactams.[A234364] This synergistic activity is not only important for the treatment of complex infections, but can also contribute to dose optimization and reduced adverse effects.[A234359,A234364]

Although gentamicin is well-established and may be used in a variety of clinical applications, it is also associated with severe adverse effects including nephrotoxicity and ototoxicity which may limit its use.[A234369]', '["S01AA11", "S02AA14", "D06AX07", "S03AA06", "J01GB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18417, 'epigent 80mg/2ml i.m./i.v. 3 amps.', 'ابيجينت 80مجم/2مل 3 امبولات', '54', '15', 'Aminoglycoside antibiotic', 'gentamicin', 'eipico', 'ampoule', 'أمبول', '80mg', '3', NULL, 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', '6221032320506', NULL, 1685, '2025-12-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Gentamicin is a bactericidal aminoglycoside that was discovered and isolated from _Micromonospora purpurea_ in 1963.[A234349] It is one of the most frequently prescribed aminoglycosides due to its spectrum of activity, low cost, and availability.[A234339,A234354] Gentamicin is effective against both gram-positive and gram-negative organisms but is particularly useful for the treatment of severe gram-negative infections including those caused by _Pseudomonas aeruginosa_.[A233325,A234359,A234364] There is the added benefit of synergy when gentamicin is co-administered with other antibacterials such as beta-lactams.[A234364] This synergistic activity is not only important for the treatment of complex infections, but can also contribute to dose optimization and reduced adverse effects.[A234359,A234364]

Although gentamicin is well-established and may be used in a variety of clinical applications, it is also associated with severe adverse effects including nephrotoxicity and ototoxicity which may limit its use.[A234369]', '["S01AA11", "S02AA14", "D06AX07", "S03AA06", "J01GB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18418, 'Epigonal 75 i.u. 1 amp.', 'ابيجونال 75 وحدة دولية 1 امبول', '286', '200', 'Infertility drugs.human menopausal gonadotrophin', 'Human menopausal gonadotrophin (fsh+lh)', 'Eipico', 'Amp', 'أمبول', NULL, '1', 'يساعد في حالات تأخر الانجاب في الرجال والسيدات -- يساعد علي انتاج الحيوانات المنوية -- تحفيز انتاج البويضات', 'description menotropins contains follicle stimulating hormone (fsh) and luteinizing hormone (lh) purified from the urine of postmenopausal women. it is used as a fertility medication that is injected either subcutaneously or intramuscularl mechanism of ac', '6221032323002', NULL, 16898, '2024-07-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'G03GA02', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18419, 'Epikavit 10mg 10 chew. tabs.', 'ابيكافيت 10 مجم 10 اقراص', '5', NULL, 'Vitamin k', 'Vitamin k1', 'Eipico', 'Tab', 'أقراص', '10mg', '1', NULL, 'about vitamin k fat soluble vitamin antihemorrhagic. mechanism of action of vitamin k phytonadione (vitamin k1) is a synthetic form of vitamin k and is lipid soluble. vitamin k acts as a cofactor in the synthesis of coagulation proteins; prothrombin facto', NULL, NULL, 790, '2022-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18421, 'Aaa', 'ششش', '7', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 640, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18422, 'Aaa', 'ششش', '4', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 638, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18423, 'Aaa', 'ششش', '6', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 618, '2022-10-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18425, 'Epilog 250mg/5ml 10 amp. for i.v. inj.', 'ابيلوج 250 مجم / 5 مل 10 امبول', '50', '30', 'Anti-epileptic.hydantoin', 'Phenytoin', 'Mup', 'Inj', 'حقن', '250mg', '10', 'يستخدم في علاج الصرع حيث يعمل العلاج على إبطاء السيالات العصبية و منع تكون نوبات الصرع أو السيطرة عليها', 'about phenytoin hydantoin derivative anticonvulsant class ib antiarrhythmic agent. mechanism of action of phenytoin phenytoin acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizure discharge. it prolongs the inac', NULL, NULL, 1708, '2024-12-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Phenytoin is classified as a hydantoin derivative and despite its narrow therapeutic index, it is one of the most commonly used anticonvulsants.[A33595,A188832,A189219] Since it''s introduction about 80 years ago, phenytoin has not only been established as an effective anti-epileptic, but has also been investigated for several other indications such as bipolar disorder, retina protection, and wound healing.[A188826,A188832]

Clinicians are advised to initiate therapeutic drug monitoring in patients who require phenytoin since even small deviations from the recommended therapeutic range can lead to suboptimal treatment, or adverse effects.[A189219,A35884] Both parenteral and oral formulations of phenytoin are available on the market.[A189219]', '["N03AB02", "N03AB52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18427, 'Epimate 100mg 10 caps.', 'ابيمات 100مجم 10 كبسولات', '14', NULL, 'Anti-epileptic.fructose derivative', 'Topiramate', 'Sedico', 'Cap', 'كبسولة', '100mg', '1', 'علاج التشنجات.', 'about topiramate a sulfamate-substituted monosaccharide carbonic anhydrase inhibitor anticonvulsant antimigraine. mechanism of action of topiramate topiramate acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizur', NULL, NULL, 879, '2022-05-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines.[A175249] It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults.[A188309,L10544,L43478] Since 2012, the extended-release formulation has been approved in combination with [phentermine] for chronic weight management therapy in adults.[L10550] 

Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen.[A175249] Interestingly, topiramate was discovered by chance when attempts were made to formulate a novel antidiabetic drug.[A188330]', '["N03AX11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18428, 'Epimate 200 mg 10 caps.', 'ابيمات 200 مجم 10 كبسولات', '24', NULL, 'Anti-epileptic.fructose derivative', 'Topiramate', 'Sedico', 'Cap', 'كبسولة', '200 mg', '1', NULL, 'about topiramate a sulfamate-substituted monosaccharide carbonic anhydrase inhibitor anticonvulsant antimigraine. mechanism of action of topiramate topiramate acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizur', NULL, NULL, 766, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines.[A175249] It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults.[A188309,L10544,L43478] Since 2012, the extended-release formulation has been approved in combination with [phentermine] for chronic weight management therapy in adults.[L10550] 

Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen.[A175249] Interestingly, topiramate was discovered by chance when attempts were made to formulate a novel antidiabetic drug.[A188330]', '["N03AX11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18429, 'Epimate 25 mg 10 caps.', 'ابيمات 25 مجم 10 كبسولات', '10', NULL, 'Anti-epileptic.fructose derivative', 'Topiramate', 'Sedico', 'Cap', 'كبسولة', '25 mg', '1', NULL, 'about topiramate a sulfamate-substituted monosaccharide carbonic anhydrase inhibitor anticonvulsant antimigraine. mechanism of action of topiramate topiramate acts on the motor cortex where it stabilizes neuronal membrane and inhibits the spread of seizur', NULL, NULL, 886, '2022-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines.[A175249] It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults.[A188309,L10544,L43478] Since 2012, the extended-release formulation has been approved in combination with [phentermine] for chronic weight management therapy in adults.[L10550] 

Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen.[A175249] Interestingly, topiramate was discovered by chance when attempts were made to formulate a novel antidiabetic drug.[A188330]', '["N03AX11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18430, 'Aaa', 'ششش', '6', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 678, '2022-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18431, 'Epimazepine cr 200 mg 10 controlled release f.c. tabs.', 'ابيمازيبين سي ار 200 مجم 10 اقراص', '6', NULL, 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Eipico', 'Tab', 'أقراص', '200 mg', '1', 'علاج حالات الصرع مثل بعض حالات نوبات الصرع الجزئية الصرع الكبير.اضطراب النوبة.الصرع الذي يظهر فيه أكتر من نوع واحد من أنواع النوبات.', 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', NULL, NULL, 3183, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Carbamazepine, also known as Tegretol, is an anticonvulsant drug and analgesic drug used to control seizures and to treat pain resulting from trigeminal neuralgia. It was initially approved by the FDA in 1965.[A180301] Aside from the above uses, this drug is also given to control the symptoms of bipolar 1.[L1335] Interestingly, carbamazepine was the first anticonvulsant used to treat individuals with bipolar disorder.[A180319]', '["N03AF01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18432, 'Epimazepine cr 400 mg 10 controlled release f.c. tabs.', 'ابيمازيبين سي ار 400 مجم 10 اقراص', '10', NULL, 'Anti-epileptic.carboxamides', 'Carbamazepine', 'Eipico', 'Tab', 'أقراص', '400 mg', '1', NULL, 'about carbamazepine tricyclic anticonvulsant iminostilbene derivative anticonvulsant in trigeminal neuralgia. mechanism of action of carbamazepine carbamazepine prolongs the inactivated state of voltage sensitive neuronal sodium ion channel either by incr', NULL, NULL, 1097, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Carbamazepine, also known as Tegretol, is an anticonvulsant drug and analgesic drug used to control seizures and to treat pain resulting from trigeminal neuralgia. It was initially approved by the FDA in 1965.[A180301] Aside from the above uses, this drug is also given to control the symptoms of bipolar 1.[L1335] Interestingly, carbamazepine was the first anticonvulsant used to treat individuals with bipolar disorder.[A180319]', '["N03AF01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18433, 'Epimiraflu 75 mg 10 caps.', 'ابيميرافلو 75مجم 10 كبسولات', '202', '140', 'Anti-viral.release phase', 'Oseltamivir', 'Eipico', 'Cap', 'كبسولة', '75 mg', '1', 'مضاد للفيروسات', 'about oseltamivir antiviral neuraminidase inhibitor mechanism of action of oseltamivir oseltamivir is an ethyl ester prodrug requiring ester hydrolysis for conversion to active form oseltamivir carboxylate. oseltamivir is a neuraminidase inhibitor serving', '6221032131775', NULL, 6831, '2025-11-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Oseltamivir (marketed as the product TamifluⓇ), is an antiviral neuraminidase inhibitor used for the treatment and prophylaxis of infection with influenza viruses A (including pandemic H1N1) and B. Oseltamivir exerts its antiviral activity by inhibiting the activity of the viral neuraminidase enzyme found on the surface of the virus, which prevents budding from the host cell, viral replication, and infectivity.

The clinical benefit of use of oseltamivir is greatest when administered within 48 hours of the onset of influenza symptoms since effectiveness decreases significantly after that point in time; there is generally no benefit in use beyond 48 hours for healthy, low-risk individuals as influenza is a self-limiting illness.[A180574, L7267, A180580] However, antiviral treatment might be beneficial when initiated after 48 hours for patients with severe, complicated or progressive illness or for hospitalized patients.[A180583] According to the CDC, data from clinical trials and observational studies have demonstrated that early antiviral treatment can shorten the duration of fever and illness symptoms, and may reduce the risk of some complications (including pneumonia and respiratory failure). They recommend the use of oseltamivir in people with a higher risk of developing complications including children younger than 2 years, people over 65 years, people with some chronic conditions or immunosuppression, pregnant women, residents of long term care facilities, and indigenous communities for example.[L7264]

The benefits of oseltamivir use are controversial; a 2014 Cochrane Review of the evidence found that oseltamivir treatment had limited benefit. The authors concluded that oseltamivir use in healthy adults had small, non-specific effects on symptoms (where the time to first alleviation of symptoms was only reduced from 7 to 6.3 days), it had no effect on hospitalizations, and that there was no evidence for any reductions in complications of influenza such as pneumonia.[A179962, A179965, A179968] Due to the risk of adverse effects such as nausea, vomiting, psychiatric effects and renal adverse events in adults and vomiting in children, the harms are generally considered to outweigh the small clinical benefit of use of oseltamivir. 

Notably, in 2017, the World Health Organization downgraded oseltamivir from its essential medicines list from a "core" drug to a "complementary" drug, due to limited cost-effectiveness.[A179086] Yearly vaccination with the influenza vaccine is still considered the best preventative measure.', '["J05AH02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18434, 'Aaa', 'ششش', '88', '67', NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 853, '2023-08-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18435, 'Epinephrine-memphis 1 mg/ml 5 i.m./s.c. amp.', 'ابينفرين ممفيس 1مجم /مل 5 امبولات', '10', NULL, 'Alpha and beta adrenergic agonist', 'Adrenaline', 'Memphis', 'Amp', 'أمبول', '1 mg', '5', 'علاج حالات الحساسية المفرطة', 'about adrenaline alpha and beta adrenergic agonist catecholamine vasoconstrictor. anti asthma inanaphylatic shock. mechanism of action of adrenaline adrenaline is an alpha and beta adrenergic agonist which exerts it`s therapeutic actions through predomina', NULL, NULL, 1228, '2023-05-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18436, 'Epinephrine-misr 1 mg/ml 100 amp.', 'ابينفرين - مصر 1مجم/مل 100 امبولة', '750', '600', 'Alpha and beta adrenergic agonist', 'Adrenaline', 'Misr', 'Amp', 'أمبول', '1 mg', '100', NULL, 'about adrenaline alpha and beta adrenergic agonist catecholamine vasoconstrictor. anti asthma inanaphylatic shock. mechanism of action of adrenaline adrenaline is an alpha and beta adrenergic agonist which exerts it`s therapeutic actions through predomina', NULL, NULL, 1484, '2024-12-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18438, 'Epinos fruit 6 eff. salt sachet', 'ايبينوس فواكه 6 اكياس فوار', '4', NULL, 'Antacid', 'Citric acid+sodium bicarbonte+tartaric acid', 'Eipico', 'Sachet', 'أكياس', NULL, '1', NULL, 'interactions: antacids concurrent use of antacids with citrates may result in systemic alkalosis. concomitant administration of antacids with sodium citrate and sodium bicarbonate may promote the development of calcium stones in patients with uric acid st', NULL, NULL, 1010, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18439, 'Epinos pineapple 6 eff. salt 6sachet', 'ابينوس اناناس 6 اكياس فوار', '4', NULL, 'Antacid', 'Citric acid+sodium bicarbonte+tartaric acid', 'Eipico', 'Sachet', 'أكياس', NULL, '1', NULL, 'interactions: antacids concurrent use of antacids with citrates may result in systemic alkalosis. concomitant administration of antacids with sodium citrate and sodium bicarbonate may promote the development of calcium stones in patients with uric acid st', NULL, NULL, 808, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18440, 'Epinos pineapple 60 eff. salt sachet', 'ابينوس اناناس 60 اكياس فوار', '18', NULL, 'Antacid', 'Citric acid+sodium bicarbonte+tartaric acid', 'Eipico', 'Sachet', 'أكياس', NULL, '1', NULL, 'interactions: antacids concurrent use of antacids with citrates may result in systemic alkalosis. concomitant administration of antacids with sodium citrate and sodium bicarbonate may promote the development of calcium stones in patients with uric acid st', NULL, NULL, 1066, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18442, 'Epiphenicol 1% eye oint. 5 gm', 'ابيفينيكول 1% مرهم للعين 5 جم', '7', NULL, 'Antibiotic', 'Chloramphenicol', 'Eipico', 'Oint', 'مرهم', '1%', '1', NULL, 'description an antibiotic first isolated from cultures of streptomyces venequelae in 1947 but now produced synthetically. it has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. it acts by interfering with bacter', NULL, NULL, 919, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An antibiotic first isolated from cultures of _Streptomyces venequelae_ in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)

The FDA has withdrawn all oral drug products containing chloramphenicol, due to the high risk of fatal aplastic anemia associated with this specific route of administration.[L43942,L44022]', '["D06AX02", "S02AA01", "D10AF03", "S01AA01", "G01AA05", "J01BA01", "S03AA08"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18443, 'Epiquantel 600mg 4 f.c. tabs.', 'ابيكوانتيل 600 مجم 4 اقراص', '32', '16.5', 'Anthelmintic', 'Praziquantel', 'Eipico', 'Tab', 'أقراص', '600mg', '1', NULL, 'about praziquantel anthelmintic a trematodicide. mechanism of action of praziquantel it is a broad spectrum anthelminthic against trematodes & cestodes and their larval forms. the drug exerts its action by producing strong muscular contractions which lead', '6221032115683', NULL, 1799, '2025-04-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An anthelmintic used in most schistosome and many cestode infestations.', '["P02BA01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18444, 'Carla extra 30 tabs.', 'كارلا اكسترا 30 قرص', '125', '98', 'Calcium', 'Calcium+magnesum+vitamin d3+zinc', 'Pharmazad>renovo', 'Tab', 'أقراص', NULL, '1', 'مكمل غذائى لدعم النمو الطبيعى للعظام والوقاية من الكساح وهشاشة العظام وتخفيف الشد العضلى', NULL, '795697032808', NULL, 4431, '2025-06-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18445, 'Update body oil 60 ml', 'ابديت زيت للجسم 60 مل', '225', '80', NULL, 'Bergamot oil', 'Abs pharma', 'Oil', 'زيت', '60 ml', '1', NULL, NULL, NULL, NULL, 3441, '2024-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18447, 'Aaa', 'ششش', '44', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 805, '2022-10-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18448, 'Epirelefan 40mg/ml i.m amp.', 'ابيريليفان 40مجم فيال', '38', '26', 'Anti-inflammatory.glucocorticoid.', 'Triamcinolone acetonide', 'Eipico', 'Amp', 'أمبول', '40mg', '1', 'مضاد للالتهابات ومخفف للالام', 'about triamcinolone acetonide a synthetic glucocorticoid topical anti-inflammatory(steroidal). mechanism of action of triamcinolone acetonide the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and causes', '6221032318305', NULL, 6447, '2024-09-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18449, 'Aaa', 'ششش', '16', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 725, '2022-10-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18450, 'Dexamethasone-inad 8mg/2ml 3amp', 'ديكساميثازون ايناد 8مجم/2مل 3 امبولات', '36', '22.5', NULL, 'Dexamethasone phosphate', 'Inad pharma', 'Amp', 'أمبول', '8mg', '3', NULL, NULL, NULL, NULL, 1940, '2024-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Developed in 1957, it is structurally similar to other corticosteroids like [hydrocortisone] and [prednisolone].[A188724]

Dexamethasone was granted FDA approval on 30 October 1958.[L10695] In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.[L14318]', '["R01AD53", "D07XB05", "R01AD03", "D10AA03", "S01CB01", "S02CA06", "S03CA01", "C05AA09", "S01CA01", "D07CB04", "H02AB02", "S01BA01", "A01AC02", "S03BA01", "D07AB19", "S02BA06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18451, 'Epirovastin 10 mg 14 scored f.c. tab', 'ابيروفاستين 10مجم 14 قرص', '56', '21', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Eipico', 'Tab', 'أقراص', '10 mg', '2', 'دواء خافض لدهون الدم والكوليسترول الضار', 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', '6221032119896', NULL, 3787, '2024-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America.[A181087, A181406]

Rosuvastatin and other drugs from the statin class of medications including [atorvastatin], [pravastatin], [simvastatin], [fluvastatin], and [lovastatin] are considered first-line options for the treatment of dyslipidemia.[A181087, A181406] This is largely due to the fact that cardiovascular disease (CVD), which includes heart attack, atherosclerosis, angina, peripheral artery disease, and stroke, has become a leading cause of death in high-income countries and a major cause of morbidity around the world.[A181084] Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087,A181553] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475,A181538] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]

While all statin medications are considered equally effective from a clinical standpoint, rosuvastatin is considered the most potent; doses of 10 to 40mg rosuvastatin per day were found in clinical studies to result in a 45.8% to 54.6% decreases in LDL cholesterol levels, which is about three-fold more potent than [atorvastatin]''s effects on LDL cholesterol.[A181409,A1793] However, the results of the SATURN trial[A181427] concluded that despite this difference in potency, there was no difference in their effect on the progression of coronary atherosclerosis.

Rosuvastatin is also a unique member of the class of statins due to its high hydrophilicity which increases hepatic uptake at the site of action, low bioavailability, and minimal metabolism via the Cytochrome P450 system.[A181523] This last point results in less risk of drug-drug interactions compared to [atorvastatin], [lovastatin], and [simvastatin], which are all extensively metabolized by Cytochrome P450 (CYP) 3A4, an enzyme involved in the metabolism of many commonly used drugs.[A181460] Drugs such as [ciclosporin], [gemfibrozil], and some antiretrovirals are more likely to interact with this statin through antagonism of OATP1B1 organic anion transporter protein 1B1-mediated hepatic uptake of rosuvastatin.[F4649, F4652]', '["C10BX10", "C10BX05", "C10BX07", "C10AA07", "A10BH52", "G01AE10", "C10BX13", "C10BX09", "C10BA09", "C10BX16", "C10BX17", "C10BX14", "C10BA06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18452, 'Epirovastin 20 mg 14 f.c. tab', 'ابيروفاستين 20مجم 14 قرص', '76', '28.5', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Eipico', 'Tab', 'أقراص', '20 mg', '2', 'دواء خافض لدهون الدم', 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', '6221032107664', NULL, 3556, '2024-11-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America.[A181087, A181406]

Rosuvastatin and other drugs from the statin class of medications including [atorvastatin], [pravastatin], [simvastatin], [fluvastatin], and [lovastatin] are considered first-line options for the treatment of dyslipidemia.[A181087, A181406] This is largely due to the fact that cardiovascular disease (CVD), which includes heart attack, atherosclerosis, angina, peripheral artery disease, and stroke, has become a leading cause of death in high-income countries and a major cause of morbidity around the world.[A181084] Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087,A181553] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475,A181538] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]

While all statin medications are considered equally effective from a clinical standpoint, rosuvastatin is considered the most potent; doses of 10 to 40mg rosuvastatin per day were found in clinical studies to result in a 45.8% to 54.6% decreases in LDL cholesterol levels, which is about three-fold more potent than [atorvastatin]''s effects on LDL cholesterol.[A181409,A1793] However, the results of the SATURN trial[A181427] concluded that despite this difference in potency, there was no difference in their effect on the progression of coronary atherosclerosis.

Rosuvastatin is also a unique member of the class of statins due to its high hydrophilicity which increases hepatic uptake at the site of action, low bioavailability, and minimal metabolism via the Cytochrome P450 system.[A181523] This last point results in less risk of drug-drug interactions compared to [atorvastatin], [lovastatin], and [simvastatin], which are all extensively metabolized by Cytochrome P450 (CYP) 3A4, an enzyme involved in the metabolism of many commonly used drugs.[A181460] Drugs such as [ciclosporin], [gemfibrozil], and some antiretrovirals are more likely to interact with this statin through antagonism of OATP1B1 organic anion transporter protein 1B1-mediated hepatic uptake of rosuvastatin.[F4649, F4652]', '["C10BX10", "C10BX05", "C10BX07", "C10AA07", "A10BH52", "G01AE10", "C10BX13", "C10BX09", "C10BA09", "C10BX16", "C10BX17", "C10BX14", "C10BA06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18453, 'Aaa', 'ششش', '80', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 711, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18454, 'Epirubicin (ebewe) 50mg/25ml vial', 'ايبريوبسين ابيوي 50مجم/25مل مل فيال', '740', '300', 'Antineoplastic', 'Epirubicin', 'Sandoz > b.p pharma', 'Vial', 'فيال', '50mg', '1', NULL, 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', NULL, NULL, 792, '2025-01-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18455, 'Epirubicin (ebewe) 10mg/5ml vial', 'ابيوريسين 2مجم/مل 10مجم فيال', '221', '80', 'Antineoplastic', 'Epirubicin', 'Sandoz > b.p pharma', 'Vial', 'فيال', '10mg', '1', NULL, 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', NULL, NULL, 813, '2025-01-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18457, 'Epirubicin mylan 100mg/50ml vial i.v. inf.', 'ايبريوبسين ميلان 100مجم/50مل مل فيال', '643', NULL, 'Antineoplastic', 'Epirubicin', 'Mylan s.a.s-france > ramco', 'Vial', 'فيال', '100mg', '1', NULL, 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', NULL, NULL, 830, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18458, 'Epirubicin mylan 10mg/5ml vial i.v. inf.', 'ايبريوبسين ميلان 10مجم/5مل مل فيال', '85', NULL, 'Antineoplastic', 'Epirubicin', 'Mylan s.a.s-france > ramco', 'Vial', 'فيال', '10mg', '1', NULL, 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', NULL, NULL, 860, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18459, 'Epirubicin mylan 200mg/100ml vial i.v. inf.', 'ايبريوبسين ميلان 200مجم/100مل مل فيال', '1,260', NULL, 'Antineoplastic', 'Epirubicin', 'Mylan s.a.s-france > ramco', 'Vial', 'فيال', '200mg', '1', NULL, 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', NULL, NULL, 850, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18460, 'Aaa', 'ششش', '378', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 712, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18462, 'Episovir 400mg 28 f.c. tablets', 'ابيسوفير 400 مجم 28 قرص', '900', NULL, 'Antiviral', 'Sofosbuvir', 'Eipico', 'Tablet', 'أقراص', '400mg', '4', NULL, 'indications and usage: it is a hepatitis c virus (hcv) nucleotide analog ns5b polymerase inhibitor indicated for the treatment of chronic hepatitis c (chc) infection as a component of a combination antiviral treatment regimen. *efficacy has been establish', NULL, NULL, 744, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Sofosbuvir (tradename Sovaldi) is a direct acting antiviral medication used as part of combination therapy to treat chronic Hepatitis C, an infectious liver disease caused by infection with Hepatitis C Virus (HCV). HCV is a single-stranded RNA virus that is categorized into nine distinct genotypes, with genotype 1 being the most common in the United States, and affecting 72% of all chronic HCV patients [L852]. Treatment options for chronic Hepatitis C have advanced significantly since 2011, with the development of Direct Acting Antivirals (DAAs) such as sofosbuvir. As a prodrug nucleotide analog, Sofosbuvir is metabolized into its active form as the antiviral agent 2''-deoxy-2''-α-fluoro-β-C-methyluridine-5''-triphosphate (also known as GS-461203), which acts as a defective substrate for NS5B (non-structural protein 5B) [synthesis]. NS5B, an RNA-dependent RNA polymerase, is essential for the transcription of Hepatitis C viral RNA and for its high replicative rate and genetic diversity [A19594]. Sofosbuvir and other direct acting antivirals are therefore very potent options for the treatment of Hepatitis C, as they exhibit a high barrier to the development of resistance [A19593]. This is an important advantage relative to HCV drugs that target other viral enzymes such as the protease, for which rapid development of resistance has proven to be an important cause of therapeutic failure.  

In a joint recommendation published in 2016, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) recommend Sofosbuvir as first line therapy in combination with other antivirals for all six genotypes of Hepatitis C [L852]. Depending on the genotype, sofosbuvir is often used in combination with other antivirals such as [DB09027], [DB11613], [DB09102], [DB06290], [DB11574], [DB11575], [DB00811], [DB00008], or [DB00022] with the intent to cure, or achieve a sustained virologic response (SVR), after 12 weeks of daily therapy. SVR and eradication of HCV infection is associated with significant long-term health benefits including reduced liver-related damage, improved quality of life, reduced incidence of Hepatocellular Carcinoma, and reduced all-cause mortality [A19626]. Treatment with direct acting antivirals such as sofosbuvir is associated with very minimal side effects, with the most common being headache and fatigue [FDA Label]. Lack of significant side effects and short duration of therapy is a considerable advantage over older interferon- and ribavirin-based regimens, which were limited by infusion site reactions, reduced blood count, and neuropsychiatric effects [A19635]. 

Since 2014, sofosbuvir has been available as a fixed dose combination product with [DB09027] (tradename Harvoni) used for the treatment of chronic Hepatitis C. Approved in October 2014 by the FDA, Harvoni is indicated for the treatment of HCV genotypes 1, 4, 5, and 6 with or without [DB00811] depending on the level of liver damage or cirrhosis [FDA Label].  When combined together, ledipasvir and sofosbuvir as the combination product Harvoni has been shown to achieve a SVR between 93 and 99% after 12 weeks of treatment [A7535]. Its use has also proven successful in the treatment of HCV in patients co-infected with HIV [A19627].

Sofosbuvir is also available as a fixed dose combination product with [DB11613] as the commercially available product Epclusa. First approved in June 2016, Epclusa is the first combination HCV product indicated for the treatment of all genotypes of Hepatitis C with or without cirrhosis. Epclusa is also currently the most potent HCV antiviral medication on the market with a sustained virologic response (SVR) after 12 weeks of therapy of 93-99% depending on genotype and level of cirrhosis [L852]. Both Canadian and American guidelines list Epclusa as a first line recommendation for all genotypes of HCV [L852, A19626].

Notably, sofosbuvir has come under intense scrutiny since its release to market in 2013. With the price per pill set at $1000, a 12-week treatment can cost upwards of $84,000 per patient [A19636].', '["J05AP08", "J05AP51", "J05AP55", "J05AP56"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18463, 'Aaa', 'ششش', '10', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 762, '2022-05-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18464, 'Epistigmin 2.5mg/ml vial', 'ابيستجمين 2.5مجم/مل فيال', '42', '18', 'Para-sympathomimetic', 'Neostigmine', 'Eipico', 'Vial', 'فيال', '2.5mg', '1', 'علاج الوهن العضلي', NULL, '6221032316615', NULL, 1076, '2024-11-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier.', '["N07AA01", "S01EB06", "N07AA51"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18465, 'Epitaxol 0.5% eye drops 5 ml', 'ابيتاكسول 0.5% قطرة 5 مل', '19', '13.2', 'Antihypertensive.beta blocker.selective b1', 'Betaxolol', 'Eipico', 'Drops', 'نقط', '0.5%', '1', NULL, 'about betaxolol cardioselective beta 1-adrenergic blocker anti glaucoma antihypertensive. mechanism of action of betaxolol betaxolol is a selective beta 1 (? 1) blocker. it inhibits the beta receptors present in the eye such as in the ciliary body epithel', '6221032331908', NULL, 1025, '2025-05-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A cardioselective beta-1-adrenergic antagonist with no partial agonist activity.', '["S01ED02", "C07AB05", "S01ED52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18466, 'Epitens 30 tab.', 'ابيتينس 30 قرص', '7', NULL, 'Antihypertensive', 'Triamterene+xipamide', 'Eipico', 'Tab', 'أقراص', NULL, '3', 'علاج ارتفاع ضغط الدم', NULL, '6221032112446', NULL, 1357, '2023-01-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'C03BA10', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18468, 'Epival 10 mg 20 tabs.', 'ابيفال 10 مجم 20 قرص', '11', NULL, 'Anti-epileptic.benzodiazepines', 'Diazepam', 'Eipico', 'Tab', 'أقراص', '10 mg', '2', NULL, 'about diazepam a benzodiazepine derivative with cns depressant anxiolytic anticonvulsant hypnotic sedative skeletal muscle relaxant and amnestic. mechanism of action of diazepam diazepam mainly acts on limbic system and ascending reticular formation in th', NULL, NULL, 819, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589)

Given diazepam''s storied history as a commonly used and effective medication for a variety of indications, contemporary advancements in the formulation and administration of the agent include the development and US FDA approval of an auto-injectable formulation for the rapid treatment of uncontrolled seizures in 2015-2016 [L5200]. Combining diazepam, a proven effective therapy for acute repetitive seizures, with an auto-injector designed for subcutaneous administration that is quickly and easily administered offers the potential for complete, consistent drug absorption and rapid onset of effect [L5200]. This current development is subsequently an important addition to the rescue therapy tool chest for patients with epilepsy [L5200].', '["N05BA01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18469, 'Epival 10mg/2ml 3 amp.', 'ابيفال 10 مجم /2مل 3 امبولات', '15', '5', 'Anti-epileptic.benzodiazepines', 'Diazepam', 'Eipico', 'Amp', 'أمبول', '10mg', '6', 'علاج حالات الصرع -- تقليل للتشنجات المصاحبة للصرع', 'about diazepam a benzodiazepine derivative with cns depressant anxiolytic anticonvulsant hypnotic sedative skeletal muscle relaxant and amnestic. mechanism of action of diazepam diazepam mainly acts on limbic system and ascending reticular formation in th', NULL, NULL, 1279, '2024-11-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of gamma-aminobutyric acid activity. It is used in the treatment of severe anxiety disorders, as a hypnotic in the short-term management of insomnia, as a sedative and premedicant, as an anticonvulsant, and in the management of alcohol withdrawal syndrome. (From Martindale, The Extra Pharmacopoeia, 30th ed, p589)

Given diazepam''s storied history as a commonly used and effective medication for a variety of indications, contemporary advancements in the formulation and administration of the agent include the development and US FDA approval of an auto-injectable formulation for the rapid treatment of uncontrolled seizures in 2015-2016 [L5200]. Combining diazepam, a proven effective therapy for acute repetitive seizures, with an auto-injector designed for subcutaneous administration that is quickly and easily administered offers the potential for complete, consistent drug absorption and rapid onset of effect [L5200]. This current development is subsequently an important addition to the rescue therapy tool chest for patients with epilepsy [L5200].', '["N05BA01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18470, 'Epivel cream 80 gm', 'ابيفيل كريم 80 جم', '80', NULL, 'Moisturizing topicals', 'Shea butter+jojoba oil+wheat germ oil+aloe vera+carrot seed oil+castor seed oil+apricot oil+xanthan gum', 'Nikim co. > al watania co. herbs-food-cosmetics', 'Cream', 'كريم', '80 gm', '1', 'كريم مرطب', 'emollient cream', NULL, NULL, 1375, '2022-05-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18471, 'Epizin 10mg vial for i.v. inj./inf.', 'ابيزين 10 مجم فيال', '75', NULL, 'Antineoplastic', 'Epirubicin', 'Korea united pharma > eimc', 'Inj', 'حقن', '10mg', '1', NULL, 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', NULL, NULL, 794, '2022-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18472, 'Epizin 50mg vial for i.v. inf.', 'ابيزين 50 مجم فيال وريد', '300', NULL, 'Antineoplastic', 'Epirubicin', 'Korea united pharma > eimc', 'Vial', 'فيال', '50mg', '1', NULL, 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', NULL, NULL, 743, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18473, 'Epizithro 200mg/5ml 15ml susp.', 'ابيزيثرو 200 مجم/5 مل 15 مل', '47', '32.5', 'Antibiotic.macrolide', 'Azithromycin', 'Eipico', 'Susp', 'معلق', '200mg', '1', 'مضاد حيوى واسع المدى يستخدم فى علاج العديد من الالتهابات', 'description: azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. dose: adult: po- respiratory tract skin and soft tissue infections- 500 mg once daily for 3 days. or 500mg on day 1 followed by 250mg on days 2 to 5. typhoid- 500 mg', '6221032162014', NULL, 1178, '2025-04-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration [A174172]. It was initially approved by the FDA in 1991 [A174175].

It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. It is structurally related to erythromycin [A174169].

Azithromycin [9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin] is a part of the _azalide_ subclass of macrolides, and contains a 15-membered ring, with a methyl-substituted nitrogen instead of a carbonyl group at the 9a position on the aglycone ring, which allows for the prevention of its metabolism. This differentiates azithromycin from other types of macrolides [A174175].

In March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 with a combination of azithromycin and the anti-malaria drug [hydroxychloroquine]. The results were positive, all patients taking the combination were virologically cured within 6 days of treatment, however, larger studies are required.[A192546]', '["J01RA07", "S01AA26", "J01FA10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18474, 'Epizithro 200mg/5ml 30ml susp.', 'ابيزيثرو 200 مجم/5 مل 30 مل', '68', '47.5', 'Antibiotic.macrolide', 'Azithromycin', 'Eipico', 'Susp', 'معلق', '200mg', '1', 'مضاد حيوى واسع المدى يستخدم لعلاج العديد من الالتهابات', 'description: azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. dose: adult: po- respiratory tract skin and soft tissue infections- 500 mg once daily for 3 days. or 500mg on day 1 followed by 250mg on days 2 to 5. typhoid- 500 mg', '6221032162007', NULL, 4131, '2025-04-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration [A174172]. It was initially approved by the FDA in 1991 [A174175].

It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. It is structurally related to erythromycin [A174169].

Azithromycin [9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin] is a part of the _azalide_ subclass of macrolides, and contains a 15-membered ring, with a methyl-substituted nitrogen instead of a carbonyl group at the 9a position on the aglycone ring, which allows for the prevention of its metabolism. This differentiates azithromycin from other types of macrolides [A174175].

In March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 with a combination of azithromycin and the anti-malaria drug [hydroxychloroquine]. The results were positive, all patients taking the combination were virologically cured within 6 days of treatment, however, larger studies are required.[A192546]', '["J01RA07", "S01AA26", "J01FA10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18475, 'Epizithro 500 mg 3 caps.', 'ابيزيثرو 500 مجم 3 كبسولات', '62', '43.5', 'Antibiotic.macrolide', 'Azithromycin', 'Eipico', 'Cap', 'كبسولة', '500 mg', '1', 'مضاد حيوي', 'description: azithromycin is a semi-synthetic macrolide antibiotic of the azalide class. dose: adult: po- respiratory tract skin and soft tissue infections- 500 mg once daily for 3 days. or 500mg on day 1 followed by 250mg on days 2 to 5. typhoid- 500 mg', '6221032137876', NULL, 11780, '2025-07-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and a high degree of tissue penetration [A174172]. It was initially approved by the FDA in 1991 [A174175].

It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used instead of other macrolides for some sexually transmitted and enteric infections. It is structurally related to erythromycin [A174169].

Azithromycin [9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin] is a part of the _azalide_ subclass of macrolides, and contains a 15-membered ring, with a methyl-substituted nitrogen instead of a carbonyl group at the 9a position on the aglycone ring, which allows for the prevention of its metabolism. This differentiates azithromycin from other types of macrolides [A174175].

In March 2020, a small study was funded by the French government to investigate the treatment of COVID-19 with a combination of azithromycin and the anti-malaria drug [hydroxychloroquine]. The results were positive, all patients taking the combination were virologically cured within 6 days of treatment, however, larger studies are required.[A192546]', '["J01RA07", "S01AA26", "J01FA10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18476, 'Epizolone-depot 40mg/ml 1 ml i.m. vial', 'ابيزولون-ديبوت 40مجم/مل 1 مل فيال', '39', '27', 'Glucocorticoid', 'Methylprednisolone', 'Eipico', 'Vial', 'فيال', '40mg', '1', NULL, 'indication adjunctive therapy for short-term administration in rheumatoid arthritis. mechanism of action unbound glucocorticoids cross cell membranes and bind with high affinity to specific cytoplasmic receptors modifying transcription and protein synthes', '6221032311276', NULL, 2621, '2025-05-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Methylprednisolone is a [prednisolone] derivative glucocorticoid with higher potency than [prednisone].[A188811] It was first described in the literature in the late 1950s.[A188811,A188814]

Methylprednisolone was granted FDA approval on 24 October 1957.[L10785] In the outbreak of COVID-19, low dose methylprednisolone-based therapy was successful in treating COVID-19-associated pneumonia in one patient with long-term immunosuppression.[A192813] The efficacy of methylprednisolone in novel coronavirus pneumonia is being investigated further in clinical trials.[L12666]', '["D10AA02", "H02AB04", "H02BX01", "D07CA02", "S01CA08", "D07AA01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18477, 'Eplorefix 25 mg 7 f.c. tab', 'ايبلورفيكس 25مجم 7 اقراص', '22', NULL, 'Aldosterone receptor antagonist', 'Eplerenone', 'Hikma pharma', 'Tab', 'أقراص', '25 mg', '1', NULL, NULL, NULL, NULL, 846, '2022-06-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.', '["C03DA04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18478, 'Eplorefix 50mg 7 f.c. tab.', 'ايبلورفيكس 50مجم 7 قرص', '27', NULL, 'Aldosterone receptor antagonist', 'Eplerenone', 'Hikma pharma', 'Tab', 'أقراص', '50mg', '1', NULL, 'description eplerenone an aldosterone receptor antagonist similar to spironolactone has been shown to produce sustained increases in plasma renin and serum aldosterone consistent with inhibition of the negative regulatory feedback of aldosterone on renin', NULL, NULL, 1004, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.', '["C03DA04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18479, 'Epoetin sedico 2000 i.u./ml vial.', 'ايبوتين سيديكو 2000 وحدة دولية / مل فيال', '84', NULL, 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Sedico', 'Vial', 'فيال', NULL, '1', NULL, 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', NULL, NULL, 910, '2023-04-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18480, 'Epoetin sedico 4000 i.u./ml vial.', 'ايبوتين سيديكو 4000 وحدة دولية / مل فيال', '196', '149.5', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Sedico', 'Vial', 'فيال', NULL, '1', NULL, 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '6221042550016', NULL, 10780, '2024-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18481, 'Epoform 2000 i.u vial', 'ايبوفورم 2000 وحدة دولية فيال', '60', NULL, 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Eipico', 'Vial', 'فيال', NULL, '1', NULL, 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '6221032321183', NULL, 725, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18482, 'Egunaz d3 oral drops 10 ml', 'ايجوناز د3 نقط للفم 10 مل', '65', NULL, 'Dietary supplement', 'Vitamin d3', 'Core pharm', 'Drops', 'نقط', '10 ml', '1', NULL, NULL, NULL, NULL, 891, '2023-05-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18483, 'Epojet 10000 i.u./ml prefilled syringe', 'ايبوجيت 10000 وحدة دولية/مل سرنجة معبأة للحقن', '275', NULL, 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Vacsera > multipharma', 'Syringe', 'حقنة', NULL, '1', NULL, 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', NULL, NULL, 824, '2022-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18484, 'Epojet 2000 i.u./0.5ml prefilled syringe', 'ايبوجيت 2000وحدة دولية/0.5مل سرنجة معبأة للحقن', '60', NULL, 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Vacsera > multipharma', 'Syringe', 'حقنة', '0.5ml', '1', NULL, 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', NULL, NULL, 619, '2022-08-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18485, 'Azotec mix massage spray 200 ml', 'ازوتك مكس مساج سبراي 200 مل', '350', '290', 'Massage spray', 'Tocopherol (vit e)+laurocapram+menthol+eucalyptus globulus leaf (eucalyptus)+eugenia caryophyllus flower extract (clove)+allantoin+magnesium sulfate+(camphora oil)+panax ginseng root extract+persea gratissima oil (avocado oil)+butyrospermum parkii butter (shea butter)+glyceryl stearate+arctium lappa root extract+carbomer+phenoxyethanol+10-hydroxystearic acid+triethanolamine', 'Koncieve', 'Spray', 'بخاخ', '200 ml', '1', NULL, NULL, NULL, NULL, 1861, '2025-12-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18486, 'Eposin 20mg/ml vial', 'ايبوسين 20 مجم / مل فيال', '40', NULL, 'Antineoplastic', 'Etoposide', 'Pharmachemie-netherlands > copad pharma', 'Vial', 'فيال', '20mg', '1', NULL, 'about etoposide derivative of podophyllotoxin antineoplastic agent. mechanism of action of etoposide this semi synthetic derivative of podophyllotoxin arrests cells in g2 phase. it stabilizes the dna cleavage normally catalysed by topoisomerase 2 and inhi', NULL, NULL, 739, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.', '["L01CB01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18487, 'Eposino 2000 i.u./1ml prefilled syringe', 'ايبوسينو 2000 وحدة دولية / 1 مل حقنة', '60', NULL, 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Shandong kexing bioproducts co. > united pharma international-egypt', 'Syringe', 'حقنة', '1ml', '1', NULL, 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', NULL, NULL, 784, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18488, 'Eposino 4000 i.u./ml prefilled syringe', 'ايبوسينو 4000وحدة دولية/مل سرنجة معبأة للحقن', '175', '98', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Shandong kexing bioproducts co. > united pharma international-egypt', 'Syringe', 'حقنة', NULL, '1', 'علاج الانيميا', 'description human erythropoietin with 2 aa substitutions to enhance glycosylation (5 n-linked chains) 165 residues (mw=37 kd). produced in chinese hamster ovary (cho) cells by recombinant dna technology. indication for the treatment of anemia (from renal', '6923564236989', NULL, 6388, '2024-03-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18489, 'Aaa', 'ششش', '60', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 650, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18490, 'Epotin julphar 4000 i.u/1ml s.c/i.v. vial', 'ايبوتين جلفار 4000 وحدة دولية/مل فيال', '115', NULL, 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Julphar', 'Vial', 'فيال', '1ml', '1', NULL, NULL, '6221042550405', NULL, 1118, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18491, 'Aaa', 'ششش', '4,896', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 762, '2022-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18492, 'Vavra d3 10 000 iu 30 caps', 'فافرا دي 3 10000 وحدة دولية 30 كبسولة', '150', '126', 'vitamin d3', 'Cholecalciferol', 'Trendy for manufacturing specialised nutrition and dietary supplements', 'Cap', 'كبسولة', '000 iu', '3', NULL, NULL, NULL, NULL, 740, '2025-01-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight [L5689]. Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake [L5689]. Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 [L5689]. Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use [L5689].

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism [A223, L5689, L1782, L5771, F4027, F4042, F4048]. However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency [L5689].', '["M05BB09", "M05BX53", "M05BB07", "M05BB08", "A11CC55", "M05BB05", "A11CC05", "M05BB03", "M05BB04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18493, 'Eprex 3000 i.u./0.3ml 6 prefilled syringe', 'ايبريكس 3000 وحدة دولية/0.3مل 6 سرنجات معبأة', '1,470', NULL, 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Janssen cilag > soficopharm', 'Syringe', 'حقنة', '0.3ml', '6', NULL, NULL, NULL, NULL, 938, '2022-07-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18494, 'Eprex 4000 i.u./0.4ml 6 prefilled syringes', 'ابريكس 4000 وحدة دولية/0.4مل 6 سرنجات معبأة', '2,793', '1995', 'Hematopoietic.erythropoiesis-stimulating agent (esa)', 'Erythropoietin-alpha', 'Janssen cilag > soficopharm', 'Syringe', 'حقنة', '0.4ml', '6', 'علاج فقر الدم و انخفاض عدد كرات الدم الحمراء', NULL, NULL, NULL, 16236, '2023-12-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'B03XA01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18495, 'Cefaxotrez 1 gm i.v. vial', 'سيفاكسوتريز 1 جم وريد فيال', '96', '66.5', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Boston care pharmaceuticals', 'Vial', 'فيال', '1 gm', '1', NULL, NULL, NULL, NULL, 756, '2024-10-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18496, 'Eraloner 25 mg 20 f.c.tab.', 'ايرالونير 25مجم 20 قرص', '136', '102', 'Aldosterone receptor antagonist', 'Eplerenone', 'Multi-apex', 'Tab', 'أقراص', '25 mg', '2', 'علاج ارتفاع ضغط الدم ( قد يستخدم وحده أو مع غيره من أدوية ارتفاع ضغط الدم) قُصُورُ القلْبِ الاحْتِقانِي الذي يحدث بعد احتشاء عضلة القلب.', 'description eplerenone an aldosterone receptor antagonist. similar to spironolactone has been shown to produce sustained increases in plasma renin and serum aldosterone consistent with inhibition of the negative regulatory feedback of aldosterone on renin', '6223003205331', NULL, 10910, '2025-06-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.', '["C03DA04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18497, 'Eraloner 50 mg 20 f.c. tab.', 'ايرالونير 50مجم 20 قرص', '198', '149', 'Aldosterone receptor antagonist', 'Eplerenone', 'Multi-apex', 'Tab', 'أقراص', '50 mg', '2', 'علاج ارتفاع ضغط الدم', 'description eplerenone an aldosterone receptor antagonist similar to spironolactone has been shown to produce sustained increases in plasma renin and serum aldosterone consistent with inhibition of the negative regulatory feedback of aldosterone on renin', '6223003205355', NULL, 2577, '2025-06-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Eplerenone, an aldosterone receptor antagonist similar to spironolactone, has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion. The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone. Eplerenone selectively binds to recombinant human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone and androgen receptors.', '["C03DA04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18498, 'Erastapex 20 mg 30 f.c.tab.', 'ايراستابكس 20مجم 30 قرص', '75', '52.5', 'Antihypertensive.angiotensin blocker', 'Olmesartan', 'Multi-apex', 'Tab', 'أقراص', '20 mg', '3', NULL, 'about olmesartan an angiotensin ii receptor antagonist imidazole derivative antihypertensive. mechanism of action of olmesartan olmesartan is a competitive antagonist of angiotensin-ii at at-1 receptor. it decreases peripheral resistance and lowers bp in', '6223003202729', NULL, 2305, '2024-10-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Olmesartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes [telmisartan], [candesartan], [losartan], [valsartan], and [irbesartan]. ARBs selectively bind to angiotensin receptor 1 (AT1) and prevent the protein angiotensin II from binding and exerting its hypertensive effects, which include vasoconstriction, stimulation and synthesis of aldosterone and ADH, cardiac stimulation, and renal reabsorption of sodium, among others. Overall, olmesartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 

Olmesartan also affects the renin-angiotensin aldosterone system (RAAS), which plays an important role in hemostasis and regulation of kidney, vascular, and cardiac functions. Pharmacological blockade of RAAS via  AT1 receptor blockade inhibits negative regulatory feedback within RAAS, which is a contributing factor to the pathogenesis and progression of cardiovascular disease, heart failure, and renal disease. In particular, heart failure is associated with chronic activation of RAAS, leading to inappropriate fluid retention, vasoconstriction, and ultimately a further decline in left ventricular function. ARBs have been shown to have a protective effect on the heart by improving cardiac function, reducing afterload, increasing cardiac output and preventing ventricular hypertrophy and remodelling.[A174154] 

By comparison, the angiotensin-converting enzyme inhibitor (ACEi) class of medications (which includes drugs such as [ramipril], [lisinopril], and [perindopril]) inhibit the conversion of angiotensin I to angiotensin II through inhibition of the ACE enzyme. However, this does not prevent the formation of all angiotensin II within the body. The angiotensin II receptor blocker (ARB) family of drugs unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized. 

Olmesartan is commonly used for the management of hypertension and Type 2 Diabetes-associated nephropathy, particularly in patients who are unable to tolerate ACE inhibitors. ARBs such as olmesartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Like other ARBs, olmesartan blockade of RAAS slows the progression of diabetic nephropathy due to its renoprotective effects.[A185906,A185909,A185912] 

Orally available olmesartan is produced as the prodrug olmesartan medoxomil which is rapidly converted _in vivo_ to the pharmacologically active olmesartan.[A175330] It was developed by Daiichi Sankyo Pharmaceuticals and approved in 2002.[A175345, L12882]', '["C09DA08", "C09DX03", "C09CA08", "C09DB02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18499, 'Freemove 30 tabs.', 'فري موف 30 قرص', '690', '590', 'Anti-rheumatic.osteoarthritis.anabolic agents', 'Glucosamine+chondroitin+msm+collagen+ginko biloba+copper+manganese+vitamin c+vitamin d3', 'Maddox pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1208, '2025-06-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18500, 'Erastapex 5 mg 30 f.c.tab. (n/a)', 'ايراستابكس 5مجم 30 قرص', '18', NULL, 'Antihypertensive.angiotensin blocker', 'Olmesartan', 'Multi-apex', 'Tab', 'أقراص', '5 mg', '3', NULL, 'about olmesartan an angiotensin ii receptor antagonist imidazole derivative antihypertensive. mechanism of action of olmesartan olmesartan is a competitive antagonist of angiotensin-ii at at-1 receptor. it decreases peripheral resistance and lowers bp in', NULL, NULL, 923, '2023-06-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Olmesartan belongs to the angiotensin II receptor blocker (ARB) family of drugs, which also includes [telmisartan], [candesartan], [losartan], [valsartan], and [irbesartan]. ARBs selectively bind to angiotensin receptor 1 (AT1) and prevent the protein angiotensin II from binding and exerting its hypertensive effects, which include vasoconstriction, stimulation and synthesis of aldosterone and ADH, cardiac stimulation, and renal reabsorption of sodium, among others. Overall, olmesartan''s physiologic effects lead to reduced blood pressure, lower aldosterone levels, reduced cardiac activity, and increased excretion of sodium. 

Olmesartan also affects the renin-angiotensin aldosterone system (RAAS), which plays an important role in hemostasis and regulation of kidney, vascular, and cardiac functions. Pharmacological blockade of RAAS via  AT1 receptor blockade inhibits negative regulatory feedback within RAAS, which is a contributing factor to the pathogenesis and progression of cardiovascular disease, heart failure, and renal disease. In particular, heart failure is associated with chronic activation of RAAS, leading to inappropriate fluid retention, vasoconstriction, and ultimately a further decline in left ventricular function. ARBs have been shown to have a protective effect on the heart by improving cardiac function, reducing afterload, increasing cardiac output and preventing ventricular hypertrophy and remodelling.[A174154] 

By comparison, the angiotensin-converting enzyme inhibitor (ACEi) class of medications (which includes drugs such as [ramipril], [lisinopril], and [perindopril]) inhibit the conversion of angiotensin I to angiotensin II through inhibition of the ACE enzyme. However, this does not prevent the formation of all angiotensin II within the body. The angiotensin II receptor blocker (ARB) family of drugs unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized. 

Olmesartan is commonly used for the management of hypertension and Type 2 Diabetes-associated nephropathy, particularly in patients who are unable to tolerate ACE inhibitors. ARBs such as olmesartan have been shown in a number of large-scale clinical outcomes trials to improve cardiovascular outcomes including reducing risk of myocardial infarction, stroke, the progression of heart failure, and hospitalization.[A174124,A178153,A173869,A185324,A185327,A185333,A185342,A185345] Like other ARBs, olmesartan blockade of RAAS slows the progression of diabetic nephropathy due to its renoprotective effects.[A185906,A185909,A185912] 

Orally available olmesartan is produced as the prodrug olmesartan medoxomil which is rapidly converted _in vivo_ to the pharmacologically active olmesartan.[A175330] It was developed by Daiichi Sankyo Pharmaceuticals and approved in 2002.[A175345, L12882]', '["C09DA08", "C09DX03", "C09CA08", "C09DB02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18501, 'Aaa', 'ششش', '90', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 714, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18502, 'nan 3 milk 400 gm', 'نان 3 لبن اطفال 400 جم', '360', '350', 'Milk products.third stage (age 1-3 years)', 'milk formula stage 3', 'nestle', 'piece', 'غير محدد', '400 gm', '1', NULL, 'not to replace mother s milk. for children from age 1 year and onward. to be used within 3 weeks from opening.', '7613033358555', NULL, 994, '2026-01-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18504, 'Letracitolin120ml syrup', 'ليتراسيتولين 120 مل شراب', '120', NULL, 'Support brain function', 'Citicoline', 'Medicolena', 'Syrup', 'شراب', '120ml', '1', NULL, NULL, NULL, NULL, 1084, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'N06BX06', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18507, 'Erastapex trio 5/40/12.5mg 30 f.c. tabs', 'ايراستابكس تريو 5/40/12.5مجم 30 قرص', '144', '108', 'Antihypertensive.combined angiotensin blocker & ca++ channel blocker & diuretic', 'Amlodipine+olmesartan+hydrochlorothiazide', 'Multi-apex', 'Tab', 'أقراص', '12.5mg', '3', 'علاج ارتفاع ضغط الدم', NULL, '6223003206567', NULL, 5960, '2024-10-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18508, 'Erbitux 100mg/20ml vial', 'اربيتوكس 100مجم/20 مل فيال', '3,631', '3026', 'Antineoplastic', 'Cetuximab', 'Boehringer ingelheim > serono scientific office', 'Vial', 'فيال', '100mg', '1', NULL, 'cetuximab is an epidermal growth factor receptor (egfr) inhibitor used for the treatment of metastatic colorectal cancer metastatic non-small cell lung cancer and head and neck cancer. cetuximab is a chimeric (mouse/human) monoclonal antibody given by int', NULL, NULL, 1316, '2025-04-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Cetuximab is a recombinant chimeric human/mouse IgG1 monoclonal antibody that competitively binds to epidermal growth factor receptor (EGFR) and competitively inhibits the binding of epidermal growth factor (EGF).[A227973] EGFR is a member of the ErbB family of receptor tyrosine kinases found in both normal and tumour cells; it is responsible for regulating epithelial tissue development and homeostasis.[A228083] EGFR has been implicated in various types of cancer, as it is often overexpressed in malignant cells [A227973] and EGFR overexpression has been linked to more advanced disease and poor prognosis.[A227963] EGFR is often mutated in certain types of cancer and serves as a driver of tumorigenesis.[A228083] _In vitro_, cetuximab was shown to mediate anti-tumour effects in numerous cancer cell lines and human tumour xenografts.[A227963]

Approved by the FDA in February 2004 under the brand name ERBITUX, cetuximab is used for the treatment of head and neck cancer and metastatic, KRAS wild-type colorectal cancer, and metastatic colorectal cancer with a BRAF V600E mutation.[A227963,L39045] It has also been investigated in advanced colorectal cancer, EGFR-expressing non-small cell lung cancer (NSCLC), and unresectable squamous cell skin cancer.[L31418] Cetuximab is administered via intravenous infusion and is used as monotherapy or in combination with other chemotherapies, including platinum agents, radiation therapy, [leucovorin], [fluorouracil], and [irinotecan].[L30448]', '["L01FE01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18509, 'Erdolytic 175mg pd. for oral susp. 100 ml', 'اردوليتيك 175 مجم / 5 مل معلق 100 مل', '27', NULL, 'Mucolytic', 'Erdosteine', 'Andalous pharma', 'Susp', 'معلق', '175mg', '1', NULL, NULL, NULL, NULL, 966, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R05CB15', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18510, 'Erdolytic 300 mg 20 caps.', 'اردوليتيك 300مجم 20 كبسولة', '124', '61', 'Mucolytic', 'Erdosteine', 'Andalous pharma', 'Cap', 'كبسولة', '300 mg', '2', 'مذيب للبلغم -- يخفف من الكحة المصحوبة بالبلغم', 'mechanism of action erdosteine an orally mucolytic agent. erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis including acute infective exacerbation of chronic bronchitis. erdosteine contains 2 blocked sulfhydryl', '6223004690037', NULL, 4342, '2024-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R05CB15', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18511, 'Erdosolvine 300 mg 10 caps.', 'اردوسولفين 300 مجم 10 كبسولات', '69', '43', 'Mucolytic', 'Erdosteine', 'Borg', 'Cap', 'كبسولة', '300 mg', '1', 'مذيب بلغم', 'mechanism of action erdosteine an orally mucolytic agent. erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis including acute infective exacerbation of chronic bronchitis. erdosteine contains 2 blocked sulfhydryl', '6223002570935', NULL, 4206, '2024-11-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R05CB15', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18512, 'Erdotinol 300mg 10 caps.', 'اردوتينول 300 مجم 10 كبسولات', '14', NULL, 'Mucolytic', 'Erdosteine', 'Multi-apex > sobol el dawa misr-egypt', 'Cap', 'كبسولة', '300mg', '1', NULL, 'mechanism of action erdosteine an orally mucolytic agent. erdosteine is a thiol derivative developed for the treatment of chronic obstructive bronchitis including acute infective exacerbation of chronic bronchitis. erdosteine contains 2 blocked sulfhydryl', NULL, NULL, 1199, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R05CB15', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18513, 'Erec 100mg 12 f.c. tablets', 'اريك 100مجم 12 قرص', '144', '100.5', 'Tonic for men', 'Sildenafil', 'Adwia', 'Tablet', 'أقراص', '100mg', '12', 'مقوي للرجال', NULL, '6223002971404', NULL, 15961, '2024-05-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'In eliciting its mechanism of action, sildenafil ultimately prevents or minimizes the breakdown of cyclic guanosine monophosphate (cGMP) by inhibiting cGMP specific phosphodiesterase type 5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The result of doing so allows cGMP present in both the penis and pulmonary vasculature to elicit smooth muscle relaxation and vasodilation that subsequently facilitates relief in pulmonary arterial hypertension and the increased flow of blood into the spongy erectile tissue of the penis that consequently allows it to grow in size and become erect and rigid [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].

Interestingly enough, it is precisely via this mechanism why sildenafil was at first researched as a potential treatment for angina - or chest pain associated with inadequate blood flow to the heart - before being serendipitously indicated for treating erectile dysfunction in the late 1980s [A175732]. Nevertheless, it is because of this mechanism that sildenafil is also indicated for treating pulmonary arterial hypertension but is also additionally notorious for interacting with various anti-anginal or anti-hypertensive agents to develop potentially rapid, excessive, and/or fatal hypotensive crises [A175579, A175582, A175654].

Regardless, sildenafil, among a variety of other similar or related PDE5 inhibitors, has become a common and effective treatment for erectile dysfunction and since its formal approval for medical use in the public in 1998 [A175732], continues to see millions of prescriptions written for it internationally. Although the medication has historically been most popularly recognized as Pfizer''s brand name Viagra, sildenafil is currently available generically and even as a non-prescription over the counter medication in some countries [L5656].', '["G01AE10", "G04BE03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18514, 'Erecanova 10 mg 4 disinteg. tabs', 'اريكانوفا 10مجم 4 اقراص سريعة الذوبان', '40', '31', 'Tonic for men', 'Vardenafil', 'Atco pharma > atm pharmaceutical industries', 'Tab', 'أقراص', '10 mg', '1', 'مقوي للرجال', NULL, '6223002977345', NULL, 21793, '2023-10-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Vardenafil (Levitra) is an oral therapy for the treatment of erectile dysfunction. It is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). Penile erection is a hemodynamic process initiated by the relaxation of smooth muscle in the corpus cavernosum and its associated arterioles. During sexual stimulation, nitric oxide is released from nerve endings and endothelial cells in the corpus cavernosum. Nitric oxide activates the enzyme guanylate cyclase resulting in increased synthesis of cyclic guanosine monophosphate (cGMP) in the smooth muscle cells of the corpus cavernosum. The cGMP in turn triggers smooth muscle relaxation, allowing increased blood flow into the penis, resulting in erection. The tissue concentration of cGMP is regulated by both the rates of synthesis and degradation via phosphodiesterases (PDEs). The most abundant PDE in the human corpus cavernosum is the cGMPspecific phosphodiesterase type 5 (PDE5); therefore, the inhibition of PDE5 enhances erectile function by increasing the amount of cGMP.', '["G04BE09"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18515, 'Erectalis 20 mg 4 f.c. tab', 'اريكتاليس 20مجم 4 قرص', '148', '100', 'Tonic for men', 'Tadalafil', 'Penta pharma-egypt', 'Tab', 'أقراص', '20 mg', '4', 'مقوي للرجال', NULL, '6224007738191', NULL, 2569, '2025-06-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Tadalafil is a selective phosphodiesterase-5 inhibitor that is used in the treatment of erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH.[A242287]', '["G04BE08", "C02KX52", "G04CA54"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18516, 'Erectalis 20 mg 8 f.c.tabs.', 'ايريكتاليس 20مجم 8 اقراص', '296', '200', 'Tonic for men', 'Tadalafil', 'Penta pharma-egypt', 'Tab', 'أقراص', '20 mg', '8', 'مقوي للرجال', 'about tadalafil a phosphodiesterase 5 enzyme inhibitor treating erectile dysfunction (ed). mechanism of action of tadalafil tadalafil is a phosphodiesterase enzyme (pde5) inhibitor. this enzyme is responsible for the degradation cyclic guanosine monophosp', NULL, NULL, 1886, '2025-06-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Tadalafil is a selective phosphodiesterase-5 inhibitor that is used in the treatment of erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH.[A242287]', '["G04BE08", "C02KX52", "G04CA54"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18518, 'Erectawest 100 mg 3 tabs.', 'اريكتاويست 100مجم 3 قرص', '20', NULL, 'Tonic for men', 'Avanafil', 'Western pharmaceuticals industries', 'Tab', 'أقراص', '100 mg', '1', NULL, 'avanafil is a pde5 inhibitor approved for erectile dysfunction by the fda on april 27 2012 and by ema on june 21 2013. avanafil is known by the trademark names stendra and spedra and was developed by vivus inc. avanafil acts by inhibiting a specific phosp', NULL, NULL, 944, '2022-09-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used in the treatment of erectile dysfunction. In comparison with other drugs of the same class, it shows greater selectivity for PDE5 over PDE6 than both [sildenafil] and [vardenafil] but less selectivity than [tadalafil], suggesting a relatively lower risk of visual disturbances associated with off-target PDE6 inhibition.[L32113]

It first received FDA approval on April 27, 2012,[L32058] with subsequent EMA approval in June 2013.[L32113]', '["G04BE10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18519, 'Erectoback 10 mg 30 f.c.tabs.', 'اريكتوباك 10مجم 30 قرص', '188', NULL, 'Tonic for men', 'Tadalafil', 'October pharma', 'Tab', 'أقراص', '10 mg', '3', 'مقوي للرجال', NULL, NULL, NULL, 1995, '2022-07-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Tadalafil is a selective phosphodiesterase-5 inhibitor that is used in the treatment of erectile dysfunction (ED), pulmonary arterial hypertension (PAH), and benign prostatic hypertrophy.[L39100, L39105] It was first approved in 2003 by the FDA for use in ED and later in 2009 for PAH. In contrast to other PDE5 inhibitors like [sildenafil], tadalafil has greater selectivity for PDE5 and a longer half-life which has made it a more suitable option for chronic once-daily dosing in the treatment of PAH.[A242287]', '["G04BE08", "C02KX52", "G04CA54"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18521, 'Ergoconazol 200 mg 10 f.c.tabs.', 'ارجوكونازول 200مجم 10 اقراص', '700', NULL, 'Antifungals.triazoles', 'Voriconazole', 'International drug agency > biocapital pharma', 'Tab', 'أقراص', '200 mg', '1', 'مضاد للفطريات', 'indication for the treatment of esophageal candidiasis invasive pulmonary aspergillosis and serious fungal infections caused by scedosporium apiospermum and fusarium spp. mechanism of action voriconazole binds and inhibits ergosterol synthesis by inhibiti', NULL, NULL, 2087, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Voriconazole (Vfend, Pfizer) is a triazole antifungal medication used to treat serious fungal infections.[L15571] It is used to treat invasive fungal infections that are generally seen in patients who are immunocompromised. These include invasive candidiasis, invasive aspergillosis, and emerging fungal infections. The increased affinity of voriconazole for 14-alpha sterol demethylase makes it useful against some [fluconazole]-resistant organisms.[A236050]

Voriconazole was approved by the FDA under the trade name Vfend on May 24, 2002.[L34660]', '["J02AC03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18522, 'Erleada 60 mg 120 tabs.', 'ارليدا 60 مجم 120 قرص', '74,164', '56500', 'Non steroidal antiandrogen', 'Apalutamide', 'Janssen cilag > soficopharm', 'Tab', 'أقراص', '60 mg', '1', NULL, 'indication (apalutamide) is an androgen receptor inhibitor indicated for the treatment of patients with: *metastatic castration-sensitive prostate cancer (mcspc) *non-metastatic castration-resistant prostate cancer (nmcrpc)', NULL, NULL, 998, '2024-09-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Apalutamide is a potent androgen receptor (AR) antagonist that selectively binds to the ligand-binding domain of AR and blocks AR nuclear translocation or binding to androgen response elements [A31846]. It has been used in trials studying the treatment of Prostate Cancer, Hepatic Impairment, Prostatic Neoplasms, Castration-Resistant Prostate Cancer, and Prostatic Neoplasms, Castration-Resistant, among others. Exerting an antitumor action, apalutamide blocking the effect of androgens that promote tumor growth. It targets the AR ligand-binding domain and prevents AR nuclear translocation, DNA binding, and transcription of AR gene targets in prostate tumors [A31846]. In mice bearing human CRPC xenograft models, apalutamide treatment produced tumor regressions in a dose-dependent manner that was more effective than that of [DB01128] or [DB08899]. Unlike bicalutamide, apalutamide antagonized AR-mediated signaling in AR overexpressing human CRPC cell lines [A31846].

Androgen-deprivation therapy, or hormone therapy, can be used as part of maintenance therapy for patients with non-metastatic prostate cancer. Although most patients achieve therapeutic responses at the initial hormone therapy, many patients progress to non-metastatic castration-resistant (resistance to hormone therapy) prostate cancer which is the second-most common cause of cancer-related deaths in American males [A31852]. Castration-resistant prostate cancer is often incurable, which poses significant clinical challenges for patients. Approximately 10 to 20 % of prostate cancer cases are castration-resistant, and up to 16% of these patients show no evidence of cancer metastasis at the time of castration-resistant diagnosis [L1295]. Higher prostate-specific antigen (PSA) and shorter PSA doubling time (PSA DT) are associated with a higher risk for metastases and death [A31846]. In a phase-2 multicenter open-label study, 89% of patients with non-metastatic, castration-resistant prostate cancer had ≥50% PSA decline at week 12 of apalutamide treatment [A31846]. In a randomized trial, the median metastasis-free survival for patients taking apalutamide was 40.5 months compared to 16.2 months for patients taking a placebo [L1295]. Apalutamide displayed good tolerability and safety profile in clinical studies. 

Apalutamide was approved in February 2018 by the FDA as Erleada for the treatment of patients with non-metastatic prostate cancer that is resistant to treatment with hormone therapy (castration-resistant). It is available as oral tablets. Apalutamide is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer [L1295].', '["L02BB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18523, 'Erovanafile 100 mg 4 tabs.', 'ايروفانافايل 100 مجم 4 اقراص', '28', NULL, 'Tonic for men', 'Avanafil', 'Andalous pharma', 'Tab', 'أقراص', '100 mg', '1', NULL, 'avanafil is a pde5 inhibitor approved for erectile dysfunction by the fda on april 27 2012 and by ema on june 21 2013. avanafil is known by the trademark names stendra and spedra and was developed by vivus inc. avanafil acts by inhibiting a specific phosp', NULL, NULL, 1052, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used in the treatment of erectile dysfunction. In comparison with other drugs of the same class, it shows greater selectivity for PDE5 over PDE6 than both [sildenafil] and [vardenafil] but less selectivity than [tadalafil], suggesting a relatively lower risk of visual disturbances associated with off-target PDE6 inhibition.[L32113]

It first received FDA approval on April 27, 2012,[L32058] with subsequent EMA approval in June 2013.[L32113]', '["G04BE10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18524, 'Erovanafile 200mg 4 tabs.', 'ايروفانافيل 200مجم 4 اقراص', '129', '56', 'Tonic for men', 'Avanafil', 'Andalous pharma', 'Tab', 'أقراص', '200mg', '1', 'مقوي للرجال', NULL, NULL, NULL, 3341, '2025-11-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used in the treatment of erectile dysfunction. In comparison with other drugs of the same class, it shows greater selectivity for PDE5 over PDE6 than both [sildenafil] and [vardenafil] but less selectivity than [tadalafil], suggesting a relatively lower risk of visual disturbances associated with off-target PDE6 inhibition.[L32113]

It first received FDA approval on April 27, 2012,[L32058] with subsequent EMA approval in June 2013.[L32113]', '["G04BE10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18525, 'Erovanafile 50mg 4 tabs.', 'ايروفانافايل 50مجم 4 اقراص', '18', NULL, 'Tonic for men', 'Avanafil', 'Andalous pharma', 'Tab', 'أقراص', '50mg', '1', NULL, NULL, NULL, NULL, 914, '2023-02-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Avanafil is a phosphodiesterase-5 (PDE5) inhibitor used in the treatment of erectile dysfunction. In comparison with other drugs of the same class, it shows greater selectivity for PDE5 over PDE6 than both [sildenafil] and [vardenafil] but less selectivity than [tadalafil], suggesting a relatively lower risk of visual disturbances associated with off-target PDE6 inhibition.[L32113]

It first received FDA approval on April 27, 2012,[L32058] with subsequent EMA approval in June 2013.[L32113]', '["G04BE10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18526, 'E-roy 10 caps.', 'اي-روي 10 كبسولات', '56', NULL, 'Multivitamins', 'Ginseng+royal jelly+wheat germ oil+garlic', 'Sedico', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, '6221042172010', NULL, 702, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18527, 'Allmed d3 adult oral spray 3000 iu /2spray 21ml', 'اولميد د3 سبراي بالفم للكبار 3000وحدة دولية/2سبراي 21 مل', '300', NULL, 'Vitamin d', 'Vitamin d', 'Allmed ltd', 'Spray', 'بخاخ', '3000 iu', '1', NULL, NULL, NULL, NULL, 688, '2023-05-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Vitamin D ultimately comprises a group of lipid-soluble secosteroids responsible for a variety of biological effects, some of which include increasing the intestinal absorption of calcium, magnesium, and phosphate. With reference to human use, there are 2 main forms of vitamin D - vitamin D3 (cholecalciferol) and vitamin D2 (ergocalciferol). When non-specific references are made about ''vitamin d'', the references are usually about the use of vitamin D3 and/or D2.

Vitamin D3 and D2 require hydroxylation in order to become biologically active in the human body. Since vitamin D can be endogenously synthesized in adequate amounts by most mammals exposed to sufficient quantities of sunlight, vitamin D functions like a hormone on vitamin D receptors to regulate calcium in opposition to parathyroid hormone. Vitamin D plays an essential physiological role in maintaining calcium homeostasis and metabolism. There are several different vitamin D supplements that are given to treat or to prevent osteomalacia and rickets, or to meet the daily criteria of vitamin D consumption.', '[]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18528, 'Erythrocin 200 mg/5ml susp. 60ml', 'اريثروسين 200مجم/5مل شراب معلق 60 مل', '8', NULL, 'Antibiotic.macrolide', 'Erythromycin', 'Kahira > abbott laboratories', 'Susp', 'معلق', '200 mg', '1', NULL, 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', '6221068904510', NULL, 1037, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]', '["J01FA01", "D10AF02", "S01AA17", "D10AF52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18532, 'Erythromycin pharco 200mg/5ml susp. 60ml', 'اريثروميسين فاركو 200مجم/5مل شراب معلق 60 مل', '8', NULL, 'Antibiotic.macrolide', 'Erythromycin', 'Pharco', 'Susp', 'معلق', '200mg', '1', NULL, 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', '6221151001270', NULL, 832, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]', '["J01FA01", "D10AF02", "S01AA17", "D10AF52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18533, 'Erythromycin stearate 250mg 10 f.c. tabs.', 'اريثروميسين ستيرات 250 مجم 10 اقراص', '7', NULL, 'Antibiotic.macrolide', 'Erythromycin', 'Hi-pharm', 'Tab', 'أقراص', '250mg', '1', NULL, 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', NULL, NULL, 842, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]', '["J01FA01", "D10AF02", "S01AA17", "D10AF52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18534, 'Erythromycin stearate 500 mg 8 f.c. tab.', 'اريثروميسين ستيرات 500 مجم 8 اقراص', '8', NULL, 'Antibiotic.macrolide', 'Erythromycin', 'Hi-pharm', 'Tab', 'أقراص', '500 mg', '2', NULL, 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', NULL, NULL, 690, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]', '["J01FA01", "D10AF02", "S01AA17", "D10AF52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18536, 'Aaa', 'ششش', '8', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 790, '2022-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18537, 'Aaa', 'ششش', '10', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 694, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18538, 'Erytin gel 20 gm', 'ايرتين 20جم جل', '9', NULL, 'Anti-acne', 'Erythromycin+tretinoin', 'Hikma pharma', 'Gel', 'جل', '20 gm', '1', NULL, 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', NULL, NULL, 916, '2022-07-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18539, 'Erytin gel 25 gm', 'اريتين جل 25 جم', '8', NULL, 'Anti-acne', 'Erythromycin+tretinoin', 'Hikma pharma', 'Gel', 'جل', '25 gm', '1', NULL, 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', NULL, NULL, 742, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18541, 'Aaa', 'ششش', '10', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 621, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18542, 'Escita 10 mg 14 f.c.tabs.', 'اسيتا 10مجم 14 قرص', '77', NULL, 'Psychiatric.antidepressants', 'Escitalopram', 'Genesis pharmaceuticals', 'Tab', 'أقراص', '10 mg', '2', NULL, 'about escitalopram selective serotonin reuptake inhibitor (ssri) antidepressant. mechanism of action of escitalopram escitalopram is the s enantiomer of racemic citalopram. it is 100 times more potent than r-enantiomer. escitalopram blocks the re-uptake o', NULL, NULL, 1609, '2022-10-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18544, 'Escitaloborg 5 mg 10 tablets', 'اسيتالوبورج 5مجم 10 اقراص', '25', NULL, 'Psychiatric.antidepressants', 'Escitalopram', 'Borg', 'Tablet', 'أقراص', '5 mg', '1', NULL, NULL, NULL, NULL, 1075, '2022-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18546, 'Escitapram 20 mg 20 f.c.tabs.', 'اسيتابرام 20 مجم 20 قرص', '116', '96', 'Psychiatric.antidepressants', 'Escitalopram', 'Sigma > pharma mix-egypt', 'Tab', 'أقراص', '20 mg', '2', NULL, 'about escitalopram selective serotonin reuptake inhibitor (ssri) antidepressant. mechanism of action of escitalopram escitalopram is the s enantiomer of racemic citalopram. it is 100 times more potent than r-enantiomer. escitalopram blocks the re-uptake o', '6225000352094', NULL, 1363, '2024-08-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18547, 'Eselinate 250mg 20 tab.', 'ازيلينات 250 مجم 20 قرص', '2', NULL, 'Systemic haemostatic', 'Ethamsylate', 'Kahira > ravizza', 'Tab', 'أقراص', '250mg', '2', NULL, 'about ethamsylate benzenesulfonate derivative systemic haemostatic. mechanism of action of ethamsylate it exerts haemostatic action by acting on the first step of haemostasis by improving platelet adhesiveness and restoring capillary resistance. it decrea', NULL, NULL, 828, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18548, 'Eselinate 250mg/2ml 2 amp.', 'ازيلينات 250 مجم/2مل 2 امبول', '2', NULL, 'Systemic haemostatic', 'Ethamsylate', 'Kahira > ravizza', 'Amp', 'أمبول', '250mg', '2', NULL, 'about ethamsylate benzenesulfonate derivative systemic haemostatic. mechanism of action of ethamsylate it exerts haemostatic action by acting on the first step of haemostasis by improving platelet adhesiveness and restoring capillary resistance. it decrea', NULL, NULL, 667, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18549, 'Eslicarba 400 mg 20 tabs.', 'ايسليكاربا 400 مجم 20 قرص', '208', NULL, 'Anti-epileptic', 'Eslicarbazepine', 'Dbk pharma > genesis pharmaceuticals', 'Tab', 'أقراص', '400 mg', '2', 'يستخدم بمفرده أو مع أدوية أخرى لعلاج نوع معين من اضطرابات الصرع (نوبات بؤرية).فهو يقلل من عدد النوبات.', 'eslicarbazepine is used for: treating partial-onset seizures. it is used along with other medicines. eslicarbazepine is an anticonvulsant. exactly how it works is not known but it may work by slowing abnormal nerve impulses in the brain.', NULL, NULL, 1037, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Eslicarbazepine is an anti-epileptic medication available commercially as [eslicarbazepine acetate].', '["N03AF04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18550, 'Eslizepine 400 mg 20 tabs.', 'ايسليزيبين 400مجم 20 قرص', '342', '262', 'Anti-epileptic', 'Eslicarbazepine', 'Andalous pharma', 'Tab', 'أقراص', '400 mg', '2', 'علاج الصرع __ تقليل نوبات التشنجات', 'eslicarbazepine is used for: treating partial-onset seizures. it is used along with other medicines. eslicarbazepine is an anticonvulsant. exactly how it works is not known but it may work by slowing abnormal nerve impulses in the brain.', '6223004690044', NULL, 3367, '2024-09-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Eslicarbazepine is an anti-epileptic medication available commercially as [eslicarbazepine acetate].', '["N03AF04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18551, 'Eslizepine 800mg 20 scored tabs.', 'ايسليزيبين 800مجم 20 قرص', '588', '451', 'Anti-epileptic', 'Eslicarbazepine', 'Andalous pharma', 'Tab', 'أقراص', '800mg', '2', 'علاج المشكلات الصحية والعصبية التالية: علاج الصرع. السيطرة على نوبات الصرع والتقليل من مرات تكرارها. علاج التشنجات العصبية.', NULL, '6223004690051', NULL, 2615, '2024-09-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Eslicarbazepine is an anti-epileptic medication available commercially as [eslicarbazepine acetate].', '["N03AF04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18552, 'Esmatac 20 mg 14 d.r. caps', 'ازماتاك 20مجم دي ار 14 كبسولة', '55', '42', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Egpi', 'Cap', 'كبسولة', '20 mg', '2', 'قرحة المعدة والحموضة', NULL, '6223003930660', NULL, 1083, '2023-09-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18553, 'Esmatac 40 mg 28 d.r. caps.', 'ازماتاك 40 مجم دي ار 28 كبسولة', '144', '96', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Egpi', 'Cap', 'كبسولة', '40 mg', '4', 'قرحة معدة وحموضة', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6223003930905', NULL, 2198, '2023-08-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18554, 'Aaa', 'ششش', '41', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 693, '2022-07-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18555, 'Esmopump 20 mg 14 e.c.tabs.', 'ازموبمب 20مجم 14 قرص', '85', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Organopharma', 'Tab', 'أقراص', '20 mg', '2', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6224000908119', NULL, 1279, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18556, 'Esmopump 40mg 14 f.c. tabs.', 'ايزموبمب 40 مجم 14 قرص', '172', '119', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Organopharma', 'Tab', 'أقراص', '40mg', '2', 'علاج عسر الهضم والتهاب وارتجاع المريء والحموضة المعوية والقضاء على بكتيريا هيليكوباكتر بيلوري (جرثومة المعدة) ومرض القرحة المعدية', 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6224000908102', NULL, 5862, '2024-09-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18557, 'Esmorap 10 mg 7 sachets', 'ازموراب 10 مجم 7 اكياس', '63', '45.5', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Aug pharma', 'Sachet', 'أكياس', '10 mg', '1', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', NULL, NULL, 2375, '2024-10-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18558, 'Esmorap 20 mg 7 sachets', 'ازموراب 20 مجم 7 اكياس', '63', '45.5', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Aug pharma', 'Sachet', 'أكياس', '20 mg', '1', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6223005464309', NULL, 1341, '2024-11-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18560, 'Esmorap 40 mg 7 sachets', 'ازموراب 40 مجم 7 اكياس', '105', '56', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Aug pharma', 'Sachet', 'أكياس', '40 mg', '1', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6223005464316', NULL, 1074, '2024-11-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18562, 'Esmorap 40mg 28 caps.', 'ازموراب 40 مجم 28 كبسولة', '276', '188', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Multi-apex > aug pharma', 'Cap', 'كبسولة', '40mg', '2', NULL, NULL, '6223005460578', NULL, 1160, '2024-11-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18563, 'Esmorap 40 mg powder for i.v. inf. vial', 'ازموراب 40 مجم بودرة فيال', '86', '60', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'El nile. > aug pharma', 'Vial', 'فيال', '40 mg', '1', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', NULL, NULL, 1466, '2025-06-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18564, 'Esogerdazole 40 mg 14 dr. caps', 'ايزوجيردازول 40 مجم 14 كبسولة', '72', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Al rowad pharmaceutical industrial co.', 'Cap', 'كبسولة', '40 mg', '2', NULL, NULL, '6224000915193', NULL, 1440, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18565, 'Aaa', 'ششش', '63', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 699, '2022-09-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18567, 'Esomelodan 40mg 3 powder for i.v. inf. vial', 'ايزوميلودان 40 مجم بودرة فيال', '114', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Global pharmaceutical industries > eva pharma', 'Vial', 'فيال', '40mg', '3', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', NULL, NULL, 945, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18568, 'Esomepex 40 mg 14 enteric coated tab.', 'ايزومبيكس 40مجم 14 قرص', '80', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'International drug agency (idi) > novell pharma', 'Tab', 'أقراص', '40 mg', '2', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6223004070068', NULL, 1462, '2022-09-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18569, 'Esomepex 40 mg pd for i.v. inf.', 'ايزوميبكس 40 مجم بودرة فيال', '42', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'International drug agency (idi) > novell pharma', 'Unknown', 'غير محدد', '40 mg', '1', NULL, NULL, '6223004900112', NULL, 874, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18570, 'Esomium 40mg 14 s.r. capsules', 'ايزوميوم 40مجم 14 كبسولة اس ار', '202', '138', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Grand pharma > mega pharma group', 'Capsule', 'كبسولة', '40mg', '2', 'للحموضة وقرحة المعدة', NULL, '6225000356412', NULL, 5967, '2025-01-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18571, 'Esomium 40mg 7 s.r. caps', 'ايزوميوم 40مجم 7 كبسولة اس ار', '101', '60', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Grand pharma > mega pharma group', 'Cap', 'كبسولة', '40mg', '1', NULL, NULL, NULL, NULL, 925, '2025-08-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18572, 'Esopiroxan 20 mg 14 del. rel. h.g. caps.', 'ايسوبيروكسان 20 مجم 14 كبسولة', '51', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Egpi > andalous pharma', 'Cap', 'كبسولة', '20 mg', '2', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', NULL, NULL, 896, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18573, 'Esopiroxan 40 mg 14 del. rel. h.g. caps.', 'ايزوبيروكسان 40مجم 14 كبسولة', '72', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Egpi > andalous pharma', 'Cap', 'كبسولة', '40 mg', '2', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', NULL, NULL, 1137, '2022-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18574, 'Eso-protocol 20 mg 10 caps.', 'ايزو-بروتوكول 20 مجم 10 كبسولات', '42', NULL, 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Medizen pharmaceutical industries > sanofi', 'Cap', 'كبسولة', '20 mg', '1', NULL, 'about esomeprazole a proton pump inhibitor substituted benzimidazole antiulcer antisecretory drug. mechanism of action of esomeprazole esomeprazole is the s enantiomer of omeprazole and is a proton pump inhibitor. it is a prodrug. after administration it', '6224000870386', NULL, 840, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18575, 'Aaa', 'ششش', '52', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 782, '2023-04-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18576, 'Espax 20 capsules', 'اسباكس 20 كبسولة', '30', NULL, 'Git disturbances', 'Peppermint oil 40 mg +ginger oil 40 mg +chamomile oil 40 mg +fennel oil 40 mg +caraway oil40 mg', 'Arab caps > egypt pharma group', 'Capsule', 'كبسولة', NULL, '2', NULL, NULL, NULL, NULL, 802, '2022-07-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18577, 'Esroblad 100mg top. gel 30 sachets', 'اسروبلاد 100مجم جل 30 كيس', '75', NULL, 'Urinary incontinence.antispasmodics.muscarinic antagonists', 'Oxybutynin', 'Al esraa pharmaceutical optima', 'Gel', 'جل', '100mg', '1', NULL, 'about oxybutynin antimuscarinic agent urinary antispasmodic agent. mechanism of action of oxybutynin this drug decreases muscle spasms of the bladder by competitively antagonizes the m1 m2 and m3 subtypes of the muscarinic acetylcholine receptor. it also', NULL, NULL, 858, '2022-06-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Overactive bladder (OAB) is a common condition negatively impacting the lives of millions of patients worldwide.  Due to its urinary symptoms that include nocturia, urgency, and frequency, this condition causes social embarrassment and a poor quality of life.[A185996,A185999] 

Oxybutynin, also marketed as Ditropan XL, is an anticholinergic medication used for the relief of overactive bladder symptoms that has been optimized for high levels of safety and efficacy since initial FDA approval in 1975.[A183782,L8648] This drug relieves undesirable urinary symptoms, increasing the quality of life for patients affected by OAB.  It is often used as first-line therapy for OAB.[A185990]', '["G04BD04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18578, 'Essential amino energy 270 gm', 'اسنشيال امينو انرجي 270 جم', '1,250', '400', 'Supplement', 'Amino blend+energy blend', 'Optimum nutrition > ramco', 'Unknown', 'غير محدد', '270 gm', '1', NULL, 'mix up essential amin.o. energy anytime you want a fruit flavored or coffeehouse inspired boost of energy and alertness. you can determine what appropriate for any situation adding a 2-scoop serving to water for an afternoon pick-me-up or increasing the a', NULL, NULL, 800, '2024-01-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18579, 'Essentiale 300mg 30 caps.', 'اسنشيال 300 مجم 30 كبسولة', '195', '95', 'Liver support supplements', 'Nicotinamide+phospholipids+vitamin b1+vitamin b2+vitamin b6+vitamin b12+vitamin e', 'Amriya > sanofi aventis', 'Cap', 'كبسولة', '300mg', '3', 'مكمل غذائى مدعم لصحة الكبد', NULL, '6221075020104', NULL, 2800, '2025-11-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18580, 'Ester-c 30 tabs.', 'استر-سي 30 قرص', '55', '48.75', 'Vitamin c', 'Calcium+vitamin c', 'Amcomed > s&s pharmaceuticals', 'Tab', 'أقراص', NULL, '3', NULL, 'dietary supplement for vitamin c', NULL, NULL, 933, '2025-08-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18581, 'Ester-cal 30 tabs.', 'استر-كال30 قرص', '55', NULL, 'Calcium supplement', 'Calcium+vitamin d3', 'Med care > gepard pharma', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 862, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18582, 'Estero-map 10mg 30 f.c.tab.', 'استيرو-ماب 10مجم 30 قرص', '132', '93', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Multi-apex', 'Tab', 'أقراص', '10mg', '3', NULL, 'about rosuvastatin statin hmg-coa reductase inhibitor antilipemic. mechanism of action of rosuvastatin it is a hypolipidaemic statin which competitively inhibits the conversion of 3-hydroxy-3-methyl glutaryl coenzyme a (hmg coa) to mevalonate. the drug ex', '6223003207854', NULL, 1511, '2025-03-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America.[A181087, A181406]

Rosuvastatin and other drugs from the statin class of medications including [atorvastatin], [pravastatin], [simvastatin], [fluvastatin], and [lovastatin] are considered first-line options for the treatment of dyslipidemia.[A181087, A181406] This is largely due to the fact that cardiovascular disease (CVD), which includes heart attack, atherosclerosis, angina, peripheral artery disease, and stroke, has become a leading cause of death in high-income countries and a major cause of morbidity around the world.[A181084] Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087,A181553] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475,A181538] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]

While all statin medications are considered equally effective from a clinical standpoint, rosuvastatin is considered the most potent; doses of 10 to 40mg rosuvastatin per day were found in clinical studies to result in a 45.8% to 54.6% decreases in LDL cholesterol levels, which is about three-fold more potent than [atorvastatin]''s effects on LDL cholesterol.[A181409,A1793] However, the results of the SATURN trial[A181427] concluded that despite this difference in potency, there was no difference in their effect on the progression of coronary atherosclerosis.

Rosuvastatin is also a unique member of the class of statins due to its high hydrophilicity which increases hepatic uptake at the site of action, low bioavailability, and minimal metabolism via the Cytochrome P450 system.[A181523] This last point results in less risk of drug-drug interactions compared to [atorvastatin], [lovastatin], and [simvastatin], which are all extensively metabolized by Cytochrome P450 (CYP) 3A4, an enzyme involved in the metabolism of many commonly used drugs.[A181460] Drugs such as [ciclosporin], [gemfibrozil], and some antiretrovirals are more likely to interact with this statin through antagonism of OATP1B1 organic anion transporter protein 1B1-mediated hepatic uptake of rosuvastatin.[F4649, F4652]', '["C10BX10", "C10BX05", "C10BX07", "C10AA07", "A10BH52", "G01AE10", "C10BX13", "C10BX09", "C10BA09", "C10BX16", "C10BX17", "C10BX14", "C10BA06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18583, 'Estero-map 20mg 30 f.c. tab', 'استيرو-ماب 20مجم 30 قرص', '141', '105', 'Antihyperlipidemic.statins', 'Rosuvastatin', 'Multi-apex', 'Tab', 'أقراص', '20mg', '3', NULL, NULL, '6223003207823', NULL, 1140, '2024-09-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous production of cholesterol in the liver. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid and is the third step in a sequence of metabolic reactions involved in the production of several compounds involved in lipid metabolism and transport including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very low-density lipoprotein (VLDL). Prescribing of statin medications is considered standard practice following any cardiovascular events and for people with a moderate to high risk of development of CVD, such as those with Type 2 Diabetes. The clear evidence of the benefit of statin use coupled with very minimal side effects or long term effects has resulted in this class becoming one of the most widely prescribed medications in North America.[A181087, A181406]

Rosuvastatin and other drugs from the statin class of medications including [atorvastatin], [pravastatin], [simvastatin], [fluvastatin], and [lovastatin] are considered first-line options for the treatment of dyslipidemia.[A181087, A181406] This is largely due to the fact that cardiovascular disease (CVD), which includes heart attack, atherosclerosis, angina, peripheral artery disease, and stroke, has become a leading cause of death in high-income countries and a major cause of morbidity around the world.[A181084] Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD.[A181087,A181553] Use of statins to target and reduce LDL levels has been shown in a number of landmark studies to significantly reduce the risk of development of CVD and all-cause mortality.[A181090,A181093,A181096,A181427,A181475,A181538] Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within 5 years) statins cause a 20%-22% relative reduction in major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]

While all statin medications are considered equally effective from a clinical standpoint, rosuvastatin is considered the most potent; doses of 10 to 40mg rosuvastatin per day were found in clinical studies to result in a 45.8% to 54.6% decreases in LDL cholesterol levels, which is about three-fold more potent than [atorvastatin]''s effects on LDL cholesterol.[A181409,A1793] However, the results of the SATURN trial[A181427] concluded that despite this difference in potency, there was no difference in their effect on the progression of coronary atherosclerosis.

Rosuvastatin is also a unique member of the class of statins due to its high hydrophilicity which increases hepatic uptake at the site of action, low bioavailability, and minimal metabolism via the Cytochrome P450 system.[A181523] This last point results in less risk of drug-drug interactions compared to [atorvastatin], [lovastatin], and [simvastatin], which are all extensively metabolized by Cytochrome P450 (CYP) 3A4, an enzyme involved in the metabolism of many commonly used drugs.[A181460] Drugs such as [ciclosporin], [gemfibrozil], and some antiretrovirals are more likely to interact with this statin through antagonism of OATP1B1 organic anion transporter protein 1B1-mediated hepatic uptake of rosuvastatin.[F4649, F4652]', '["C10BX10", "C10BX05", "C10BX07", "C10AA07", "A10BH52", "G01AE10", "C10BX13", "C10BX09", "C10BA09", "C10BX16", "C10BX17", "C10BX14", "C10BA06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18584, 'Estikana 10mg 28 f.c.tab.', 'استيكانا 10مجم 28 قرص', '132', '60', 'Psychiatric.antidepressants', 'Escitalopram', 'Hochster pharmaceutical industries', 'Tab', 'أقراص', '10mg', '2', 'مضاد للاكتئاب', NULL, NULL, NULL, 939, '2024-10-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18585, 'Estikana 10 mg 14 f.c. tab', 'استيكانا 10مجم 14 قرص', '48', '34', 'Psychiatric.antidepressants', 'Escitalopram', 'Hochster pharmaceutical industries', 'Tab', 'أقراص', '10 mg', '1', 'مضاد للاكتئاب والامراض النفسية', NULL, '6221000000539', NULL, 5478, '2024-11-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18586, 'Estohalt 10 mg 14 caps.', 'استوهالت 10 مجم 14 كبسولة', '17', NULL, 'Peptic ulcer.proton pump inhibitor', 'Omeprazole', 'Amriya', 'Cap', 'كبسولة', '10 mg', '1', NULL, 'about omeprazole proton pump inhibitor substituted benzimidazole anti-secretory antiulcer. mechanism of action of omeprazole omeprazole is a proton pump inhibitor and it is a prodrug. after administration it diffuses in to the parietal cell of the stomach', '6221075021521', NULL, 831, '2022-07-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Originally approved by the FDA in 1989, omeprazole is a _proton-pump inhibitor_, used to treat gastric acid-related disorders. These disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid.  This drug was the first clinical useful drug in its class, and its approval was followed by the formulation of many other proton pump inhibitor drugs [A174232]. Omeprazole is generally effective and well-tolerated, promoting its popular use in children and adults [FDA label].', '["A02BC01", "A02BD05", "A02BD16", "A02BD01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18588, 'Aaa', 'ششش', '12', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 806, '2022-07-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18589, 'Estovlar 0.25/0.035mg 21 tabs.', 'استوفلار 0.25/0.035مجم 21 قرص', '30', '11.5', 'Contraceptives', 'Ethinyl estradiol+norgestimate', 'Marcyrl co.', 'Tab', 'أقراص', '0.035mg', '1', NULL, 'this combination hormone medication is used to prevent pregnancy. it contains 2 hormones: a progestin and an estrogen. it works mainly by preventing the release of an egg (ovulation) during your menstrual cycle. it also makes vaginal fluid thicker to help', NULL, NULL, 1046, '2025-08-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18590, 'Estoza (chocolate) 24 pieces', 'استوزا 24 قطعة بالشوكولاتة', '125', '95', 'Multivitamins', 'Iron+zinc+folic acid+selenium+biotin+vitamin (c+e+d3+ b complex)+iodine+copper', 'Pharma zad > medinza pharm', 'Piece', 'قطعة', NULL, '1', 'اقراص مدعمة بالحديد و الفيتامينات و المعادن لعلاج نقص الحديد و الانيميا و للعناية بصحة البشرة و الشعر.', 'hematinic - multi-vitamins ** dose: once daily', NULL, NULL, 6140, '2025-08-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18591, 'Estraceptive 0.25/0.035mg 21 tabs', 'استراسبتيف 21 قرص', '41', '30', 'Contraceptives', 'Ethinyl estradiol+norgestimate', 'Hi-pharm', 'Tab', 'أقراص', '0.035mg', '1', 'مانع للحمل', NULL, '6224001050688', NULL, 4055, '2024-07-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18593, 'Etacynone 250mg 20 tab.', 'ايتاسينون 250 مجم 20 قرص', '13', NULL, 'Systemic haemostatic', 'Ethamsylate', 'Alexandria', 'Tab', 'أقراص', '250mg', '2', NULL, 'about ethamsylate benzenesulfonate derivative systemic haemostatic. mechanism of action of ethamsylate it exerts haemostatic action by acting on the first step of haemostasis by improving platelet adhesiveness and restoring capillary resistance. it decrea', NULL, NULL, 728, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18594, 'Etacynone 250mg/2ml 3 amp.', 'ايتاسينون 250 مجم/2مل 3 امبولات', '7', NULL, 'Systemic haemostatic', 'Ethamsylate', 'Alexandria', 'Amp', 'أمبول', '250mg', '3', NULL, 'about ethamsylate benzenesulfonate derivative systemic haemostatic. mechanism of action of ethamsylate it exerts haemostatic action by acting on the first step of haemostasis by improving platelet adhesiveness and restoring capillary resistance. it decrea', NULL, NULL, 651, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18595, 'Aaa', 'ششش', '21', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 667, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18596, 'Aaa', 'ششش', '7', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 657, '2022-12-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18597, 'Aaa', 'ششش', '14', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 654, '2022-12-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18598, 'Aaa', 'ششش', '34', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', 'مهدئ الكحة -- موسع للقصبات الهوائية -- العلاج والوقاية من الربو', NULL, NULL, NULL, 689, '2022-12-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18599, 'Aaa', 'ششش', '8', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, '6221050140032', NULL, 796, '2022-12-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18601, 'Etasylsunny 250mg/2ml 5 amp.', 'ايتاسيلسونى 250 مجم / 2 مل 5 امبول', '40', '18.5', 'Systemic haemostatic', 'Ethamsylate', 'Sunny medical', 'Amp', 'أمبول', '250mg', '5', NULL, 'about ethamsylate benzenesulfonate derivative systemic haemostatic. mechanism of action of ethamsylate it exerts haemostatic action by acting on the first step of haemostasis by improving platelet adhesiveness and restoring capillary resistance. it decrea', NULL, NULL, 1114, '2024-11-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18602, 'Aaa', 'ششش', '9', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 615, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18603, 'Ethanolamine oleate 5% amp', 'ايثانولامين اوليات 5%؜ امبول', '7', '5', NULL, 'Ethanolamine oleate', 'Eipico', 'Amp', 'أمبول', '5%', '1', 'يستخدم في علاج الدوالي', 'ethanolamine oleate is indicated in the treatment of bleeding esophageal varices and the prevention of recurrent bleeding in patients whose varices have recently bled.', NULL, NULL, 1442, '2024-12-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'C05BB01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18605, 'Ethoxa 250 mg 50 caps.', 'ايثوكسا 250 مجم 50 كبسولة', '56', NULL, 'Anti-epileptic.succinimide', 'Ethosuximide', 'Delta pharma', 'Cap', 'كبسولة', '250 mg', '5', NULL, 'about ethosuximide imide derivative a succinimide anticonvulsant(mainly in absence seizures). mechanism of action of ethosuximide ethosuximide reduces low threshold t current in ca2+ channel in thalamic neurons. thalamus is responsible for the production', NULL, NULL, 1084, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.', '["N03AD01", "N03AD51"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18607, 'Ethyl chloride 88gm/100ml topical spray', 'ايثيل كلوريد 88 جم / 100 مل بخاخ موضعي', '29', NULL, 'Analgesic', 'Ethyl chloride', 'Walter ritter- germany > egyptian pharmaceutical trading company', 'Spray', 'بخاخ', '88gm', '1', NULL, 'skin anaesthesia for prompt relief of pain.', '4014852580104', NULL, 1933, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'N01BX01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18608, 'Ethyronate 200mg/5ml susp. 100 ml', 'ايثيرونيت 200 مجم / 5 مل معلق 100 مل', '10', NULL, 'Antibiotic.macrolide', 'Erythromycin', 'Unipharma co.', 'Susp', 'معلق', '200mg', '1', NULL, 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', NULL, NULL, 790, '2022-07-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]', '["J01FA01", "D10AF02", "S01AA17", "D10AF52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18609, 'Ethyronate 400mg/5ml susp. 100 ml', 'ايثيرونيت 400 مجم / 5 مل معلق 100 مل', '12', NULL, 'Antibiotic.macrolide', 'Erythromycin', 'Unipharma co.', 'Susp', 'معلق', '400mg', '1', NULL, 'about erythromycin macrolide antibiotic. mechanism of action of erythromycin erythromycin is a member of macrolide antibiotics. it binds to the 50s sub unit of bacterial ribosome and inhibits translocation.ie: they interfere with the transfer of the newly', NULL, NULL, 819, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Erythromycin is a bacteriostatic antibiotic drug produced by a strain of Saccharopolyspora erythraea (formerly Streptomyces erythraeus) and belongs to the macrolide group of antibiotics which consists of [Azithromycin], [Clarithromycin], [Spiramycin] and others. It was originally discovered in 1952.[L5245] Erythromycin is widely used for treating a variety of infections, including those caused by gram-positive and gram-negative bacteria.[L5245,L7261] It is available for administration in various forms, including intravenous, topical, and eye drop preparations.[L5245]', '["J01FA01", "D10AF02", "S01AA17", "D10AF52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18610, 'Aaa', 'ششش', '17', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 626, '2023-01-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18611, 'Aaa', 'ششش', '10', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 661, '2022-11-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18612, 'Aaa', 'ششش', '14', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 599, '2022-11-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18613, 'Aaa', 'ششش', '14', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 655, '2022-12-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18614, 'Aaa', 'ششش', '36', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 666, '2022-12-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18615, 'Aaa', 'ششش', '90', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 648, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18616, 'Aaa', 'ششش', '34', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 763, '2022-07-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18617, 'Etoposide-mylan 100mg/5ml 10 vials', 'ايتوبوسايد 100مجم/5مل 10 فيال', '900', NULL, 'Antineoplastic', 'Etoposide', 'Mylan s.a.s-france > ramco', 'Vial', 'فيال', '100mg', '1', NULL, NULL, NULL, NULL, 2358, '2022-05-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.', '["L01CB01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18618, 'Etoposide 200mg/10ml 10 vial', 'ايتوبوسيد 200 مجم / 10 مل 10 فيال', '765', NULL, 'Antineoplastic', 'Etoposide', 'Mylan s.a.s-france > ramco', 'Vial', 'فيال', '200mg', '10', NULL, NULL, NULL, NULL, 995, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.', '["L01CB01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18619, 'Etopul 100mg/5ml 5 amps. i.v inj./inf.', 'ايتوبول 100 مجم / 5 مل 5 امبولات', '1,000', '452.5', 'Antineoplastic', 'Etoposide', 'Hikma specialized pharmaceuticals', 'Inj', 'حقن', '100mg', '5', NULL, NULL, NULL, NULL, 2298, '2024-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.', '["L01CB01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18620, 'Etosid 100mg/5ml vial', 'ايتوسيد 100 مجم /5 مل فيال', '201', '90', 'Antineoplastic', 'Etoposide', 'Cipla ltd. - india > star international company', 'Vial', 'فيال', '100mg', '1', NULL, NULL, NULL, NULL, 797, '2025-04-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.', '["L01CB01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18621, 'Etosid 50mg 4 soft gelatin caps.', 'ايتوسيد 50 مجم 4 كبسولات', '50', NULL, 'Antineoplastic', 'Etoposide', 'Cipla ltd. - india > star international company', 'Cap', 'كبسولة', '50mg', '1', NULL, NULL, NULL, NULL, 1162, '2022-07-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A semisynthetic derivative of podophyllotoxin that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle.', '["L01CB01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18623, 'Eucal cream 50 gm', 'يوكال كريم 50 جم', '75', '40', 'Massage', 'Eucalyptus globulus+gaultheria procumbens+salvia officinalis+cassia angustifolia+colchicum+centaureu', 'El-dawlia co. > el-sisi international co.', 'Cream', 'كريم', '50 gm', '1', NULL, 'herbal massage cream that relax the body and remove muscle fatigue', '6224000663155', NULL, 1051, '2025-11-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18624, 'Eucal gel 30 gm', 'يوكال جل 30 جم', '60', '27.5', 'Massage', 'Eucalyptus oil+peppermint oil+camphor oil+common juniper+arnica extract+thyme oil+clove oil+carrot o', 'El-dawlia co. > el-sisi international co.', 'Gel', 'جل', '30 gm', '1', NULL, 'herbal massage gel that relax the body and remove muscle fatigue', '6224000663162', NULL, 742, '2025-11-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18625, 'Aaa', 'ششش', '40', '35', NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 701, '2024-03-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18626, 'Eucamenth cream 50 gm', 'ايوكامينث كريم 50 جم', '35', NULL, 'Massage', 'Eucalyptus oil+camphor+menthol+thyme ext+paraffin oil+cetyl alc+stearic acid+glyceryl monostearate', 'Hi-care > al-ashraf co.', 'Cream', 'كريم', '50 gm', '1', 'كريم مساج لتسكين الالام وباسط للعضلات', 'helping in relieving muscle pain and your body ** applied 2-3 times daily.', NULL, NULL, 768, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18627, 'Eucaphol 6 inf. supp.', 'يوكافول 6 اقماع لبوس اطفال', '4', NULL, 'Cough drugs', 'Camphor+eucalyptol+guaiacol+pholcodine', 'Misr', 'Cap', 'كبسولة', NULL, '1', NULL, NULL, '6221035005004', NULL, 1068, '2023-04-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18629, 'Eudyna 0.05% cream 20 gm (n/a)', 'يودينا 0.05% كريم 20 جم', '3', NULL, 'Anti-acne', 'Tretinoin', 'Alexandria > abbott laboratories', 'Cream', 'كريم', '0.05%', '1', NULL, 'about tretinoin retinoid vitamin a metabolite anti-acne in hyperpigmentation. mechanism of action of tretinoin tretinoin is all trans retinoic acid (acid form of vitamin a). tretinoin is a potent comedolytic. it stimulates mitosis and epidermal cell turno', '6223000176870', NULL, 932, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).', '["L01XF01", "D10AD51", "D10AD01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18630, 'Eudyna 0.05% gel (n/a)', 'يودينا 0.05% جل', '3', NULL, 'Anti-acne', 'Tretinoin', 'Alexandria > abbott laboratories', 'Gel', 'جل', '0.05%', '1', NULL, 'about tretinoin retinoid vitamin a metabolite anti-acne in hyperpigmentation. mechanism of action of tretinoin tretinoin is all trans retinoic acid (acid form of vitamin a). tretinoin is a potent comedolytic. it stimulates mitosis and epidermal cell turno', '6223000176856', NULL, 1017, '2023-08-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Tretinoin, also known as all-trans-retinoic acid (ATRA), is a naturally occurring derivative of vitamin A (retinol). Retinoids such as tretinoin are important regulators of cell reproduction, proliferation, and differentiation and are used to treat acne and photodamaged skin and to manage keratinization disorders such as ichthyosis and keratosis follicularis. Tretinoin also represents the class of anticancer drugs called differentiating agents and is used in the treatment of acute promyelocytic leukemia (APL).', '["L01XF01", "D10AD51", "D10AD01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18631, 'Aaa', 'ششش', '12', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 771, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18632, 'Aaa', 'ششش', '13', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 702, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18633, 'Aaa', 'ششش', '16', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 735, '2023-01-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18634, 'Eumovate 0.05% top. cream 15 gm', 'ايموفيت 0.05% كريم 15 جم', '13', NULL, 'Topical adenocorticoid', 'Clobetasone', 'Glaxo smithkline', 'Cream', 'كريم', '0.05%', '1', NULL, 'about clobetasone corticosteroid ophthalmic anti inflammatory. mechanism of action of clobetasone clobetasone is a topical corticosteroid. it induces peptide lipocortins which inhibit the enzyme phospholipase a2. phospholipase a2 is essential for the conv', '6221045000693', NULL, 1108, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'D07AB01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18635, 'Eumovate 0.05% top. oint. 15 gm', 'ايموفيت 0.05% مرهم 15 جم', '13', NULL, 'Glucocorticoid', 'Clobetasone', 'Smithkline beecham > glaxo smithkline', 'Oint', 'مرهم', '0.05%', '1', NULL, 'about clobetasone corticosteroid ophthalmic anti inflammatory. mechanism of action of clobetasone clobetasone is a topical corticosteroid. it induces peptide lipocortins which inhibit the enzyme phospholipase a2. phospholipase a2 is essential for the conv', '6221045000709', NULL, 613, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'D07AB01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18636, 'Eupifalgan 1gm/100ml vial for i.v. inf. 100 ml', 'ايوبيفالجان 1جم/100مل فيال 100 مل', '15', NULL, 'Antipyretic', 'Paracetamol(acetaminophen)', 'Eimc', 'Vial', 'فيال', '1gm', '1', NULL, 'about paracetamol acetanilide derivative non narcotic analgesic antipyretic. mechanism of action of paracetamol paracetamol has analgesic and antipyretic action. it is more active on cyclo-oxygenase enzyme in brain. peripherally it is a poor inhibitor of', NULL, NULL, 892, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'N02AJ01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18637, 'Eupifiban 12.5mg/50ml i.v.infusion', 'ايوبيفالجان 12.5مجم/50مل', '900', NULL, 'Antiplatelet', 'Tirofiban', 'Hikma specialized pharmaceuticals', 'Unknown', 'غير محدد', '12.5mg', '1', NULL, 'about tirofiban non peptide glycoprotein iib/iiia inhibitor antiplatelet agent. mechanism of action of tirofiban tirofiban is an antiplatelet drug. it is glycoprotein iib / iiia inhibitors. it is a reversible antagonist of fibrinogen binding to the glycop', NULL, NULL, 843, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Tirofiban prevents the blood from clotting during episodes of chest pain or a heart attack, or while the patient is undergoing a procedure to treat a blocked coronary artery. It is a non-peptide reversible antagonist of the platelet glycoprotein (GP) IIb/IIIa receptor, and inhibits platelet aggregation.', '["B01AC17"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18638, 'Eupifluda 10 mg 5 f.c.tabs.(n/a yet)', 'ايوبيفلودا 10 مجم 5 أقراص', '446', NULL, 'Antineoplastic', 'Fludarabine', 'Hikma specialized pharmaceuticals', 'Tab', 'أقراص', '10 mg', '1', NULL, 'about fludarabine antimetabolite (purine antagonist) organofluoride derivative antineoplastic. mechanism of action of fludarabine intracellularly drug is converted into its active form 2-flouro-ara-atp by the enzyme deoxycytidine kinase through dephosphor', NULL, NULL, 754, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Fludarabine is a chemotherapeutic agent used in the treatment of hematological malignancies. It is commonly marketed under the brand name Fludara.', '["L01BB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18639, 'Eupivora 1mg/ml 5 amps. i.v.', 'يوبيفورا 1 مجم / مل 5 امبول', '125', NULL, '5-ht3 antagonist.anti-emetic', 'Granisetron', 'Hikma specialized pharmaceuticals', 'Amp', 'أمبول', '1mg', '5', NULL, NULL, NULL, NULL, 809, '2022-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients.', '["A04AA02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18640, 'Eupivora 2 mg 4 f.c. tabs.', 'يوبيفورا 2 مجم 4 اقراص', '104', NULL, '5-ht3 antagonist.anti-emetic', 'Granisetron', 'Hikma specialized pharmaceuticals', 'Tab', 'أقراص', '2 mg', '1', NULL, NULL, NULL, NULL, 885, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients.', '["A04AA02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18641, 'Eupivora 3mg/3ml 5 amps. i.v.', 'يوبيفورا 3مجم/3مل 5 امبول', '350', NULL, '5-ht3 antagonist.anti-emetic', 'Granisetron', 'Hikma specialized pharmaceuticals', 'Amp', 'أمبول', '3mg', '5', NULL, NULL, NULL, NULL, 838, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A serotonin receptor (5HT-3 selective) antagonist that has been used as an antiemetic and antinauseant for cancer chemotherapy patients.', '["A04AA02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18642, 'Eupizar 1 gm i.v. inf. vial', 'يوبيزار 1 جم فيال', '1,027', '603', 'Antineoplastic', 'Gemcitabine', 'Hikma specialized pharmaceuticals', 'Vial', 'فيال', '1 gm', '1', 'علاج الاورام السرطانية', NULL, NULL, NULL, 1639, '2025-01-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Gemcitabine is a nucleoside analog and a chemotherapeutic agent. It was originally investigated for its antiviral effects, but it is now used as an anticancer therapy for various cancers.[A233135] Gemcitabine is a cytidine analog with two fluorine atoms replacing the hydroxyl on the ribose.[A233145] As a prodrug, gemcitabine is transformed into its active metabolites that work by replacing the building blocks of nucleic acids during DNA elongation, arresting tumour growth and promoting apoptosis of malignant cells.[L32960] The structure, metabolism, and mechanism of action of gemcitabine are similar to [cytarabine], but gemcitabine has a wider spectrum of antitumour activity.[A233140]

Gemcitabine is marketed as Gemzar and it is available as intravenous injection. It is approved by the FDA to treat advanced ovarian cancer in combination with [carboplatin], metastatic breast cancer in combination with [paclitaxel], non-small cell lung cancer in combination with [cisplatin], and pancreatic cancer as monotherapy.[L32950] It is also being investigated in other cancer and tumour types.', '["L01BC05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18643, 'Eurax 10% cream 30 gm', 'يوراكس 10% كريم 30 جم', '9', NULL, 'Antipruritic', 'Crotamiton', 'Novartis', 'Cream', 'كريم', '10%', '1', NULL, 'about crotamiton antiparasitic agent pediculicide scabicidal and antipruritic. mechanism of action of crotamiton crotamiton exerts its pharmacological action (pruritis) by virtue of its counter irritant property. after topical application it produces a co', '6223002640546', NULL, 1202, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18644, 'Eurax 10% lotion 50 ml', 'يوراكس 10% لوشن 50 مل', '8', NULL, 'Antipruritic', 'Crotamiton', 'Novartis', 'Lotion', 'لوشن', '10%', '1', NULL, 'about crotamiton antiparasitic agent pediculicide scabicidal and antipruritic. mechanism of action of crotamiton crotamiton exerts its pharmacological action (pruritis) by virtue of its counter irritant property. after topical application it produces a co', '6223002640553', NULL, 795, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18645, 'Eurobutamin 200mg 20 f.c. tab.', 'يوروبوتامين 200 مجم 20 قرص', '10', NULL, 'Nootropic', 'Sulbutiamine', 'European egyptian pharm. ind.', 'Tab', 'أقراص', '200mg', '2', NULL, 'about sulbutiamine a synthetic derivative of thiamine a centrally acting cholinergic agent nootropic antiasthenic. mechanism of action of sulbutiamine sulbutiamine is a centrally acting cholinergic agent. this drug inhibits the enzyme acetyl cholinesteras', NULL, NULL, 1446, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A11DA02', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18646, 'Eurobutamin 400mg 15 scored f.c. tab.', 'يوروبوتامين 400 مجم 15 قرص', '11', NULL, 'Nootropic', 'Sulbutiamine', 'European egyptian pharm. ind.', 'Tab', 'أقراص', '400mg', '3', 'مقوى للرجال', 'about sulbutiamine a synthetic derivative of thiamine a centrally acting cholinergic agent nootropic antiasthenic. mechanism of action of sulbutiamine sulbutiamine is a centrally acting cholinergic agent. this drug inhibits the enzyme acetyl cholinesteras', NULL, NULL, 1983, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A11DA02', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18647, 'Aaa', 'ششش', '19', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 779, '2022-10-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18649, 'Euronemia 100mg/5ml 5 amp for i.v. or inf.', 'يورونيميا 100مجم/5 مل 5 امبولات', '275', '192.5', 'Anemia.iron supplement', 'Iron', 'Amriya > european egyptian pharm. ind.', 'Amp', 'أمبول', '100mg', '5', 'يستخد لعلاج الانيميا -- تعويض نقص مستوي الحديد', NULL, '6221076030980', NULL, 5452, '2025-03-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.', '["B03AE02", "A11AA01", "B03AE01", "B03AE04", "B03AE03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18650, 'Europack for cold 5 eff. sachet', 'يوروباك فور كولد فوار 5 اكياس', '5', NULL, 'Cold drugs', 'Paracetamol(acetaminophen)+pseudoephedrine+sodium ascorbate+vitamin c', 'European egyptian pharm. ind.', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, '6221076180241', NULL, 993, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18651, 'Europack for cough 5 eff.sachets', 'يوروباك فور كاف للكحة فوار 5 اكياس', '7', NULL, 'Cold drugs', 'Paracetamol(acetaminophen)+pseudoephedrine +dextromethorphan+chlorpheniramine', 'European egyptian pharm. ind.', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, '6221076180234', NULL, 925, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18652, 'Europack plus for cold 5 eff. sachets', 'يوروباك بلس فور كولد فوار 5 اكياس', '6', NULL, 'Cold drugs', 'Chlorpheniramine+paracetamol(acetaminophen)+pseudoephedrine+sodium ascorbate+vitamin c', 'European egyptian pharm. ind.', 'Sachet', 'أكياس', NULL, '1', NULL, NULL, NULL, NULL, 896, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18653, 'Eurotinib 100 mg 10 tabs.(n/a yet)', 'يوروتينيب 100 مجم 10 اقراص', '250', NULL, 'Tyrosine- kinase inhibitor', 'Imatinib', 'European egyptian pharm. ind.', 'Tab', 'أقراص', '100 mg', '1', NULL, 'about imatinib anticancer tyrosine- kinase inhibitor first generation. mechanism of action of imatinib imatinib is an inhibitor of multiple tyrosine kinases including kit abl and pdgfr( platelet-derived growth factor receptor) and inhibit phosphorelation.', NULL, NULL, 789, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Imatinib is a small molecule kinase inhibitor that revolutionized the treatment of cancer, particularly chronic myeloid leukemia, in 2001.[A249305] It was deemed a "miracle drug" due to its clinical success, as oncologist Dr. Brian noted that "complete hematologic responses were observed in 53 of 54 patients with CML treated with a daily dosage of 300 mg or more and typically occurred in the first four weeks of therapy".[A249315]. The discovery of imatinib also established a new group of therapy called "targeted therapy", since treatment can be tailored specifically to the unique cancer genetics of each patient.[L42220]', '["L01EA01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18654, 'Eurovasculita mr 35mg 30 f.c. tab.', 'يوروفاسكوليتا ام ار 35 مجم 30 قرص', '26', NULL, 'Anti-ischemic', 'Trimetazidine', 'European egyptian pharm. ind. > technopharm', 'Tab', 'أقراص', '35mg', '3', NULL, 'about trimetazidine cytoprotective vasodilator anti-ischemic (anti-anginal) agent. mechanism of action of trimetazidine it is a cytoprotective drug which reduces anginal attacks and improves exercise tolerance by nonhaemodynamic mechanisms. it improves ce', NULL, NULL, 1075, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'C01EB15', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18655, 'Aaa', 'ششش', '9', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 750, '2022-10-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18656, 'Eutaxer 20 mg vial', 'يوتاكسير 20 مجم فيال', '350', NULL, 'Antineoplastic', 'Docetaxel', 'Hikma specialized pharmaceuticals', 'Vial', 'فيال', '20 mg', '1', NULL, 'about docetaxel antimicrotubular natural source (plant) derivative taxane derivative antineoplastic. mechanism of action of docetaxel this paclitaxel congener binds to beta tubuline and enhances the polymerization of tubuline to stable microtubules. it al', NULL, NULL, 829, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel reversibly binds to tubulin with high affinity in a 1:1 stoichiometric ratio', '["L01CD02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18657, 'Eutaxer 80 mg vial', 'يوتاكسير 80 مجم فيال', '1,350', NULL, 'Antineoplastic', 'Docetaxel', 'Hikma specialized pharmaceuticals', 'Vial', 'فيال', '80 mg', '1', NULL, 'about docetaxel antimicrotubular natural source (plant) derivative taxane derivative antineoplastic. mechanism of action of docetaxel this paclitaxel congener binds to beta tubuline and enhances the polymerization of tubuline to stable microtubules. it al', NULL, NULL, 1056, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Docetaxel is a clinically well established anti-mitotic chemotherapy medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer. Docetaxel reversibly binds to tubulin with high affinity in a 1:1 stoichiometric ratio', '["L01CD02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18658, 'Euthyrox 100mcg 50 tab.', 'يوثيروكس 100 ميكروجرام 50 قرص', '70', '44', 'Thyroid hormone', 'Levothyroxine', 'Merck kgaa f.r.germany > amoun', 'Tab', 'أقراص', '100mcg', '2', 'هرمون الغدة الدرقية', 'indication for use alone or in combination with antithyroid agents to treat hypothyroidism goiter chronic lymphocytic thyroiditis myxedema coma and stupor. mechanism of action levothyroxine acts like the endogenous thyroid hormone thyroxine (t4 a tetra-io', '6221025018359', '01040548399999871726123110G027NJ 2145376034685', 13435, '2024-10-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Levothyroxine is a synthetically produced form of thyroxine, a major endogenous hormone secreted by the thyroid gland.[F4633] Also known as L-thyroxine or the brand name product Synthroid, levothyroxine is used primarily to treat hypothyroidism, a condition where the thyroid gland is no longer able to produce sufficient quantities of the thyroid hormones T4(tetraiodothyronine or thyroxine) and T3(triiodothyronine or [DB00279]), resulting in diminished down-stream effects of these hormones. Without sufficient quantities of circulating thyroid hormones, symptoms of hypothyroidism begin to develop such as fatigue, increased heart rate, depression[A179620], dry skin and hair, muscle cramps, constipation, weight gain, memory impairment, and poor tolerance to cold temperatures.[F4636,A35722]

In response to Thyroid Stimulating Hormone (TSH) release by the pituitary gland, a normally functioning thyroid gland will produce and secrete T4, which is then converted through deiodination (by type I or type II 5′-deiodinases)[A179941] into its active metabolite T3. While T4is the major product secreted by the thyroid gland,  T3exerts the majority of the physiological effects of the thyroid hormones; T4and T3have a relative potency of ~1:4 (T4:T3).[F4633] T4and T3act on nearly every cell of the body, but have a particularly strong effect on the cardiac system.[A179935] As a result, many cardiac functions including heart rate, cardiac output, and systemic vascular resistance are closely linked to thyroid status.[A179938]

Prior to the development of levothyroxine, [DB09100] or desiccated thyroid, used to be the mainstay of treatment for hypothyroidism. However, this is no longer recommended for the majority of patients due to several clinical concerns including limited controlled trials supporting its use. Desiccated thyroid products contain a ratio of T4 to T3 of 4.2:1, which is significantly lower than the 14:1 ratio of secretion by the human thyroid gland. This higher proportion of T3 in desiccated thyroid products can lead to supraphysiologic levels of T3 which may put patients at risk of thyrotoxicosis if thyroid extract therapy is not adjusted according to the serum TSH.[A35722, F4636]', '["H03AA01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18659, 'Euthyrox 25mcg 100 tab.', 'يوثيروكس 25 مكجم 100 قرص', '30', NULL, 'Thyroid hormone', 'Levothyroxine', 'Merck kgaa f.r.germany > amoun', 'Tab', 'أقراص', '25mcg', '1', NULL, 'indication for use alone or in combination with antithyroid agents to treat hypothyroidism goiter chronic lymphocytic thyroiditis myxedema coma and stupor. mechanism of action levothyroxine acts like the endogenous thyroid hormone thyroxine (t4 a tetra-io', NULL, NULL, 4050, '2022-10-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Levothyroxine is a synthetically produced form of thyroxine, a major endogenous hormone secreted by the thyroid gland.[F4633] Also known as L-thyroxine or the brand name product Synthroid, levothyroxine is used primarily to treat hypothyroidism, a condition where the thyroid gland is no longer able to produce sufficient quantities of the thyroid hormones T4(tetraiodothyronine or thyroxine) and T3(triiodothyronine or [DB00279]), resulting in diminished down-stream effects of these hormones. Without sufficient quantities of circulating thyroid hormones, symptoms of hypothyroidism begin to develop such as fatigue, increased heart rate, depression[A179620], dry skin and hair, muscle cramps, constipation, weight gain, memory impairment, and poor tolerance to cold temperatures.[F4636,A35722]

In response to Thyroid Stimulating Hormone (TSH) release by the pituitary gland, a normally functioning thyroid gland will produce and secrete T4, which is then converted through deiodination (by type I or type II 5′-deiodinases)[A179941] into its active metabolite T3. While T4is the major product secreted by the thyroid gland,  T3exerts the majority of the physiological effects of the thyroid hormones; T4and T3have a relative potency of ~1:4 (T4:T3).[F4633] T4and T3act on nearly every cell of the body, but have a particularly strong effect on the cardiac system.[A179935] As a result, many cardiac functions including heart rate, cardiac output, and systemic vascular resistance are closely linked to thyroid status.[A179938]

Prior to the development of levothyroxine, [DB09100] or desiccated thyroid, used to be the mainstay of treatment for hypothyroidism. However, this is no longer recommended for the majority of patients due to several clinical concerns including limited controlled trials supporting its use. Desiccated thyroid products contain a ratio of T4 to T3 of 4.2:1, which is significantly lower than the 14:1 ratio of secretion by the human thyroid gland. This higher proportion of T3 in desiccated thyroid products can lead to supraphysiologic levels of T3 which may put patients at risk of thyrotoxicosis if thyroid extract therapy is not adjusted according to the serum TSH.[A35722, F4636]', '["H03AA01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18660, 'Aaa', 'ششش', '23', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 800, '2022-10-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18661, 'Euvax-b 20mcg/ml i.m (0.5ml) vial', 'ايفاكس-بي 20 ميكروجرام/مل (0.5مل) فيال', '8', NULL, 'Vaccine', 'Vaccine hepatitis b', 'Lg life science ltd -korea > egycopharm', 'Vial', 'فيال', '20mcg', '1', NULL, NULL, NULL, NULL, 918, '2022-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18662, 'Euvax-b 20mcg/ml i.m (10ml) vial', 'ايفاكس-بي 20 ميكروجرام/مل (10مل) فيال', '74', NULL, 'Vaccine', 'Vaccine hepatitis b', 'Lg life science ltd -korea > egycopharm', 'Vial', 'فيال', '20mcg', '1', NULL, NULL, NULL, NULL, 856, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18663, 'Euvax-b 20mcg/ml i.m (1ml) vial', 'ايفاكس-بي 20 ميكروجرام/مل (1مل) فيال', '15', NULL, 'Vaccine', 'Vaccine hepatitis b', 'Lg life science ltd -korea > egycopharm', 'Vial', 'فيال', '20mcg', '1', NULL, NULL, NULL, NULL, 842, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18664, 'Euvax-b 20mcg/ml i.m (5ml) vial', 'ايفاكس-بي 20 ميكروجرام/مل (5مل) فيال', '37', NULL, 'Vaccine', 'Vaccine hepatitis b', 'Lg life science ltd -korea > egycopharm', 'Vial', 'فيال', '20mcg', '1', NULL, NULL, NULL, NULL, 890, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18666, 'Aaa', 'ششش', '10', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 712, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18667, 'Aaa', 'ششش', '36', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 681, '2022-10-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18668, 'Evastine 10mg 20 f.c.tab.', 'ايفاستين 10مجم 20 قرص', '54', '36', 'Antihistamine.antiallergy', 'Ebastine', 'Marcyrl co.', 'Tab', 'أقراص', '10mg', '2', NULL, 'about ebastine second generation long-acting and selective h1 antagonist non-sedative antihistamine. mechanism of action of ebastine drug and its active metabolite is selective peripheral histamine h1 receptor antagonist. thus it prevents the attachment o', '6223003570248', NULL, 5283, '2024-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R06AX22', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18669, 'Aaa', 'ششش', '14', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 673, '2023-01-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18670, 'Evening primrose oil 1000 mg 120 softgels (illegal import)', 'زيت زهرة الربيع المسائية 1000 مجم 120 كبسولة', '0', NULL, 'Evening primrose oil', 'Evening primrose oil+cis-linoleic acid(la)+gamma-linolenic acid(gla)', 'Puritans pride', 'Gel', 'جل', '1000 mg', '1', NULL, 'for centuries epo has been used to provide nutritional support for women with premenstrual syndrome (pms); it may also play a role in promoting smooth healthy-looking skin.** these easy-to-swallow softgels are a natural source of gla (gamma linolenic acid', NULL, NULL, 1171, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18671, 'Evening primrose oil 500 mg 100 softgels (illegal import)', 'زيت زهرة الربيع المسائية 500 مجم 100 كبسولة', '0', NULL, 'Evening primrose oil', 'Evening primrose oil+cis-linoleic acid(la)+gamma-linolenic acid(gla)', 'Puritans pride', 'Gel', 'جل', '500 mg', '1', NULL, 'for centuries epo has been used to provide nutritional support for women with premenstrual syndrome (pms); it may also play a role in promoting smooth healthy-looking skin. these easy-to-swallow softgels are a natural source of gla (gamma linolenic acid).', NULL, NULL, 956, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18672, 'Evirinse vag.douche 250 ml', 'افرينز دش مهبلي 250 مل', '37', NULL, 'Vaginal wash', 'Alum+chamomile extract+thymol+menthol+calendula extract+rosemary extract+vitamin c', 'Macro group pharmaceuticals', 'Unknown', 'غير محدد', '250 ml', '1', NULL, '*external wash for intimate female care with bio active vitamin system *helps in restoring healthy vaginal moisturization & natural physiological vaginal ph *contains natural antimicrobial cooling refreshing & soothing ingredients use: 1-2 provided measur', '6224000437619', NULL, 687, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18673, 'Aaa', 'ششش', '95', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '2', NULL, NULL, NULL, NULL, 583, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18674, 'E-viton 100 mg 20 caps.', 'اي-فيتون 100مجم 20 كبسولة', '3', NULL, 'Vitamin e', 'Vitamin e', 'Kahira', 'Cap', 'كبسولة', '100 mg', '2', NULL, 'mechanism of action of vitamin e vitamin e acts as an antioxidant and protecting unsaturated lipids in the cell membrane coenzyme q vitamin a vitamin c etc. from free radical oxidation damage and generation of toxic peroxidation products. it also decrease', '6221068101070', NULL, 1254, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'In 1922, vitamin E was demonstrated to be an essential nutrient[A32448]. Vitamin E is a term used to describe 8 different fat soluble tocopherols and tocotrienols, alpha-tocopherol being the most biologically active[A176104]. Vitamin E acts as an antioxidant, protecting cell membranes from oxidative damage[A176104]. The antioxidant effects are currently being researched for use in the treatment of diseases causing bone loss, cardiovascular diseases, diabetes mellitus and associated comorbidities, eye diseases, inflammatory diseases (including skin conditions), lipid disorders, neurological diseases, and radiation damage[A176369]. Though this research is so far inconclusive, vitamin E remains a popular supplement and is generally considered safe by the FDA[FDA Label].', '[]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18675, 'Aaa', 'ششش', '40', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 756, '2022-07-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18676, 'Exacinop 750 mg 10 f.c. tabs.', 'اكساسينوب 750 مجم 10 اقراص', '80', '55.5', 'Antibiotic.quinolone', 'Levofloxacin', 'El-obour > massa group pharma', 'Tab', 'أقراص', '750 mg', '1', NULL, NULL, NULL, NULL, 1176, '2023-10-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Levofloxacin is a fluoroquinolone antibiotic and the optical S-(-) isomer of racemic [ofloxacin].[A190663] It reportedly carries 8 to 128-fold more activity against both gram-negative and gram-positive bacteria compared to R-(+)-ofloxacin[A190663] and remains stereochemically stable following administration (i.e. it does not invert to the inactive isomer).[L11638] Levofloxacin, along with other quinolones such as [gatifloxacin] and [moxifloxacin], is a member of the third generation of fluoroquinolones, colloquially referred to as the "respiratory quinolones" due to improved activity against gram-positive bacteria commonly implicated in respiratory infections.[A31453,A190756]

Levofloxacin was first approved by the FDA in 1996, and was approved in Canada and several South American countries soon after.[A190663]', '["J01MA12", "A02BD10", "J01RA05", "S01AE05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18677, 'Exact 150mg 30 caps.', 'اكساكست 150 مجم 30 كبسولة', '18', NULL, 'Liver support supplements', 'Silymarin', 'Napco', 'Cap', 'كبسولة', '150mg', '3', NULL, 'about silymarin a polyphenolic flavonoid hepatoprotective(antihepatotoxic) antioxidant. mechanism of action of silymarin silymarin stimulates rna polymerase a and results in an increase in ribosomal protein synthesis and leads to the synthesis of new hepa', NULL, NULL, 948, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A05BA03', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18678, 'Aaa', 'ششش', '63', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 671, '2022-07-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18679, 'Examide 10mg/ml amp. for i.v inj.', 'اكساميد 10مجم/مل امبول', '15', '11.25', 'Diuretic.loop', 'Torsemide', 'Sunny pharmaceuticals > multi-apex', 'Inj', 'حقن', '10mg', '1', NULL, 'about torsemide pyridine-sulfonylurea class loop diuretic antihypertensive in chf diuretic. mechanism of action of torsemide torsemide is a high ceiling loop diuretic which exerts it`s diuretic action by acting at site-2(thick ascending loop of henle). it', '6223003204761', NULL, 1086, '2023-09-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18681, 'Examide 5mg 30 tabs.', 'اكساميد 5مجم 30 قرص', '66', '48', 'Diuretic.loop', 'Torsemide', 'Multi-apex', 'Tab', 'أقراص', '5mg', '3', 'مدر للبول يستخدم فى علاج تجمع السوائل (الوذمة) المرتبطة بقصور القلب الاحتقاني، أمراض الكبد، أو الكلى . يستخدم هذا الدواء وحده أو مع غيره من الأدوية لعلاج ارتفاع ضغط الدم.', NULL, '6223003204198', NULL, 5879, '2024-11-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18682, 'Exaretic 10 mg 30 tab', 'ايكساريتيك 10 مجم 30 قرص', '108', '81', 'Diuretic.loop', 'Torsemide', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '10 mg', '3', NULL, NULL, '6223004900532', NULL, 1730, '2025-01-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18683, 'Exaretic 20 mg 30 tab.', 'ايكساريتيك 20 مجم 30 قرص', '141', '106.5', 'Diuretic.loop', 'Torsemide', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '20 mg', '3', 'مدر للبول يستخدم فى علاج ارتفاع ضغط الدم وعلاج احتباس السوائل (الوذمة) المصاحبة لأمراض فشل القلب الاحتقاني، الكبد، الكلى.', NULL, '6223004900549', NULL, 3654, '2025-01-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18684, 'Exaretic 20mg/2ml 3 amp', 'ايكساريتيك 10 مجم /2 مل 3 امبولات', '48', '32.5', 'Diuretic.loop', 'Torsemide', 'Global napi pharmaceuticals', 'Amp', 'أمبول', '20mg', '3', NULL, 'about torsemide pyridine-sulfonylurea class loop diuretic antihypertensive in chf diuretic. mechanism of action of torsemide torsemide is a high ceiling loop diuretic which exerts it`s diuretic action by acting at site-2(thick ascending loop of henle). it', '6223004900556', NULL, 1072, '2025-01-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18685, 'Aaa', 'ششش', '13', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 728, '2022-10-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18686, 'Aaa', 'ششش', '13', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 745, '2022-10-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18687, 'Excelsa 10mg 14 f.c.tab.', 'اكسيلسا 10مجم 14 قرص', '66', '36', 'Psychiatric.antidepressants', 'Escitalopram', 'Pharopharma', 'Tab', 'أقراص', '10mg', '2', 'مضاد اكتئاب --مهدئ نفسي -- الامراض النفسية والعصبية -- يؤخذ تحت اشراف طبي', NULL, '6221094502742', NULL, 1341, '2024-10-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18688, 'Excelsa 10mg 7 f.c.tab', 'اكسيلسا 10مجم 7 اقراص', '33', '18', 'Psychiatric.antidepressants', 'Escitalopram', 'Pharopharma', 'Tab', 'أقراص', '10mg', '1', 'مضاد اكتئاب --مهدئ نفسي -- الامراض النفسية والعصبية -- يؤخذ تحت اشراف طبي', NULL, '6221094035929', NULL, 1910, '2024-10-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18689, 'Excelsa 20mg 14 f.c.tab.', 'اكسيلسا 20 مجم 14 قرص', '114', '67.2', 'Psychiatric.antidepressants', 'Escitalopram', 'Pharopharma', 'Tab', 'أقراص', '20mg', '2', 'مضاد اكتئاب --مهدئ نفسي -- الامراض النفسية والعصبية -- يؤخذ تحت اشراف طبي', NULL, '6221094001177', NULL, 1101, '2024-10-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18690, 'Excelsa 20mg 7 f.c.tab.', 'اكسيلسا 20 مجم 7 اقراص', '57', '33.6', 'Psychiatric.antidepressants', 'Escitalopram', 'Pharopharma', 'Tab', 'أقراص', '20mg', '1', 'مضاد اكتئاب --مهدئ نفسي -- الامراض النفسية والعصبية -- يؤخذ تحت اشراف طبي', NULL, '6221094035936', NULL, 1061, '2024-11-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Escitalopram is a selective serotonin re-uptake inhibitor (SSRI) and the S-enantiomer of racemic [citalopram].[A185420] It is used to restore serotonergic function in the treatment of depression and anxiety.[L8513,L8516,L8522] Escitalopram is approximately 150 times more potent than citalopram’s R-enantiomer and is responsible for the vast majority of citalopram’s clinical activity, with some evidence suggesting that the R-enantiomer of racemic citalopram actively dampens the activity of escitalopram rather than existing simply as an inactive enantiomer.[A39738,A185819] Amongst SSRIs, escitalopram exerts the highest degree of selectivity for the serotonin transporter (SERT) relative to other off-targets which may explain its lower rates of adverse effects as compared to other agents in this class.[A185726] Escitalopram also differentiates itself from other SSRIs via allosteric action on its target - this may be the mechanism responsible for its observed superior efficacy and faster onset compared to other SSRIs.[A185825,A185726,A185822]', '["N06AB10"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18691, 'Exe top syrup 120ml', 'اكسي توب شراب 120 مل', '9', NULL, 'Cough drugs', 'Guaifenesin+oxomemazine+paracetamol(acetaminophen)', 'Sigma > top pharm', 'Syrup', 'شراب', '120ml', '1', NULL, 'description an expectorant that also has some muscle relaxing action mechanism of action guaifenesin may act as an irritant to gastric vagal receptors and recruit efferent parasympathetic reflexes that cause glandular exocytosis of a less viscous mucus mi', '6221051840276', NULL, 861, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18692, 'Exeedolip 1 gm 30 s.g.caps.', 'اكسيدوليب 1جم 30 كبسولة', '576', '441', 'Antihyperlipidemic', 'Icosapent ethyl', 'Arab caps > xeedia pharma', 'Cap', 'كبسولة', '1 gm', '3', 'خافض للكوليسترول والدهون في الدم', 'severe hypertriglyceridemia indicated as an adjunct to diet to reduce high triglyceride levels (ie =500 mg/dl) mechanism of action ethyl ester of eicosapentaenoic acid (epa); epa has been shown to reduce hepatic very low-density lipoprotein triglycerides', NULL, NULL, 10786, '2024-12-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18693, 'Exelon 1.5mg 14 caps.', 'اكسيلون 1.5 مجم - 14 كبسولة', '105', NULL, 'Anticholinesterase', 'Rivastigmine', 'Novartis', 'Cap', 'كبسولة', '1.5mg', '1', NULL, 'about rivastigmine a central reversible non competitive anticholinesterase antidementia. mechanism of action of rivastigmine alzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another.', NULL, NULL, 827, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer''s type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.', '["N06DA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18694, 'Exelon 1.5mg 28 caps.', 'اكسيلون 1.5 مجم 28 كبسولة', '350', '210', 'Anticholinesterase', 'Rivastigmine', 'Novartis', 'Cap', 'كبسولة', '1.5mg', '2', NULL, 'about rivastigmine a central reversible non competitive anticholinesterase antidementia. mechanism of action of rivastigmine alzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another.', NULL, NULL, 733, '2024-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer''s type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.', '["N06DA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18695, 'Exelon 18 mg 10 cm 9.5mg/24h 30 transdermal patches', 'اكسيلون 9مجم 5 سم 4.5مجم/24 ساعة 30 لصقة', '1,069', '822', 'Anticholinesterase', 'Rivastigmine', 'Lts lohmann therapie systeme ag-germany > novartis', 'Patch', 'لصقة', '18 mg', '1', NULL, 'about rivastigmine a central reversible non competitive anticholinesterase antidementia. mechanism of action of rivastigmine alzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another.', NULL, NULL, 1022, '2024-12-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer''s type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.', '["N06DA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18696, 'Exelon 3mg 14 caps.', 'اكسيلون 3 مجم 14 كبسولة', '105', NULL, 'Anticholinesterase', 'Rivastigmine', 'Novartis', 'Cap', 'كبسولة', '3mg', '1', NULL, 'about rivastigmine a central reversible non competitive anticholinesterase antidementia. mechanism of action of rivastigmine alzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another.', NULL, NULL, 983, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer''s type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.', '["N06DA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18697, 'Exelon 3mg 28 caps.', 'اكسيلون 3 مجم 28 كبسولة', '350', '210', 'Anticholinesterase', 'Rivastigmine', 'Novartis', 'Cap', 'كبسولة', '3mg', '2', NULL, 'about rivastigmine a central reversible non competitive anticholinesterase antidementia. mechanism of action of rivastigmine alzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another.', NULL, NULL, 858, '2024-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer''s type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.', '["N06DA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18698, 'Exelon 4.5mg 14 caps.', 'اكسيلون 4.5 مجم 14 كبسولة', '105', NULL, 'Anticholinesterase', 'Rivastigmine', 'Novartis', 'Cap', 'كبسولة', '4.5mg', '1', NULL, 'about rivastigmine a central reversible non competitive anticholinesterase antidementia. mechanism of action of rivastigmine alzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another.', NULL, NULL, 767, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer''s type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.', '["N06DA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18699, 'Exelon 4.5mg 28 caps.', 'اكسيلون 4.5 مجم 28 كبسولة', '350', '210', 'Anticholinesterase', 'Rivastigmine', 'Novartis', 'Cap', 'كبسولة', '4.5mg', '2', NULL, 'about rivastigmine a central reversible non competitive anticholinesterase antidementia. mechanism of action of rivastigmine alzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another.', NULL, NULL, 689, '2024-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer''s type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.', '["N06DA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18700, 'Exelon 6 mg 14 caps.', 'اكسيلون 6 مجم 14 كبسولة', '105', NULL, 'Anticholinesterase', 'Rivastigmine', 'Novartis', 'Cap', 'كبسولة', '6 mg', '1', NULL, 'about rivastigmine a central reversible non competitive anticholinesterase antidementia. mechanism of action of rivastigmine alzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another.', NULL, NULL, 949, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer''s type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.', '["N06DA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18701, 'Exelon 6mg 28 caps.', 'اكسيلون 6 مجم 28 كبسولة', '350', '210', 'Anticholinesterase', 'Rivastigmine', 'Novartis', 'Cap', 'كبسولة', '6mg', '2', NULL, 'about rivastigmine a central reversible non competitive anticholinesterase antidementia. mechanism of action of rivastigmine alzheimer`s disease may result from a deficiency in neurotransmitters used by nerves in the brain to communicate with one another.', NULL, NULL, 681, '2024-12-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer''s type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase.', '["N06DA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18702, 'Lierre syrup 100 ml', 'ليير شراب 100 مل', '50', '39', 'Anti-cough antitussive expectorant', 'Ivy extract+thyme extract+licorice extract', 'Better health pharm', 'Syrup', 'شراب', '100 ml', '1', 'مكمل غذائى مضاد للسعال وطارد للبلغم يدعم الجهاز التنفسي ويخفف من اعراض البرد', NULL, NULL, NULL, 764, '2025-05-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18707, 'Aaa', 'ششش', '1,350', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 715, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18708, 'Aaa', 'ششش', '2,550', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 751, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18710, 'Exluton 0.5mg 28 tab.', 'اكسلوتون 0.5مجم 28 قرص', '11', NULL, 'Contraceptives', 'Lynestrenol', 'Schering plough > merck sharp & dohme scientific office', 'Tab', 'أقراص', '0.5mg', '1', NULL, 'about lynestrenol synthetic progestogen hormonal contraception mechanism of action of lynestrenol as a synthetic oral progestogen lynestrenol has similar effects as that of the natural progesterone hormone. it has a strong progestational effect on the ute', NULL, NULL, 950, '2022-12-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'G03AC02', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18711, 'Exocalm massage cream 50 gm', 'ايكسوكالم كريم مساج 50جم', '45', NULL, 'Massage', 'Ginger extract + wormwood extract + thyme extract + mint extract', 'Hi-care > violine', 'Cream', 'كريم', '50 gm', '1', NULL, NULL, NULL, NULL, 625, '2022-08-02', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18712, 'Exofol cream 60 gm', 'اكسوفول كريم 60 جرام', '65', '55', 'Anti-acne', 'Vitamin c+glycerol+glycolic acid+salicylic acid+urea+zinc oxide+licorice extract+triethanolamine', 'Hi-care > roventis pharma', 'Cream', 'كريم', '60 gm', '1', 'علاج حب الشباب', 'indications ï¿½ treatment of acne and management of acne scars. ï¿½ peeling procedures. ï¿½ lightening moisturizing and softening the skin. ***directions for use apply exofol cream to the affected area once or twice a day with gentle rubbing until complet', '6224011042147', NULL, 2281, '2025-01-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18713, 'Exofol soap 80 gm', 'اكسوفول صابونة 80 جم', '55', '45', 'Anti-acne', NULL, 'Hi-care > roventis pharma', 'Soap', 'صابون', '80 gm', '1', NULL, 'indications ï¿½helps in the exfoliation of cracked and darkened areas like elbows knees & feet . ï¿½helps in the exfoliation of hyperpigmented areas due to acne scars sun damage. ï¿½acts as cleansing soap moisturizer & improves elasticity and smoothness o', NULL, NULL, 1015, '2025-01-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18715, 'Expectoflu 20 caps.', 'اكسبكتوفلو 20 كبسولة', '28', NULL, 'Cold drugs', 'Guaifenesin+paracetamol(acetaminophen)+phenylepherine', 'International drug agency (idi) > novell pharma', 'Cap', 'كبسولة', NULL, '2', 'علاج ادوار البرد والانفلونزا --علاج السعال و العطس -- علاج الكحة و التخلص من البلغم', 'effective for cold & flu.', '6223004071423', NULL, 2379, '2023-05-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18716, 'Expectyl syrup 120ml', 'اكسبكتيل شراب 120 مل', '5', NULL, 'Cough drugs', 'Ammonium chloride+promethazine+senega extract+sodium benzoate+squill tincture', 'Arab drug company.', 'Syrup', 'شراب', '120ml', '1', 'مهدئ للسعال -- حالات الكحة المصحوبة بالبلغم -- طارد ومذيب للبلغم -- حالات البرد المصحوبة بالكحة', 'about ammonium chloride ammonium compound acidifier expectorant.', '6221060001149', NULL, 1115, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'D04AA10', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18717, 'Exquiste massage gel 60 gm', 'اكسكويست جل مساج 60 جم', '24', NULL, 'Massage', 'Glycerin+phenoxyethanol+menthol+chamomile oil+carbomer+potassium sorbate+horse chestnut+xanthan gum', 'Egyptian company for cosmetics > miracle', 'Gel', 'جل', '60 gm', '1', NULL, NULL, NULL, NULL, 511, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18718, 'Exquiste massage gel 75 gm', 'اكسكويست جل مساج 60 جم', '45', NULL, 'Massage', 'Glycerin+phenoxyethanol+menthol+chamomile oil+carbomer+potassium sorbate+horse chestnut+xanthan gum', 'Egyptian company for cosmetics > miracle', 'Gel', 'جل', '75 gm', '1', NULL, NULL, NULL, NULL, 570, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18719, 'Extra calcium 30 chew. pieces', 'اكسترا كالسيوم 30 قرص مضغ', '35', NULL, 'Calcium supplement', 'Calcium+vitamin d3+vitamin k', 'B.m. > maxben pharmaceutical', 'Piece', 'قطعة', NULL, '1', NULL, NULL, NULL, NULL, 1269, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18720, 'Extra clear eye drops 15 ml', 'اكسترا كلير قطرة 15 مل', '6', NULL, 'Ophthalmic decongestant', 'Tetrahydrozoline+zinc sulphate', 'Rameda > pharco', 'Drops', 'نقط', '15 ml', '1', NULL, 'tetrahydrozoline is a decongestant used to relieve redness in the eyes caused by minor eye irritations (e.g. smog swimming dust or smoke). it belongs to a class of drugs known as sympathomimetic amines. it works by temporarily narrowing the blood vessels', NULL, NULL, 833, '2022-07-30', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18721, 'Extra cream 50 gm', 'اكسترا كريم 30 جم', '65', '45', 'Haemorrhoids', 'Glycerin+glyceryl trinitrate+clove extract+panthenol+grape seed oil+chamomile extract+wheat germ oil', 'El-helou perfumes & cosmetics > master pharma', 'Cream', 'كريم', '50 gm', '1', 'علاج البواسير -- تقليل الالتهابات اثناء التبرز -- تقليل الالام و الحكة والنزيف', 'emollient cream', NULL, NULL, 3655, '2024-10-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18723, 'Extra protein powder 10 sachets', 'اكسترا بروتين بودرة 10 اكياس', '220', '200', 'Dietary supplement', 'Skimmed milk+whey protein+maltodextrine+sucrose+natural flavour', 'Lemaco egypt > eval pharma', 'Powder', 'بودرة', NULL, '1', 'مكمل غذائي.', 'dose: 2-3 sachets / day (to be added to 1 cup of milk)', NULL, NULL, 10745, '2025-07-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18724, 'Extra vitol plus syrup 120 ml', 'اكسترا فيتول بلس 120 مل', '16', NULL, 'Multivitamins', 'Multivitamins+minerals', 'Modern pharma > rashdeen pharma group', 'Syrup', 'شراب', '120 ml', '1', NULL, NULL, NULL, NULL, 931, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18726, 'Aaa', 'ششش', '34', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 799, '2022-07-19', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18727, 'Extrasolv syrup 120 ml', 'اكستراسولف شراب 120 مل', '9', NULL, 'Anti-cough.antitussive and expectorant', 'Carbocysteine+guaifenesin+oxomemazine', 'Sabaa > pharmakon pharmaceuticals', 'Syrup', 'شراب', '120 ml', '1', 'مضاد للسعال وطارد للبلغم ويدعم الجهاز التنفسي', NULL, NULL, NULL, 1353, '2022-06-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18728, 'Extrauma dna cream 40 gm', 'اكستروما دي إن إيه كريم 25 جم', '31', NULL, 'Anticoagulant.direct thrombin inhibitor', 'Recombinant hirudin', 'Mina pharm', 'Cream', 'كريم', '40 gm', '1', '1- علاج الكدمات والتجمعات الدموية.', 'indication : contusions distortions muscular tears traumatic hematomas edema erythema varicositis periphlebitis and anal periphlebitis with hemorrhoids. dose : dispense 2-3 cm of cream two ï¿½ three times per day and carry out a light massage until comple', NULL, NULL, 2855, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18729, 'Extrauma dna forte topical gel 25 gm', 'اكستروما دى ان اي فورت جل 25 جم', '41', '27', 'Anti-inflammatory', 'Hirudin', 'Mina pharm', 'Gel', 'جل', '25 gm', '1', '1- علاج الكدمات والتجمعات الدموية.', 'indication : contusions distortions muscular tears traumatic hematomas edema erythema varicositis periphlebitis and anal periphlebitis with hemorrhoids. dose : dispense 2-3 cm of gel two ï¿½ three times per day and carry out a light massage until complete', '6222003701959', NULL, 5613, '2024-08-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18730, 'Extrauma dna forte topical gel 40 gm', 'اكستروما دي ان ايه فورت جل 40 جم', '58', '39', 'Anti-inflammatory', 'Hirudin', 'Mina pharm', 'Gel', 'جل', '40 gm', '1', '1- علاج الكدمات والتجمعات الدموية.', 'indication : contusions distortions muscular tears traumatic hematomas edema erythema varicositis periphlebitis and anal periphlebitis with hemorrhoids. dose : dispense 2-3 cm of gel two ï¿½ three times per day and carry out a light massage until complete', '6222003702666', NULL, 1691, '2024-08-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18731, 'Aaa', 'ششش', '48', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 784, '2023-01-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18734, 'Eye clear 0.05% eye drops 15 ml', 'اي كلير 0.05% محلول معقم للعين 15 مل', '6', NULL, 'Ophthalmic decongestant', 'Tetrahydrozoline', 'Pharco', 'Drops', 'نقط', '0.05%', '1', NULL, 'tetrahydrozoline is a decongestant used to relieve redness in the eyes caused by minor eye irritations (e.g. smog swimming dust or smoke). it belongs to a class of drugs known as sympathomimetic amines. it works by temporarily narrowing the blood vessels', '6221151000860', NULL, 985, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18735, 'Eye mix eye contour gel 30 gm', 'ايي ميكس جل 30 ​​جم', '295', '250', 'Eye contour', 'Caffeine+glutathion+glycolic acid+ coenzyme q10', 'Egyptian company for cosmetics > pharmix', 'Gel', 'جل', '30 gm', '1', NULL, 'for dark circles around the eye.', NULL, NULL, 753, '2025-08-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18736, 'E-yeast 20 caps', 'اي-يست 20 كبسولة', '125', '90', 'Multivitamins', 'Wheat germ oil+dry yeast', 'Arab caps > tristar', 'Cap', 'كبسولة', NULL, '2', NULL, NULL, '6224000879013', NULL, 5986, '2025-09-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18737, 'We kids 30ml oral drops', 'وي كيدز نقط فم 30 مل', '50', NULL, 'Multi vitamins', 'Dhe(omega3)+vitamin d3+vitamin e', 'We pharma', 'Drops', 'نقط', '30ml', '1', NULL, NULL, NULL, NULL, 585, '2022-10-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18738, 'Eylea 40mg sol. for intravitreal inj.', 'ايليا 40مجم محلول للحقن بالعين', '12,250', '8260', 'Antineoplastic', 'Aflibercept', 'Bayer bitterfeld gmbh-germany > bayer healthcare', 'Inj', 'حقن', '40mg', '1', NULL, 'eylea is indicated for the treatment of: neovascular (wet) age-related macular degeneration (amd) macular edema following retinal vein occlusion (rvo) diabetic macular edema (dme) diabetic retinopathy (dr) in patients with dme', NULL, NULL, 1239, '2024-03-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Aflibercept is a recombinant protein composed of the binding domains of two human vascular endothelial growth factor (VEGF) receptors fused with the Fc region of human immunoglobulin gamma 1 (IgG1). Structurally, Aflibercept is a dimeric glycoprotein with a protein molecular weight of 96.9 kilo Daltons (kDa). It contains approximately 15% glycosylation to give a total molecular weight of 115 kDa. All five putative N-glycosylation sites on each polypeptide chain predicted by the primary sequence can be occupied with carbohydrate and exhibit some degree of chain heterogeneity, including heterogeneity in terminal sialic acid residues, except at the single unsialylated site associated with the Fc domain. Aflibercept, as an ophthalmic agent, is used in the treatment of macular edema following Central Retinal Vein Occlusion (CRVO) and neovascular Age-Related Macular Degeneration (AMD). Ziv-aflibercept, under the brand name Zaltrap, was developed as an injection for treatment of metastatic colorectal cancer. FDA approved in November 18, 2011 and EMA approved in November 2012.', '["S01LA05", "L01XX44"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18739, 'Talinorose 250 ml intimate feminine wash', 'تالينوروز غسول مهبلي 250 مل', '55', NULL, 'Intimate feminine wash', 'Citric acid+rose oil+chamomile+tea tree oil+aloe vera+triclosan', 'Taleno pharma', 'Unknown', 'غير محدد', '250 ml', '1', NULL, NULL, NULL, NULL, 1334, '2022-08-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18740, 'Ezadex 5% cream 20 gm (n/a)', 'ايزاديكس 5% كريم 20 جم', '18', NULL, 'Antineoplastic', 'Fluorouracil', 'Kahira > multipharma', 'Cream', 'كريم', '5%', '1', NULL, 'description a pyrimidine analog that is an antineoplastic antimetabolite. it interferes with dna synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid mechanism of action the precise mechanism of action has n', NULL, NULL, 1346, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the thymidylate synthetase conversion of deoxyuridylic acid to thymidylic acid.', '["L01BC52", "L01BC02"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18741, 'Azotec flex roll on 80 ml', 'ازوتك فلكس رول اون 80 مل', '200', '170', 'Massage roll on', 'Rosmarinus officinalis extract (rosemary)+hydrogenated potato starch+allium sativum bulb extract+magnesium sulfate+zinc oxide+phenoxyethanol+menthol+(camphora oil)+eugenia caryophyllus cinnamomum camphora bark oil carbomer+phenoxyethanol+aqua+eucalyptus globulus leaf oil (eucalyptus)+laurocapram+triethanolamine+aqua.', 'Koncieve', 'Unknown', 'غير محدد', '80 ml', '1', NULL, NULL, NULL, NULL, 891, '2025-12-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18743, 'Aaa', 'ششش', '22', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 733, '2023-04-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18744, 'Ezallin 2% topical paint 60 ml', 'ايزالين 2% مسة موضعية 60 مل', '26', NULL, 'Vitiligo', 'Khellin', 'Panax pharma > multipharma', 'Paint', 'مس/دهان', '2%', '1', 'حالات البهاق للاطفال والكبار', 'indication: vitiligo in adults and children. application: apply as a thin layer on the vitiliginous areas 30 minutes before sun exposure. the involved areas are then exposed to the morning or afternoon sun for 30-60 minutes. treatment should be carried ou', '6224010140219', NULL, 3352, '2023-04-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18746, 'Aaa', 'ششش', '22', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 790, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18747, 'Aaa', 'ششش', '8', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 712, '2022-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18749, 'Ambropro 20 mg 20 lozenges', 'امبرو برو 20 مجم 20 قرص', '64', '42', 'Mucolytic', 'Ambroxol', 'Penta pharma', 'Lozenges', 'استحلاب', '20 mg', '2', NULL, NULL, '6224007738368', NULL, 1576, '2024-10-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R02AD05', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18750, 'Bilastomed 12.5mg/5ml syrup 120 ml', 'بيلاستوميد 12.5مجم5 مل شراب 120 مل', '50', '36', 'Anti-histamine.second-generation', 'BILASTINE', 'Biomed', 'Syrup', 'شراب', '12.5mg', '1', NULL, NULL, NULL, NULL, 729, '2024-04-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'R06AX29', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18751, 'Cefaxotrez 500 mg i.v. vial', 'سيفاكسوتريز 500مجم وريد فيال', '63', '44', 'Antibiotic.cephalosporin.third-generation', 'Ceftriaxone', 'Boston care pharmaceuticals', 'Vial', 'فيال', '500 mg', '1', NULL, NULL, NULL, NULL, 710, '2025-06-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ceftriaxone is a broad-spectrum third-generation cephalosporin antibiotic.[A215582] It has a very long half-life compared to other cephalosporins and is high penetrable into the meninges[A215582], eyes[A215647], and inner ear[A215627]. Ceftriaxone has broader and stronger gram-negative coverage then first or second-generation cephalosporins, but worse activity against methicillin-susceptible S.aureus. Ceftriaxone is a commonly used antimicrobial due to its good activity against multi-drug resistant Enterobacteriaceae, its relatively safe adverse effect profile, and its long half-life which allows for the convenience of daily or twice-daily dosing.[A215582]', '["J01DD04", "J01DD54"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18755, 'E-ze-p 1mg 10 s.g. caps.', 'ايزي-بي 1 مجم 10 كبسولات', '6', NULL, 'Alpha1 blocker', 'Terazocin', 'European egyptian pharm. ind.', 'Cap', 'كبسولة', '1mg', '1', NULL, 'indication for the treatment of symptomatic bph and mild to moderate hypertension. mechanism of action in general a1-adrenergic receptors mediate contraction and hypertrophic growth of smooth muscle cells. a1-receptors are 7-transmembrane domain receptors', '6221076120605', NULL, 753, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18756, 'Gram bone 30 tab', 'جرام بون 30 قرص', '99', '81', 'Multivitamin', 'Calcium+vitamin d3', 'Pharma gram', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 794, '2025-08-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18757, 'E-ze-p 5mg 10 s.g. cap.', 'ايزي-بي 5 مجم 10 كبسولات', '11', NULL, 'Alpha1 blocker', 'Terazocin', 'European egyptian pharm. ind.', 'Cap', 'كبسولة', '5mg', '1', NULL, NULL, '6221076120629', NULL, 727, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18758, 'Aaa', 'ششش', '44', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 799, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18759, 'Ezequel 50 mg 4 f.c.tab.', 'ازيكويل 50 مجم 4 اقراص', '18', NULL, 'Tonic for men', 'Sildenafil', 'Copad pharma', 'Tab', 'أقراص', '50 mg', '1', NULL, 'about sildenafil citrate phosphodiesterase-5 enzyme inhibitor anti-erectile dysfunction agent. mechanism of action of sildenafil citrate sildenafil is a phosphodiesterase enzyme (pde5) inhibitor. this enzyme is responsible for the degradation cyclic guano', NULL, NULL, 1088, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'In eliciting its mechanism of action, sildenafil ultimately prevents or minimizes the breakdown of cyclic guanosine monophosphate (cGMP) by inhibiting cGMP specific phosphodiesterase type 5 (PDE5) [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614]. The result of doing so allows cGMP present in both the penis and pulmonary vasculature to elicit smooth muscle relaxation and vasodilation that subsequently facilitates relief in pulmonary arterial hypertension and the increased flow of blood into the spongy erectile tissue of the penis that consequently allows it to grow in size and become erect and rigid [F3850, F3853, F3856, F3859, F3883, F3886, L5611, L5614].

Interestingly enough, it is precisely via this mechanism why sildenafil was at first researched as a potential treatment for angina - or chest pain associated with inadequate blood flow to the heart - before being serendipitously indicated for treating erectile dysfunction in the late 1980s [A175732]. Nevertheless, it is because of this mechanism that sildenafil is also indicated for treating pulmonary arterial hypertension but is also additionally notorious for interacting with various anti-anginal or anti-hypertensive agents to develop potentially rapid, excessive, and/or fatal hypotensive crises [A175579, A175582, A175654].

Regardless, sildenafil, among a variety of other similar or related PDE5 inhibitors, has become a common and effective treatment for erectile dysfunction and since its formal approval for medical use in the public in 1998 [A175732], continues to see millions of prescriptions written for it internationally. Although the medication has historically been most popularly recognized as Pfizer''s brand name Viagra, sildenafil is currently available generically and even as a non-prescription over the counter medication in some countries [L5656].', '["G01AE10", "G04BE03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18760, 'Ezetimibe 10 mg 10 tab', 'ازيتيميب 10مجم 10 اقراص', '21', '14.4', 'Hypolipidemic agent', 'Ezetimibe', 'Borg', 'Tab', 'أقراص', '10 mg', '1', 'لتقليل الدهون والكوليسترول بالدم', NULL, '6223002570652', NULL, 2242, '2025-11-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ezetimibe is a lipid-lowering compound that inhibits intestinal cholesterol and phytosterol absorption. The discovery and research of this drug began in the early 1990s, after the intravenous administration of radiolabelled ezetimibe in rats revealed that it was being localized within enterocytes of the intestinal villi - this prompted studies investigating the effect of ezetimibe on intestinal cholesterol absorption.[A15202] Ezetimibe is used as an adjunctive therapy to a healthy diet to lower cholesterol levels in primary hyperlipidemia, mixed hyperlipidemia, homozygous familial hypercholesterolemia (HoFH), and homozygous sitosterolemia (phytosterolemia).[L11347]

Unlike other classes of cholesterol-reducing compounds including statins and bile acid sequestrants, ezetimibe has a distinct mechanism of action involving the sterol transporter Niemann-Pick C1-Like 1 (NPC1L1), and is unique in that it does not affect the absorption of fat-soluble nutrients such as fat-soluble vitamins, triglycerides, or bile acids.[A33313] In genetically NPC1L1-deficient mice, a 70% reduction in intestinal cholesterol absorption was seen, and these mice were insensitive to ezetimibe treatment - it was determined based on these findings that NPC1L1 plays an essential role in promoting intestinal cholesterol uptake via an ezetimibe-sensitive pathway.[A15202] By interfering with the intestinal uptake of cholesterol and phytosterols, ezetimibe reduces the delivery of intestinal cholesterol to the liver.[L11347]', '["C10BA02", "C10BA11", "C10BA10", "C10BA05", "C10BA12", "C10AX09", "C10BA06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18761, 'Ezetrol 10mg 7 tab.', 'ايزيترول 10مجم 7 قرص', '90', NULL, 'Hypolipidemic agent', 'Ezetimibe', 'Merck sharp & dohme > global napi pharmaceuticals', 'Tab', 'أقراص', '10mg', '1', NULL, 'about ezetimibe cholesterol absorption inhibitor 2-azetidinone derivative hypolipidemic agent. mechanism of action of ezetimibe it reduces the absorption of cholesterol from the intestine by localising at the brush border of the small intestine where it i', '6223002140572', NULL, 1556, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ezetimibe is a lipid-lowering compound that inhibits intestinal cholesterol and phytosterol absorption. The discovery and research of this drug began in the early 1990s, after the intravenous administration of radiolabelled ezetimibe in rats revealed that it was being localized within enterocytes of the intestinal villi - this prompted studies investigating the effect of ezetimibe on intestinal cholesterol absorption.[A15202] Ezetimibe is used as an adjunctive therapy to a healthy diet to lower cholesterol levels in primary hyperlipidemia, mixed hyperlipidemia, homozygous familial hypercholesterolemia (HoFH), and homozygous sitosterolemia (phytosterolemia).[L11347]

Unlike other classes of cholesterol-reducing compounds including statins and bile acid sequestrants, ezetimibe has a distinct mechanism of action involving the sterol transporter Niemann-Pick C1-Like 1 (NPC1L1), and is unique in that it does not affect the absorption of fat-soluble nutrients such as fat-soluble vitamins, triglycerides, or bile acids.[A33313] In genetically NPC1L1-deficient mice, a 70% reduction in intestinal cholesterol absorption was seen, and these mice were insensitive to ezetimibe treatment - it was determined based on these findings that NPC1L1 plays an essential role in promoting intestinal cholesterol uptake via an ezetimibe-sensitive pathway.[A15202] By interfering with the intestinal uptake of cholesterol and phytosterols, ezetimibe reduces the delivery of intestinal cholesterol to the liver.[L11347]', '["C10BA02", "C10BA11", "C10BA10", "C10BA05", "C10BA12", "C10AX09", "C10BA06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18762, 'Aaa', 'ششش', '82', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 709, '2023-06-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18763, 'Ezogast 40mg 14 dela. rel. caps', 'ايزوجاست 40مجم 14 كبسولة', '160', '109', 'Peptic ulcer.proton pump inhibitor', 'Esomeprazole', 'Copad pharma', 'Cap', 'كبسولة', '40mg', '2', 'للحموضة وقرحة المعدة', NULL, '6224008933007', NULL, 9849, '2024-06-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Esomeprazole, sold under the brand name Nexium, is a proton pump inhibitor (PPI) medication used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be found in quadruple regimens for the treatment of _H. pylori_ infections along with other antibiotics including [DB01060], [DB01211], and [DB00916], for example.[A177271, F4498] Its efficacy is considered similar to other medications within the PPI class including [DB00338], [DB00213], [DB00448], [DB05351], and [DB01129]. Esomeprazole is the s-isomer of [DB00338], which is a racemate of the S- and R-enantiomer. Esomeprazole has been shown to inhibit acid secretion to a similar extent as [DB00338], without any significant differences between the two compounds _in vitro_. 

Esomeprazole exerts its stomach acid-suppressing effects by preventing the final step in gastric acid production by covalently binding to sulfhydryl groups of cysteines found on the (H+, K+)-ATPase enzyme at the secretory surface of gastric parietal cells. This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus. As the binding of esomeprazole to the (H+, K+)-ATPase enzyme is irreversible and new enzyme needs to be expressed in order to resume acid secretion, esomeprazole''s duration of antisecretory effect persists longer than 24 hours.[FDA Label]

PPIs such as esomeprazole have also been shown to inhibit the activity of dimethylarginine dimethylaminohydrolase (DDAH), an enzyme necessary for cardiovascular health. DDAH inhibition causes a consequent accumulation of the nitric oxide synthase inhibitor asymmetric dimethylarginie (ADMA), which is thought to cause the association of PPIs with increased risk of cardiovascular events in patients with unstable coronary syndromes.[A177577, A177580]

Due to their good safety profile and as several PPIs are available over the counter without a prescription, their current use in North America is widespread. Long term use of PPIs such as esomeprazole has been associated with possible adverse effects, however, including increased susceptibility to bacterial infections (including gastrointestinal _C. difficile_), reduced absorption of micronutrients such as iron and B12, and an increased risk of developing hypomagnesemia and hypocalcemia which may contribute to osteoporosis and bone fractures later in life.[A177571]

Rapid discontinuation of PPIs such as esomeprazole may cause a rebound effect and a short term increase in hypersecretion.[A177574] Esomeprazole doses should be slowly lowered, or tapered, before discontinuing to prevent this rebound effect.', '["A02BD06", "A02BC05", "M01AE52"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18764, 'Ezypent gel 30 gm', 'ايزيبنت جل 30 جم', '40', NULL, 'Delay action', 'Vitamin', 'Hi-care > pure pharmaceuticals', 'Pen', 'قلم', '30 gm', '1', 'للتأخير للرجال', 'the use of ezypent delay gel is perhaps one of the easiest and fastest solutions for men who deal with premature ejaculation. ï¿½ make sure your penis is clean before applying the gel. ï¿½ do not use the product if you have any cut or bruise on your penis', NULL, NULL, 1863, '2022-09-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A11D', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18766, 'Fabb hair oil 60 ml', 'فاب زيت شعر 60 مل', '12', NULL, 'Hair care', NULL, 'Cosmopack for cosmetics > digma pharma', 'Hair oil', 'زيت شعر', '60 ml', '1', NULL, NULL, NULL, NULL, 964, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18768, 'Vonalei vaginal atrophy cream 30 gm', 'فونالي اتروفي كريم مهبلي 30 جم', '600', '220', 'Vaginal care', 'Lactic acid+hyaluronic acid+aloe vera', 'Al andalous pharmaceutical services', 'Cream', 'كريم', '30 gm', '1', NULL, NULL, NULL, NULL, 1165, '2025-12-07', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18770, 'Normelan under eye cream 15 ml', 'نورميلان كريم تحت العين 15 مل', '350', NULL, 'Skin care.eye contour', NULL, 'Green pharmaceutical', 'Cream', 'كريم', '15 ml', '1', NULL, NULL, NULL, NULL, 656, '2022-08-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18773, 'Falco kiva 10 sachets', 'فالكو كيفا 10 اكياس', '11', NULL, 'Cough drugs', 'Thyme+guava leaves+tilia+black seed', 'Nutrixia > falcon group', 'Sachet', 'أكياس', NULL, '1', NULL, 'natural herbs for cough use: 1 sachet in a cup of water', '6224000696597', NULL, 822, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18774, 'Falco vaginal cream 30 gm', 'فالكو كريم مهبلي 30جم', '25', NULL, NULL, 'Tea tree oil+propolis+thyme oil+chamomile oil+triclosan+bees wax+glycerin+propylene glycol+propyl pa', 'Hi-care > falcon group', 'Cream', 'كريم', '30 gm', '1', NULL, '*properties: -relieves itching & burning within hours of the first application. -eliminate all symptoms within 2 days of use. -has antifungal anti-inflammatory and promote healing of ulcers. *indications: -vaginal and vulvo-vaginal candidiasis. -vvc with', NULL, NULL, 831, '2022-07-25', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18775, 'Falcomix syrup 120 ml', 'فالكوميكس شراب 120 مل', '32', '16.5', 'Anti-cough', 'Guava leaves+tilia flower+fennel oil+honey+thyme+anise oil+marshmallow root liquid', 'Sigma > falcon group', 'Syrup', 'شراب', '120 ml', '1', 'مكمل غذائى مضاد للسعال ويدعم الجهاز التنفسي ويخفف من اعراض البرد', 'help in treatment of cough dose: adults: 10 to 15 ml twice daily', NULL, NULL, 1199, '2024-05-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18776, 'Falconacea plus 36 caps', 'فالكوناشيا بلس 36 كبسولة', '65', NULL, 'Immunity inhancer', 'Echinacea root powder extract+black seed oil', 'Sigma > falcon group', 'Cap', 'كبسولة', NULL, '3', NULL, NULL, NULL, NULL, 1351, '2022-06-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18777, 'Falconacea syrup 120 ml', 'فالكوناسيا شراب 120 مل', '75', '45', 'Immune enhancer', 'Echinacea purpurea extract', 'Sigma > falcon group', 'Syrup', 'شراب', '120 ml', '1', NULL, 'echinacea is widely used to fight infections especially the common cold and other upper respiratory infections. some people take echinacea at the first sign of a cold hoping they will be able to keep the cold from developing. other people take echinacea a', '6224000696450', NULL, 1517, '2024-07-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18778, 'Falcosept topical spray 60ml', 'فالكوسيبت بخاخ موضعي 60 مل', '20', NULL, 'Antiseptic', 'Chlorhexidine+cetrimide+ethyl alcohol', 'Hi-care > falcon group', 'Spray', 'بخاخ', '60ml', '1', NULL, 'intimate skin wash', NULL, NULL, 951, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18779, 'Irofetch 20 caps.', 'ايروفيتش 20 كبسولة', '85', NULL, 'Iron supplement', 'Iron+vitamin c+zinc+vitamin b6+folic acid+selenium', 'Paxal', 'Cap', 'كبسولة', NULL, '2', NULL, NULL, '6224011120173', NULL, 1025, '2022-11-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18780, 'Fam 30mg/2ml 5 amp.', 'فام 30مجم/2مل 5 امبولات', '22', NULL, 'Nsaid.acetic acid derivatives', 'Ketorolac tromethamine', 'Alfacure pharmaceuticals', 'Amp', 'أمبول', '30mg', '5', NULL, NULL, '6224000875398', NULL, 792, '2023-05-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.[L6358][L6508][L11055][L3674][L11070] 

It''s analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis.[L6520] Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.[L6511]', '["M01AB15", "S01FB51", "S01BC05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18781, 'Aaa', 'ششش', '9', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 683, '2023-05-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18782, 'Famalzyl 4mg/ml syp. 100 ml', 'فامالزيل 4مجم/مل شراب 100 مل', '458', '352', 'Alzheimer s disease', 'Galantamine', 'October pharma', 'Unknown', 'غير محدد', '4mg', '1', 'علاج حالات مرضى الزهايمر', NULL, NULL, NULL, 2130, '2025-04-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Galantamine is a tertiary alkaloid and reversible, competitive inhibitor of the acetylcholinesterase (AChE) enzyme, which is a widely studied therapeutic target used in the treatment of Alzheimer''s disease.[A1018] First characterized in the early 1950s, galantamine is a tertiary alkaloid that was extracted from botanical sources, such as _Galanthus nivalis_.[A201968] Galantamine was first studied in paralytic and neuropathic conditions, such as myopathies and postpolio paralytic conditions, and for reversal of neuromuscular blockade.[A182993,A201968] Following the discovery of its AChE-inhibiting properties, the cognitive effects of galantamine were studied in a wide variety of psychiatric disorders such as mild cognitive impairment, cognitive impairment in schizophrenia and bipolar disorder, and autism; however, re-development of the drug for Alzheimer’s disease did not commence until the early 1990s due to difficulties in extraction and synthesis.[A201968] Galantamine blocks the breakdown of acetylcholine in the synaptic cleft, thereby increasing acetylcholine neurotransmission. It also acts as an allosteric modulator of the nicotinic receptor, giving its dual mechanism of action clinical significance.[A182993]

The drug was approved by the FDA in 2001 for the treatment of mild to moderate dementia of the Alzheimer''s type. As Alzheimer''s disease is a progressive neurodegenerative disorder, galantamine is not known to alter the course of the underlying dementing process. Galantamine works to block the enzyme responsible for the breakdown of acetylcholine in the synaptic cleft, thereby enhancing cholinergic neuron function and signalling. Under this hypothesized mechanism of action, the therapeutic effects of galantamine may decrease as the disease progression advances and fewer cholinergic neurons remain functionally intact.[L13571] It is therefore not considered to be a disease-modifying drug.[A203558] Galantamine is marketed under the brand name Razadyne, and is available as oral immediate- and extended-release tablets and solution.[L13571]', '["N06DA04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18783, 'Famalzyl 8 mg 10 f.c. tabs', 'فامالزيل 8مجم 10 اقراص', '58', NULL, 'Alzheimer s disease', 'Galantamine', 'October pharma', 'Tab', 'أقراص', '8 mg', '1', 'يستخدم لعلاج الحالة الخفيفة-المتوسطة من الخرف المصاحب لمرض الالزهايمر. حيث يمكن ان يحسن من الذاكرة، الوعي', NULL, NULL, NULL, 1578, '2022-06-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Galantamine is a tertiary alkaloid and reversible, competitive inhibitor of the acetylcholinesterase (AChE) enzyme, which is a widely studied therapeutic target used in the treatment of Alzheimer''s disease.[A1018] First characterized in the early 1950s, galantamine is a tertiary alkaloid that was extracted from botanical sources, such as _Galanthus nivalis_.[A201968] Galantamine was first studied in paralytic and neuropathic conditions, such as myopathies and postpolio paralytic conditions, and for reversal of neuromuscular blockade.[A182993,A201968] Following the discovery of its AChE-inhibiting properties, the cognitive effects of galantamine were studied in a wide variety of psychiatric disorders such as mild cognitive impairment, cognitive impairment in schizophrenia and bipolar disorder, and autism; however, re-development of the drug for Alzheimer’s disease did not commence until the early 1990s due to difficulties in extraction and synthesis.[A201968] Galantamine blocks the breakdown of acetylcholine in the synaptic cleft, thereby increasing acetylcholine neurotransmission. It also acts as an allosteric modulator of the nicotinic receptor, giving its dual mechanism of action clinical significance.[A182993]

The drug was approved by the FDA in 2001 for the treatment of mild to moderate dementia of the Alzheimer''s type. As Alzheimer''s disease is a progressive neurodegenerative disorder, galantamine is not known to alter the course of the underlying dementing process. Galantamine works to block the enzyme responsible for the breakdown of acetylcholine in the synaptic cleft, thereby enhancing cholinergic neuron function and signalling. Under this hypothesized mechanism of action, the therapeutic effects of galantamine may decrease as the disease progression advances and fewer cholinergic neurons remain functionally intact.[L13571] It is therefore not considered to be a disease-modifying drug.[A203558] Galantamine is marketed under the brand name Razadyne, and is available as oral immediate- and extended-release tablets and solution.[L13571]', '["N06DA04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18784, 'Famo-plus 20 chewable tab.', 'فامو بلس 20 قرص قابل للمضغ', '13', NULL, 'Antacid plus h2 blocker', 'Calcium carbonate+famotidine+magnesium hydroxide', 'El-obour > spimaco misr', 'Tab', 'أقراص', NULL, '2', NULL, 'uses: this combination of three medications is used to treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). famotidine is a drug that blocks acid release in the stomach and can help stop heartburn and acid indigest', NULL, NULL, 977, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18785, 'Hydrensa lip balm 5 gm', 'هيدرنسا مرطب شفاه 5 جم', '90', '85', 'Skin care', 'Hyaluronic acid+shea butter+vitamin e+cocoa butter', 'Bio stream', 'Unknown', 'غير محدد', '5 gm', '1', NULL, NULL, NULL, NULL, 732, '2024-12-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18786, 'Aaa', 'ششش', '21', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 795, '2022-08-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18787, 'Serpass 100mg 30 f.c. tab.', 'سيرباس 100مجم 30 قرص', '177', '135', 'Psychiatric.antidepressants', 'Sertraline', 'Global napi pharmaceuticals', 'Tab', 'أقراص', '100mg', '3', NULL, NULL, '6223002146574', NULL, 1180, '2024-08-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Sertraline is a popular antidepressant medication commonly known as a selective serotonin reuptake inhibitor (SSRI), and is similar to drugs such as [Citalopram] and [Fluoxetine]. Despite marked structural differences between compounds in this drug class, SSRIs exert similar pharmacological effects.

Several weeks of therapy with sertraline may be required before beneficial effects are noticed. Sertraline displays enhanced safety or tolerability than other classes of antidepressants, which frequently cause high levels of drowsiness, dizziness, blurred vision, and other undesirable effects.[A1846,A187075,T28]', '["N06AB06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18789, 'Famox 250mg/5ml susp. 60ml', 'فاموكس 250 مجم / 5 مل معلق 60 مل', '14', NULL, 'Penicillins.penicillin with b-lactamase inhibitor', 'Amoxicillin+flucloxacillin', 'Sedico > top pharm', 'Susp', 'معلق', '250mg', '1', NULL, 'amoxycillin and flucloxacillin ï¿½ generally exhibit an additive effect against sensitive bacteria and bacteria that are sensitive to amoxycillin or to flucloxacillin remain sensitive to the combination showing that antagonism does not occur when the two', NULL, NULL, 821, '2022-07-14', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'J01CF02', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18792, 'Famtocal-m 20 chewble tab.', 'فامتوكال-م 20 قرص', '13', NULL, 'Antacid plus h2 blocker', 'Calcium carbonate+famotidine+magnesium hydroxide', 'Jedco int. co. for pharmaceuticals', 'Tab', 'أقراص', NULL, '2', 'مضاد للحموضة -- لعلاج قرحة المعدة', 'uses: this combination of three medications is used to treat heartburn and other symptoms caused by too much acid in the stomach (acid indigestion). famotidine is a drug that blocks acid release in the stomach and can help stop heartburn and acid indigest', NULL, NULL, 1452, '2023-02-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18793, 'Fangrare shower gel 200 ml', 'فانجرير شاور جل 200 مل', '150', '140', 'Anti-fungal', 'Dimethicone+climbazole+tea tree oil+hibiscus ext.+chlorhexidine', 'Al helou for perfume & cosmetics > safe life', 'Gel', 'جل', '200 ml', '1', 'مضاد للفطريات', 'cleansing shower gel with anti-bacterial and anti-fungal activity. use: apply a suitable amount of the shower gel on the sponge massage the body gently then rinse thoughrouly with water.', NULL, NULL, 3898, '2024-10-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18794, 'Farabicure 1% top. cream 15 gm', 'فارابيكور 1% كريم 15 جم', '22', NULL, 'Antifungals.allylamines', 'Butenafine hydrochloride', 'Egpi > farabi', 'Cream', 'كريم', '1%', '1', NULL, NULL, NULL, NULL, 916, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'D01AE23', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18795, 'Aaa', 'ششش', '15', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 784, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18798, 'Farcocin 0.1% cream 20 gm', 'فاركوسين 0.1% كريم 20 جم', '23', '14.5', 'Aminoglycoside antibiotic', 'Gentamicin', 'Pharco', 'Cream', 'كريم', '0.1%', '1', 'مضاد حيوي كريم', 'about gentamicin aminoglycoside antibiotic. mechanism of action of gentamicin gentamicin exerts its bactericidal action against gram negative organisms & some of gram positive organisms by inhibiting bacterial protein synthesis. the process involves 1. pe', '6223000011782', NULL, 1467, '2024-11-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Gentamicin is a bactericidal aminoglycoside that was discovered and isolated from _Micromonospora purpurea_ in 1963.[A234349] It is one of the most frequently prescribed aminoglycosides due to its spectrum of activity, low cost, and availability.[A234339,A234354] Gentamicin is effective against both gram-positive and gram-negative organisms but is particularly useful for the treatment of severe gram-negative infections including those caused by _Pseudomonas aeruginosa_.[A233325,A234359,A234364] There is the added benefit of synergy when gentamicin is co-administered with other antibacterials such as beta-lactams.[A234364] This synergistic activity is not only important for the treatment of complex infections, but can also contribute to dose optimization and reduced adverse effects.[A234359,A234364]

Although gentamicin is well-established and may be used in a variety of clinical applications, it is also associated with severe adverse effects including nephrotoxicity and ototoxicity which may limit its use.[A234369]', '["S01AA11", "S02AA14", "D06AX07", "S03AA06", "J01GB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18799, 'Aaa', 'ششش', '5', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 744, '2022-07-20', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18800, 'Farcocrom 4% eye drops 10 ml', 'فاركوكروم 4% قطرة 10 مل', '8', NULL, 'Antihistamine.antiallergy', 'Sodium cromoglycate', 'Pharco', 'Drops', 'نقط', '4%', '1', 'قطرة عين مضادة للحساسية', 'about sodium cromoglycate synthetic chromone derivative mast cell stabilizer antiallergic asthma prophylactic. mechanism of action of sodium cromoglycate this synthetic chromone derivative has several mechanism of action 1. it is a mast cell stabilizer 2.', NULL, NULL, 783, '2022-05-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18801, 'Farcodarone 200mg 30 tab.', 'فاركودارون 200 مجم 30 قرص', '21', NULL, 'Antiarrhythmias.class iii', 'Amiodarone', 'Pharco', 'Tab', 'أقراص', '200mg', '3', NULL, NULL, '6223000012048', NULL, 917, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Amiodarone is a benzofuran derivative, anti-arrhythmic drug used commonly in a variety of settings.[A36817] Most known for its approved indication in life-threatening ventricular arrhythmias, it is also used off-label in the outpatient and inpatient setting for atrial fibrillation. Because of its ability to cause serious toxicity and possibly death, amiodarone use should be reserved for its approved indications, according to prescribing information.[L3561,L11265,L11286]', '["C01BD01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18802, 'Farcodarone concentrate 50mg/ml 5 amp.', 'فاركودارون مركز 50 مجم / مل 5 امبول', '22', NULL, 'Antiarrhythmias.class iii', 'Amiodarone', 'Pharco', 'Amp', 'أمبول', '50mg', '5', NULL, 'description an antianginal and antiarrhythmic drug. it increases the duration of ventricular and atrial muscle action by inhibiting na k-activated myocardial adenosine triphosphatase. there is a resulting decrease in heart rate and in vascular resistance.', NULL, NULL, 810, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Amiodarone is a benzofuran derivative, anti-arrhythmic drug used commonly in a variety of settings.[A36817] Most known for its approved indication in life-threatening ventricular arrhythmias, it is also used off-label in the outpatient and inpatient setting for atrial fibrillation. Because of its ability to cause serious toxicity and possibly death, amiodarone use should be reserved for its approved indications, according to prescribing information.[L3561,L11265,L11286]', '["C01BD01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18803, 'Aliva 30 tabs', 'اليفا 30 قرص', '99', NULL, 'Multivitamin', 'Ca+mg', 'Swivel med', 'Tab', 'أقراص', NULL, '3', NULL, NULL, NULL, NULL, 1012, '2024-05-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18804, 'Farcolac 667gm/l syrup 120 ml', 'فاركولاك 667 جم شراب 120 مل', '8', NULL, 'Laxative', 'Lactulose', 'Pharco', 'Syrup', 'شراب', '667gm', '1', NULL, 'about lactulose a synthetic disaccharide osmotic laxative ammonium detoxicant. mechanism of action of lactulose laxative: lactulose is a synthetic disaccharide of galactose and fructose that resist intestinal disaccharidase activity. the sugars are joined', NULL, NULL, 1494, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Lactulose is a synthetic disaccharide derivative of lactose that is most commonly used as a laxative agent despite also being formally indicated to serve as an adjunct therapy in treating portal-systemic encephalopathy (PSE).[FDA Label,L6199,L6202] Despite being first synthesized in 1929[A178081], investigations regarding its possible use as a laxative for the treatment of chronic constipation did not occur until the 1960s and its first clinical use for treating PSE was not until 1966.[L6202] 

Nevertheless, although lactulose received formal FDA approval in 1977 and has since become a readily available generic and brand-name non-prescription medication listed on the World Health Organization''s List of Essential Medicines as one of the most effective and safe medicines employed in a health system[L6205], data regarding its optimal place in therapy is often ambiguous.[L6202]

Especially considering the use of lactulose as a laxative is typically only considered after lifestyle and dietary modifications fail and the fact that lactulose therapy cannot be ethically withheld from patients diagnosed with PSE in a placebo study, the substance may just be one of many options available for treating constipation and its efficacy in managing PSE may never be formally confirmed or refuted via clinical investigation.[L6202]', '["A06AD61", "A06AD11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18805, 'Doxarelax 4mg 21 tabs', 'دوكساريلاكس 4مجم 21 قرص', '60', NULL, 'Antihypertensive.selective alpha 1 receptor blockers', 'Doxazosin', 'October pharma', 'Tab', 'أقراص', '4mg', '3', NULL, NULL, NULL, NULL, 936, '2024-05-31', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Doxazosin is an alpha-1 antagonist used for the treatment of benign prostatic hypertrophy (BPH) symptoms and hypertension. Other members of this drug class include [Prazosin], [Terazosin], [Tamsulosin], and [Alfuzosin].[A180661]  Because of its long-lasting effects, doxazosin can be administered once a day.[A180649] It is marketed by Pfizer and was initially approved by the FDA in 1990.[L7285]', '["C02CA04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18807, 'Farcolin syrup 120ml', 'فاركولين شراب 120 مل', '22', '13.5', 'Cough drugs', 'Ammonium chloride+salbutamol', 'Pharco', 'Syrup', 'شراب', '120ml', '1', NULL, 'about ammonium chloride ammonium compound acidifier expectorant.', '6221151002352', NULL, 2517, '2024-09-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18809, 'Farconcil 1 gm vial', 'فاركونسيل 1 جم فيال', '8', NULL, 'Penicillins.monocomponent', 'Amoxicillin', 'Pharco', 'Vial', 'فيال', '1 gm', '1', NULL, '(indications): is a penicillin-like beta-lactam antibiotic. it is used to treat bacterial infections caused by susceptible microorganisms. it prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia bronchitis', '6223000011263', NULL, 1056, '2023-05-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Amoxicillin, or BRL-2333, is a penicillin G derivative first described in the literature in 1972.[A190648] Amoxicillin has similar activity to [penicillin] and [ampicillin], but leads to higher serum concentrations than ampicillin.[A190648]

Amoxicillin was granted FDA approval on 18 January 1974.[L11644]', '["A02BD12", "J01CR50", "A02BD14", "A02BD04", "A02BD07", "A02BD13", "A02BD10", "A02BD05", "A02BD03", "A02BD01", "A02BD15", "A02BD06", "J01CA04", "A02BD16", "A02BD11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18810, 'Farconcil 250mg vial', 'فاركونسيل 250 مجم فيال', '6', NULL, 'Penicillins.monocomponent', 'Amoxicillin', 'Pharco', 'Vial', 'فيال', '250mg', '1', NULL, '(indications): is a penicillin-like beta-lactam antibiotic. it is used to treat bacterial infections caused by susceptible microorganisms. it prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia bronchitis', '6223000010976', NULL, 1218, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Amoxicillin, or BRL-2333, is a penicillin G derivative first described in the literature in 1972.[A190648] Amoxicillin has similar activity to [penicillin] and [ampicillin], but leads to higher serum concentrations than ampicillin.[A190648]

Amoxicillin was granted FDA approval on 18 January 1974.[L11644]', '["A02BD12", "J01CR50", "A02BD14", "A02BD04", "A02BD07", "A02BD13", "A02BD10", "A02BD05", "A02BD03", "A02BD01", "A02BD15", "A02BD06", "J01CA04", "A02BD16", "A02BD11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18811, 'Farconcil 500mg vial', 'فاركونسيل 500 مجم فيال', '7', NULL, 'Penicillins.monocomponent', 'Amoxicillin', 'Pharco', 'Vial', 'فيال', '500mg', '1', NULL, '(indications): is a penicillin-like beta-lactam antibiotic. it is used to treat bacterial infections caused by susceptible microorganisms. it prevents the bacterial growth and is used in the treatment of a number of infections such as pneumonia bronchitis', '6223000010785', NULL, 949, '2023-05-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Amoxicillin, or BRL-2333, is a penicillin G derivative first described in the literature in 1972.[A190648] Amoxicillin has similar activity to [penicillin] and [ampicillin], but leads to higher serum concentrations than ampicillin.[A190648]

Amoxicillin was granted FDA approval on 18 January 1974.[L11644]', '["A02BD12", "J01CR50", "A02BD14", "A02BD04", "A02BD07", "A02BD13", "A02BD10", "A02BD05", "A02BD03", "A02BD01", "A02BD15", "A02BD06", "J01CA04", "A02BD16", "A02BD11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18812, 'Farcophylline 125mg 5 paed.supp.', 'فاركوفيلين 125 مجم 5 اقماع', '3', NULL, 'Bronchodilator', 'Piperazine theophylline ethanoate', 'Pharco', 'Supp', 'لبوس', '125mg', '1', NULL, NULL, '6223000010679', NULL, 750, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18813, 'Aaa', 'ششش', '76', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 742, '2024-06-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18814, 'Farcopril 50mg 20 tab.', 'فاركوبريل 50 مجم 20 قرص', '11', NULL, 'Antihypertensive.ace', 'Captopril', 'Pharco', 'Tab', 'أقراص', '50mg', '2', NULL, 'about captopril a specific competitive angiotensin-converting enzyme (ace) inhibitor antihypertensive. mechanism of action of captopril it is an angiotensin converting enzyme inhibitor prevents the conversion of angiotensin-1 to angiotensin-2 and abolishe', '6223000011898', NULL, 792, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Captopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Captopril may be used in the treatment of hypertension.', '["C09AA01", "C09BA01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18816, 'Farcorelaxin 10mg 5 adult supp.', 'فاركوريلاكسين 10 مجم 5 اقماع للكبار', '5', NULL, 'Antimuscarinic.antispasmodic', 'Hyoscin-n-butylbromid', 'Pharco', 'Supp', 'لبوس', '10mg', '5', NULL, 'about hyoscine butyl bromide anti-cholinergic a tropane alkaloid antispasmodic in gi and gu spasm. mechanism of action of hyoscine butyl bromide hyoscine butyl bromide is an anticholinergic drug. it exerts its action by inhibiting muscarinic (cholinergic)', NULL, NULL, 754, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18817, 'Caspofungin sdz 70mg 1lyvi eg', 'كاسبوفنجين 70مجم فيال ساندوز', '2,125', NULL, 'Antifungal', 'Caspofungin', 'Sandoz', 'Unknown', 'غير محدد', '70mg', '1', NULL, NULL, NULL, NULL, 907, '2024-07-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Caspofungin (brand name Cancidas worldwide) is an antifungal drug and the first member of a new drug class called the echinocandins, as coined by Merck & Co., Inc. It is typically administered intravenously. It shows activity against infections with Aspergillus and Candida, and works by inhibiting β(1,3)-D-Glucan of the fungal cell wall.', '["J02AX04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18818, 'Farcorelaxin 20mg i.v./i.m. 3 amp.', 'فاركوريلاكسين 20 مجم 3 امبولات', '9', NULL, 'Antimuscarinic.antispasmodic', 'Hyoscin-n-butylbromid', 'Pharco', 'Amp', 'أمبول', '20mg', '3', NULL, 'about hyoscine butyl bromide anti-cholinergic a tropane alkaloid antispasmodic in gi and gu spasm. mechanism of action of hyoscine butyl bromide hyoscine butyl bromide is an anticholinergic drug. it exerts its action by inhibiting muscarinic (cholinergic)', '6223000012598', NULL, 767, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18819, 'Farcorelaxin 7.5mg 5 infantile supp.', 'فاركوريلاكسين 7.5مجم 5 اقماع لبوس اطفال', '5', NULL, 'Antimuscarinic.antispasmodic', 'Hyoscin-n-butylbromid', 'Pharco', 'Supp', 'لبوس', '7.5mg', '1', NULL, 'about hyoscine butyl bromide anti-cholinergic a tropane alkaloid antispasmodic in gi and gu spasm. mechanism of action of hyoscine butyl bromide hyoscine butyl bromide is an anticholinergic drug. it exerts its action by inhibiting muscarinic (cholinergic)', NULL, NULL, 878, '2022-06-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18821, 'Coxorizet 90 mg 30 tabs', 'كوكسوريزيت 90 مجم 30 قرص', '249', '169.5', 'Nsaid.selective cox-2 inhibitors', 'Etoricoxib', 'Zeta pharma', 'Tab', 'أقراص', '90 mg', '3', NULL, NULL, '6225000483774', NULL, 3490, '2025-05-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M01AH05', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18822, 'Farcosef 500mg vial', 'فاركوسيف 500مجم فيال', '7', NULL, 'Antibiotic.cephalosporin.first-generation', 'Cephradine', 'Pharco b', 'Vial', 'فيال', '500mg', '1', NULL, 'description a semi-synthetic cephalosporin antibiotic. mechanism of action cefradine is a first generation cephalosporin antibiotic with a spectrum of activity similar to cefalexin. cefradine like the penicillins is a beta-lactam antibiotic. by binding to', '6223000010884', NULL, 753, '2023-02-06', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18823, 'Aaa', 'ششش', '11', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 856, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18825, 'Farcotilium 10mg 10 eff. sachets', 'فاركوتيليوم 10مجم 10 اكياس فوار', '13', '7', 'Antiemetic', 'Domperidone', 'Pharco', 'Sachet', 'أكياس', '10mg', '1', NULL, NULL, NULL, NULL, 977, '2025-04-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A03FA03', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18828, 'Farcotilium 1mg/ml susp. 120ml', 'فاركوتيليوم 1مجم/مل معلق 120 مل', '24', '21', 'Antiemetic', 'Domperidone', 'Pharco', 'Susp', 'معلق', '1mg', '1', NULL, 'about domperidone antidopaminergic motility stimulant piperidine derivative antiemetic anti-vertigo. mechanism of action of domperidone domperidone is a potent dopamine receptor antagonist. it acts centrally and blocks the dopamine receptor in the chemore', '6223000011935', NULL, 1379, '2025-04-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A03FA03', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18829, 'Intarg gel 75 gm', 'انتارج جل 75 جم', '70', NULL, 'Massage gel', 'Equisetum arvense+menthol+thymus+vit e+eucalyptus', 'Medixir pharma', 'Gel', 'جل', '75 gm', '1', NULL, NULL, NULL, NULL, 785, '2024-07-22', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18830, 'Olanvexa 5 mg 30 orally disintegrating tabs.', 'اولانفيكسا 5مجم 30 قرص', '123', '90', 'Psychiatric.antipsychotics', 'Olanzapine', 'Multicare', 'Tab', 'أقراص', '5 mg', '3', NULL, NULL, '6224001514227', NULL, 1472, '2025-08-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Olanzapine is a thienobenzodiazepine classified as an atypical or second-generation antipsychotic agent.[A176996] The second-generation antipsychotics were introduced in the 90s and quickly gained traction due to their impressive efficacy, reduced risk for extrapyramidal side effects and reduced susceptibility to drug-drug interactions.[A177011] Olanzapine very closely resembles [clozapine] and only differs by two additional methyl groups and the absence of a chloride moiety.[T554] It was discovered by scientists at Eli Lilly and approved to be marketed in the US in 1996.[T548]', '["N05AH03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18831, 'Farcozol plus susp. 120ml', 'فاركوزول بلس معلق 120 مل', '13', '6', 'Antiprotozoal.nitroimidazole', 'Diloxanide furoate+metronidazole', 'Pharco', 'Susp', 'معلق', '120ml', '1', NULL, NULL, '6221151002413', NULL, 973, '2024-12-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18832, 'Farex 20 f.c.tab.', 'فاريكس 20 قرص', '8', NULL, 'Cold drugs', 'Ibuprofen+pseudoephedrine', 'Mup', 'Tab', 'أقراص', NULL, '2', NULL, 'ibuprofen ( analgesic anti-inflammatory and anti-pyretic activity) ibuprofen is a propionic acid derivative with analgesic anti-inflammatory and anti-pyretic activity. the drug therapeutic effects are thought to result from its inhibitory effect on the en', '6221508019415', NULL, 1370, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18833, 'Farkelo cream 50 gm', 'فاركيلو كريم 50 جرام', '75', '75', 'Scar therapy', 'Dried onions extract+silicone+allantoin', 'Dreams elhabouba > new vision', 'Cream', 'كريم', '50 gm', '1', 'كريم لعلاج الندبات و الجروح واثارها -- يقلل من الاماكن الداكنة الناتجة من الجروح والندبات -- يساعد علي ترطيب الجلد و تنعيمه', NULL, NULL, NULL, 3776, '2023-08-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18834, 'Farmactive silver spray 125 ml', 'فارماكتيف سيلفر سبراي 125 مل', '699', '499', 'Healing topical', 'Silver colloid+hyaluronic acid sodic salt', 'Farmac-zabban > elegant care group', 'Spray', 'بخاخ', '125 ml', '1', 'اسبراي يستخدم للجروح و القرح -- تقليل الالتهابات -- تقليل الاحمرار و الحكة', 'topical spray for burns and ulcers', '8000246002952', NULL, 8240, '2024-02-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18835, 'Aaa', 'ششش', '131', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 798, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18836, 'Farmorubicin rd 50mg vial', 'فارموروبيسين ار دي 50 مجم فيال', '612', NULL, 'Antineoplastic', 'Epirubicin', 'Pfizer', 'Vial', 'فيال', '50mg', '1', NULL, 'about epirubicin anthracycline anibiotic antineoplastic. mechanism of action of epirubicin this anthracycline drug intercalates dna strands which results complex formation it will inhibit dna & rna synthesis. it triggers dna cleavage by inhibiting topoiso', NULL, NULL, 1122, '2022-07-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'An anthracycline which is the 4''-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.', '["L01DB03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18838, 'Farostan forte 500mg 10 tab.', 'فاروستان فورت 500 مجم 10 قرص', '5', NULL, 'Nsaid.fenamates', 'Mefenamic acid', 'Pharopharma', 'Tab', 'أقراص', '500mg', '1', NULL, 'about mefenamic acid nsaid analgesic antiinflammatory. mechanism of action of mefenamic acid mefenamic acid has analgesic anti-inflammatory and antipyretic action. it acts by inhibiting prostaglandin (pgs) synthesis and their release at the site of injury', NULL, NULL, 1274, '2022-07-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.', '["M01AG01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18842, 'Faslodex 250mg/5ml i.m. 2 prefilled syringe', 'فاسلودكس 250 مجم / 5 مل 2 حقن مملؤة مسبقاً', '10,330', '7600', 'Antineoplastic', 'Fulvestrant', 'Astra zeneca', 'Syringe', 'حقنة', '250mg', '2', NULL, NULL, NULL, NULL, 1727, '2025-08-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Fulvestrant is a drug treatment of hormone receptor (HR)-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor. While it is used as monotherapy for the treatment of breast cancers, it is also used in combination with [alpelisib] for the treatment of HR-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CA-mutated, advanced or metastatic breast cancer', '["L02BA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18843, 'Fast care cream 30 gm', 'فاست كير كريم 30جم', '14', NULL, 'Soothing topical', NULL, 'Egyptian company for cosmetics > rand pharm co.', 'Cream', 'كريم', '30 gm', '1', NULL, 'soothing & emollient cream', '6224000911034', NULL, 905, '2022-07-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18844, 'Fast care cream 50 gm', 'فاست كير كريم 50 جم', '33', NULL, 'Moisturizing topicals', 'Zinc oxide+olive oil+irgasan+emu oil', 'Sina > health well egypt', 'Cream', 'كريم', '50 gm', '1', NULL, 'soothing & emollient cream', NULL, NULL, 982, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18845, 'Fast care cream 60 gm', 'فاست كير كريم 60 جم', '25', NULL, 'Massage', NULL, 'Egyptian company for cosmetics > rand pharm co.', 'Cream', 'كريم', '60 gm', '1', NULL, 'massage cream', NULL, NULL, 808, '2022-07-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18846, 'Fast care p. hair shampoo 250ml', 'فاست كير شامبو للشعر 250 مل', '175', '145', 'Hair care', 'Olive oil+vitamin e+vitamin a+chamomile extract+jojoba extract+hydrolyzed protein', 'Leader cosmetics > original pharma group', 'Amp', 'أمبول', '250ml', '1', NULL, 'for hair falling damage and brittleness.', '6225550113329', NULL, 1675, '2025-01-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18847, 'Fast care-d shampoo 120 ml', 'فاست كير-دي شامبو 120 مل', '115', '95', 'Hair care', NULL, 'Leader cosmetics > original pharma group', 'Amp', 'أمبول', '120 ml', '1', NULL, 'anti-dandruff', '6224010525177', NULL, 1206, '2025-01-18', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18848, 'Fast cream 60 gm', 'فاست كريم 60جم', '21', NULL, 'Massage', 'Mineral oil+stearic acid+bees wax+peppermint oil+propyl paraben', 'Egyptian company for cosmetics > rand pharm co.', 'Cream', 'كريم', '60 gm', '1', NULL, 'massage cream', NULL, NULL, 956, '2022-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18849, 'Fast free i.m. 3 amp.', 'فاست فري 3 امبولات عضل', '11', NULL, 'Git.anti-spasmodic', 'Hyoscine+ketoprofen', 'Delta pharma', 'Amp', 'أمبول', NULL, '3', NULL, 'about hyoscine butyl bromide anti-cholinergic a tropane alkaloid antispasmodic in gi and gu spasm. mechanism of action of hyoscine butyl bromide hyoscine butyl bromide is an anticholinergic drug. it exerts its action by inhibiting muscarinic (cholinergic)', NULL, NULL, 1105, '2022-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18852, 'Fastcure 10 mg 21 caps', 'فاست كيور 10مجم 21 كبسولة', '60', '40.5', 'Peptic ulcer.proton pump inhibitor', 'Omeprazole', 'October pharma', 'Cap', 'كبسولة', '10 mg', '3', NULL, NULL, NULL, NULL, 1102, '2024-09-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Originally approved by the FDA in 1989, omeprazole is a _proton-pump inhibitor_, used to treat gastric acid-related disorders. These disorders may include gastroesophageal reflux disease (GERD), peptic ulcer disease, and other diseases characterized by the oversecretion of gastric acid.  This drug was the first clinical useful drug in its class, and its approval was followed by the formulation of many other proton pump inhibitor drugs [A174232]. Omeprazole is generally effective and well-tolerated, promoting its popular use in children and adults [FDA label].', '["A02BC01", "A02BD05", "A02BD16", "A02BD01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18855, 'Fastel 120mg 10 f.c. tab.', 'فاستل 120 مجم 10 اقراص', '15', NULL, 'Antihistamine.antiallergy', 'Fexofenadine', 'European egyptian pharm. ind.', 'Tab', 'أقراص', '120mg', '1', NULL, NULL, '6221076010050', NULL, 1607, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Fexofenadine is an over-the-counter second-generation antihistamine used in the treatment of various allergic symptoms.[L4269] It is selective for the H1receptor, carries little-to-no activity at off-targets, and does not cross the blood-brain barrier[L10779] - this is in contrast to previous first-generation antihistamines, such as [diphenhydramine], which readily bind to off-targets that contribute to side effects such as sedation.[A1452] Fexofenadine is the major active metabolite of [terfenadine][A1495] and is administered as a racemic mixture in which both enantiomers display approximately equivalent antihistamine activity.[L10779]', '["R06AX26"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18856, 'Fastel 180mg 10 f.c. tab.', 'فاستل 180 مجم 10 اقراص', '42', NULL, 'Antihistamine.antiallergy', 'Fexofenadine', 'European egyptian pharm. ind.', 'Tab', 'أقراص', '180mg', '1', NULL, NULL, '6221076011040', NULL, 1567, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Fexofenadine is an over-the-counter second-generation antihistamine used in the treatment of various allergic symptoms.[L4269] It is selective for the H1receptor, carries little-to-no activity at off-targets, and does not cross the blood-brain barrier[L10779] - this is in contrast to previous first-generation antihistamines, such as [diphenhydramine], which readily bind to off-targets that contribute to side effects such as sedation.[A1452] Fexofenadine is the major active metabolite of [terfenadine][A1495] and is administered as a racemic mixture in which both enantiomers display approximately equivalent antihistamine activity.[L10779]', '["R06AX26"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18858, 'Fastemo care emollient cream 50 gm', 'فاستيمو كير كريم مرطب 50 جرام', '60', '50', 'Skin care', 'Panthenol+zinc oxide+castor oil+olive oil+aloe vera+lanolin+tea tree oil', 'Egyptian co. for cosmetics > hexa pharma', 'Cream', 'كريم', '50 gm', '1', 'كريم مرطب للجلد __ يعمل علي ترطيب وتنعيم الجلد __يساعد علي تفتيح البشرة وتوحيد لونها', NULL, '6224000911034', NULL, 1437, '2024-08-29', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18859, 'Faster gel 50 gm', 'فاستر جل 50 جم', '10', NULL, 'Massage', 'Menthol+camphor', 'Al esraa pharmaceutical optima', 'Gel', 'جل', '50 gm', '1', NULL, 'massage gel', '6224002702050', NULL, 1246, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18860, 'Aaa', 'ششش', '20', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 650, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18861, 'Fastgraine rapid 200 mg 30 dispersible tab.', 'فاستجرين رابيد 200 مجم 30 قرص', '22', NULL, 'Nsaid.fenamates', 'Tolfenamic acid', 'Epci', 'Tab', 'أقراص', '200 mg', '3', NULL, NULL, NULL, NULL, 1098, '2022-07-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M01AG02', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18862, 'Fastofen 120mg 30 tab.', 'فاستوفين 120 مجم 30 قرص', '36', '36', 'Antihistamine.antiallergy', 'Fexofenadine', 'El-obour', 'Tab', 'أقراص', '120mg', '3', 'مضاد للحساسية -- مضاد للالتهابات -- تقليل الالام', 'about fexofenadine second generation h1 antagonist antihistamine. mechanism of action of fexofenadine fexofenadine blocks one type of peripheral receptor for histamine (the h1 receptor) and thus prevents activation of h1 receptor-containing cells by hista', '6223004600012', NULL, 1554, '2024-11-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Fexofenadine is an over-the-counter second-generation antihistamine used in the treatment of various allergic symptoms.[L4269] It is selective for the H1receptor, carries little-to-no activity at off-targets, and does not cross the blood-brain barrier[L10779] - this is in contrast to previous first-generation antihistamines, such as [diphenhydramine], which readily bind to off-targets that contribute to side effects such as sedation.[A1452] Fexofenadine is the major active metabolite of [terfenadine][A1495] and is administered as a racemic mixture in which both enantiomers display approximately equivalent antihistamine activity.[L10779]', '["R06AX26"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18863, 'Fastofen 180mg 30 tab.', 'فاستوفين 180مجم 30 قرص', '43', NULL, 'Antihistamine.antiallergy', 'Fexofenadine', 'El-obour', 'Tab', 'أقراص', '180mg', '3', NULL, NULL, NULL, NULL, 1294, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Fexofenadine is an over-the-counter second-generation antihistamine used in the treatment of various allergic symptoms.[L4269] It is selective for the H1receptor, carries little-to-no activity at off-targets, and does not cross the blood-brain barrier[L10779] - this is in contrast to previous first-generation antihistamines, such as [diphenhydramine], which readily bind to off-targets that contribute to side effects such as sedation.[A1452] Fexofenadine is the major active metabolite of [terfenadine][A1495] and is administered as a racemic mixture in which both enantiomers display approximately equivalent antihistamine activity.[L10779]', '["R06AX26"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18864, 'Fastofen 180mg 20 tab.', 'فاستوفين 180مجم 20 قرص', '29', NULL, 'Antihistamine.antiallergy', 'Fexofenadine', 'El-obour', 'Tab', 'أقراص', '180mg', '2', NULL, NULL, NULL, NULL, 862, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Fexofenadine is an over-the-counter second-generation antihistamine used in the treatment of various allergic symptoms.[L4269] It is selective for the H1receptor, carries little-to-no activity at off-targets, and does not cross the blood-brain barrier[L10779] - this is in contrast to previous first-generation antihistamines, such as [diphenhydramine], which readily bind to off-targets that contribute to side effects such as sedation.[A1452] Fexofenadine is the major active metabolite of [terfenadine][A1495] and is administered as a racemic mixture in which both enantiomers display approximately equivalent antihistamine activity.[L10779]', '["R06AX26"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18866, 'Aaa', 'ششش', '7', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 845, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18867, 'Aaa', 'ششش', '17', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 719, '2022-12-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18869, 'Fatestatin 20 mg 10 f.c.tab.', 'فاتستاتين 20 مجم 10 أقراص', '33', NULL, 'Antihyperlipidemic.statins', 'Atorvastatin', 'Egpi > sea pharm for pharmaceuticals', 'Tab', 'أقراص', '20 mg', '1', NULL, NULL, NULL, NULL, 1046, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Atorvastatin (Lipitor®), is a lipid-lowering drug included in the statin class of medications. By inhibiting the endogenous production of cholesterol in the liver, statins lower abnormal cholesterol and lipid levels, and ultimately reduce the risk of cardiovascular disease. More specifically, statin medications competitively inhibit the enzyme hydroxymethylglutaryl-coenzyme A (HMG-CoA) Reductase,[A181421] which catalyzes the conversion of HMG-CoA to mevalonic acid. This conversion is a critical metabolic reaction involved in the production of several compounds involved in lipid metabolism and transport, including cholesterol, low-density lipoprotein (LDL) (sometimes referred to as "bad cholesterol"), and very-low-density lipoprotein (VLDL). Prescribing statins is considered standard practice for patients following any cardiovascular event, and for people who are at moderate to high risk of developing cardiovascular disease. The evidence supporting statin use, coupled with minimal side effects and long term benefits, has resulted in wide use of this medication in North America.[A181087, A181406]

Atorvastatin and other statins including [lovastatin], [pravastatin], [rosuvastatin], [fluvastatin], and [simvastatin] are considered first-line treatment options for dyslipidemia.[A181087, A181406] The increasing use of this class of drugs is largely attributed to the rise in cardiovascular diseases (CVD) (such as heart attack, atherosclerosis, angina, peripheral artery disease, and stroke) in many countries.[A181084] An elevated cholesterol level (elevated low-density lipoprotein (LDL) levels in particular) is a significant risk factor for the development of CVD.[A181087,A181553] Several landmark studies demonstrate that the use of statins is associated with both a reduction in LDL levels and CVD risk.[A181090,A181093,A181096,A181427,A181475,A181538] Statins were shown to reduce the incidences of all-cause mortality, including fatal and non-fatal CVD, as well as the need for surgical revascularization or angioplasty following a heart attack.[A181087, A181406] Some evidence has shown that even for low-risk individuals (with <10% risk of a major vascular event occurring within five years) statin use leads to a 20%-22% relative reduction in the number of major cardiovascular events (heart attack, stroke, coronary revascularization, and coronary death) for every 1 mmol/L reduction in LDL without any significant side effects or risks.[A181397, A181403]

Atorvastatin was first synthesized in 1985 by Dr. Bruce Roth and approved by the FDA in 1996.[T568] It is a pentasubstituted pyrrole [A177415] formed by two contrasting moieties with an achiral heterocyclic core unit and a 3,5-dihydroxypentanoyl side chain identical to its parent compound.[T571] Unlike other members of the statin group, atorvastatin is an active compound and therefore does not require activation.[A177436]', '["C10BA05", "C10BX11", "C10BX12", "C10BX18", "C10AA05", "C10BX15", "C10BX03", "C10BX08", "C10BX06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18871, 'Fatlose 120 mg 10 cap.', 'فاتلوز 120مجم 10 كبسولات', '20', NULL, 'Weight loss', 'Orlistat', 'El-obour > repharma pharmaceuticals', 'Cap', 'كبسولة', '120 mg', '1', NULL, 'about orlistat anti-obese drug. saturated derivative of lipstatin. mechanism of action of orlistat its primary function is preventing the absorption of fats from the human diet thereby reducing caloric intake.orlistat works by inhibiting gastric and pancr', NULL, NULL, 1163, '2022-06-23', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'The global prevalence of obesity is increasing rapidly. Obesity-related complications lead to significant personal and economic burden by reducing quality of life and increasing the cost of healthcare.  In some individuals, diet and exercise are insufficient to maintain weight loss, and pharmacological or surgical intervention is required.[A229928]

Orlistat is a lipase inhibitor used in the treatment of obesity that works by inhibiting fat-metabolizing enzymes. It was approved by the FDA for use in combination with a reduced-calorie diet in 1999.[L11130] This drug is a generally well-tolerated and effective weight-loss aid and is now available in both over-the-counter[L31963] and prescription preparations, depending on the dosage quantity.[L11130]', '["A08AB01"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18872, 'Fatroxim 200 mg 10 f.c. tab.', 'فاتروكسيم 200مجم 10 اقراص', '81', '56.5', 'Travelers diarrhea', 'Rifaximin', 'Egpi > atm pharmaceutical industries', 'Tab', 'أقراص', '200 mg', '1', 'مضاد حيوى يستخدم فى يستخدم كعلاج في علاج الإسهال , متلازمة القولون المتهيج , اعتلال دماغي ,تشمع الكبد , او مرض الكبد', 'indication for the treatment of patients (over 12 years of age) with travelers diarrhea caused by noninvasive strains of escherichia coli. rifaximin is also designated an orphan drug by the food and drug administration for the adjunctive treatment of hepa', NULL, NULL, 1398, '2024-09-28', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that the drug will not pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It has multiple indications and is used in treatment of traveller''s diarrhea caused by E. coli; reduction in risk of overt hepatic encephalopathy recurrence; as well as diarrhea-predominant irritable bowel syndrome (IBS-D) in adult women and men. It is marketed under the brand name Xifaxan by Salix Pharmaceuticals.', '["A07AA11", "D06AX11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18873, 'Fatroxim 550 mg 10 f.c. tab', 'فاتروكسيم 550مجم 10 اقراص', '172', '120', 'Travelers diarrhea', 'Rifaximin', 'Egpi > atm pharmaceutical industries', 'Tab', 'أقراص', '550 mg', '1', 'يستخدم كعلاج في علاج الإسهال , متلازمة القولون المتهيج , اعتلال دماغي ,تشمع الكبد , او مرض الكبد', NULL, '6225000082861', NULL, 2550, '2025-02-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Rifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that the drug will not pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics. It has multiple indications and is used in treatment of traveller''s diarrhea caused by E. coli; reduction in risk of overt hepatic encephalopathy recurrence; as well as diarrhea-predominant irritable bowel syndrome (IBS-D) in adult women and men. It is marketed under the brand name Xifaxan by Salix Pharmaceuticals.', '["A07AA11", "D06AX11"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18875, 'Aaa', 'ششش', '79', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 828, '2022-10-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18876, 'Faulcurium 10mg/ml 5 amp. i.v.* 2.5 ml', 'فولكوريوم 10 مجم / مل 5 امبول* 2.5 مل', '61', NULL, 'Skeletal muscle relaxant', 'Atracurium besylate', 'Sedico', 'Amp', 'أمبول', '10mg', '5', NULL, 'indication for use as an adjunct to general anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. pharmacodynamics atracurium is a nondepolarizing skeletal muscle relaxant. atr', NULL, NULL, 1320, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M03AC04', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18877, 'Faulcurium 10mg/ml 5 amp. i.v.* 5ml', 'فولكوريوم 10 مجم / مل 5 امبول* 5 مل', '91', NULL, 'Skeletal muscle relaxant', 'Atracurium besylate', 'Sedico', 'Amp', 'أمبول', '10mg', '5', NULL, 'indication for use as an adjunct to general anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. pharmacodynamics atracurium is a nondepolarizing skeletal muscle relaxant. atr', NULL, NULL, 809, '2022-07-10', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'M03AC04', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18878, 'Aaa', 'ششش', '137', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 750, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18879, 'Aaa', 'ششش', '136', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 726, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18880, 'Fawar c 1 gm 6 eff. sachets', 'فوار سي 1جم 6 اكياس', '8', NULL, 'Vitamin c', 'Vitamin c', 'Pharco', 'Sachet', 'أكياس', '1 gm', '1', NULL, 'about vitamin c water soluble vitamin antioxidant. mechanism of action of vitamin c vitamin c exerts it`s action by influencing the biologic oxidations and reductions used in cellular respirations. it directly stimulates collagen synthesis and maintains i', '6221151003953', NULL, 1105, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'A11EB', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18881, 'Fawar cola 6 eff. sachets', 'فوار كولا 6 اكياس فوارة', '12', '9', 'Antacid', 'Citric acid+sodium bicarbonte+tartaric acid', 'Pharco', 'Sachet', 'أكياس', NULL, '1', NULL, 'interactions: antacids concurrent use of antacids with citrates may result in systemic alkalosis. concomitant administration of antacids with sodium citrate and sodium bicarbonate may promote the development of calcium stones in patients with uric acid st', '6221151001058', NULL, 1092, '2023-10-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18884, 'Fawar lemon 6 sachets', 'فوار ليمون 6 اكياس', '12', '9', 'Antacid', 'Citric acid+sodium bicarbonte+tartaric acid', 'Pharco', 'Sachet', 'أكياس', NULL, '1', NULL, 'interactions: antacids concurrent use of antacids with citrates may result in systemic alkalosis. concomitant administration of antacids with sodium citrate and sodium bicarbonate may promote the development of calcium stones in patients with uric acid st', '6223000010433', NULL, 1097, '2023-10-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18885, 'Faycid hair oil 60 ml', 'فايسيد زيت للشعر 60 مل', '30', '23', 'Anti-lice', 'Botanical ingredients', 'Fay beauty international > roma pharma', 'Hair oil', 'زيت شعر', '60 ml', '1', 'علاج لحشرات الشعر.', 'anti-lice oil for hair care to make it clean and smooth. application: add a reasonable amount of oil to the scalp for 15 minutes comb your hair with narrow comb from hair root to hair ending. used once or twice per week.', '232038717747', NULL, 3998, '2024-05-17', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18886, 'F-corten 4mg/ml 3 amps.', 'اف كورتين 4 مجم / مل 3 امبول', '12', NULL, 'Glucocorticoid', 'Dexamethasone', 'Memphis', 'Amp', 'أمبول', '4mg', '3', NULL, 'about dexamethasone a potent synthetic glucocorticoid antiasthmatic anti-inflammatory and immunosuppressant. mechanism of action of dexamethasone the drug exerts it`s pharmacological action by penetrating and binding to cytoplasmic receptor protein and ca', NULL, NULL, 751, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Developed in 1957, it is structurally similar to other corticosteroids like [hydrocortisone] and [prednisolone].[A188724]

Dexamethasone was granted FDA approval on 30 October 1958.[L10695] In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.[L14318]', '["R01AD53", "D07XB05", "R01AD03", "D10AA03", "S01CB01", "S02CA06", "S03CA01", "C05AA09", "S01CA01", "D07CB04", "H02AB02", "S01BA01", "A01AC02", "S03BA01", "D07AB19", "S02BA06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18888, 'Febrimol 500 mg 20 tab.', 'فيبريمول 500 مجم 20 قرص', '4', NULL, 'Antipyretic', 'Paracetamol(acetaminophen)', 'Pharco', 'Tab', 'أقراص', '500 mg', '2', NULL, 'about paracetamol acetanilide derivative non narcotic analgesic antipyretic. mechanism of action of paracetamol paracetamol has analgesic and antipyretic action. it is more active on cyclo-oxygenase enzyme in brain. peripherally it is a poor inhibitor of', NULL, NULL, 905, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'N02AJ01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18889, 'Febrimol oral drops 20 ml', 'فيبريمول نقط 20 مل', '4', NULL, 'Antipyretic', 'Paracetamol(acetaminophen)', 'Pharco', 'Drops', 'نقط', '20 ml', '1', NULL, 'about paracetamol acetanilide derivative non narcotic analgesic antipyretic. mechanism of action of paracetamol paracetamol has analgesic and antipyretic action. it is more active on cyclo-oxygenase enzyme in brain. peripherally it is a poor inhibitor of', NULL, NULL, 905, '2022-07-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, 'N02AJ01', NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18890, 'Febumagictam 80 mg 30 f.c. tablets', 'فبيوماجيكتام 80مجم 30 قرص', '105', NULL, 'Antigout', 'Febuxostat', 'Medizen pharmaceutical industries > magic pharma-egypt', 'Tablet', 'أقراص', '80 mg', '3', 'مضاد للنقرس واملاح اليوريك اسيد', 'indication: treatment of hyperuricaemia in conditions where urate deposition has already occured. dose: 1 tablet once daily', '6224008604051', NULL, 1226, '2022-02-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Febuxostat is a non-purine xanthine oxidase (XO) inhibitor.[A39743] In early 2008, febuxostat was granted marketing authorization by the European Commission for the treatment of chronic hyperuricemia and gout.[A230548] In the following year, the FDA for approved febuxostat for use in the chronic management of hyperuricemia in adult patients with gout who have an inadequate response or intolerance to [allopurinol].[L32238] Gout is a form of arthritis that is caused by the accumulation of uric acid crystal in or around a joint, leading to inflammation and further deposition of uric acid crystal deposition in bones, joints, tissues, and other organs in the long term. Gout is closely associated with hyperuricemia. Febuxostat works by inhibiting the activity of an enzyme that is responsible for the synthesis of uric acid, thereby reducing serum uric acid levels.[A230548] 

In February 2019, a black box warning for febuxostat was added, based on the findings of a post-market clinical study (the CARES trial) where there was an increased risk of cardiovascular (CV) fatal outcomes in patients with gout and known cardiovascular disease treated with febuxostat, when compared to those treated with allopurinol. The manufacturer and the FDA advise health professionals to limit the use of febuxostat to second-line therapy in patients who have inadequate response or intolerance to allopurinol, and to avoid the use of febuxostat in patients with cardiovascular diseases.[A2742, L13056]', '["M04AA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18892, 'Feburic 40 mg 20 f.c. tablets', 'فيبيوريك 40مجم 20 قرص', '76', '29', 'Antigout', 'Febuxostat', 'Hikma pharma', 'Tablet', 'أقراص', '40 mg', '2', 'علاج النقرص -- علاج الالام والالتهابات الناتجة عن النقرص بالمفاصل و الكعبين', NULL, '6221000000577', NULL, 8814, '2024-11-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Febuxostat is a non-purine xanthine oxidase (XO) inhibitor.[A39743] In early 2008, febuxostat was granted marketing authorization by the European Commission for the treatment of chronic hyperuricemia and gout.[A230548] In the following year, the FDA for approved febuxostat for use in the chronic management of hyperuricemia in adult patients with gout who have an inadequate response or intolerance to [allopurinol].[L32238] Gout is a form of arthritis that is caused by the accumulation of uric acid crystal in or around a joint, leading to inflammation and further deposition of uric acid crystal deposition in bones, joints, tissues, and other organs in the long term. Gout is closely associated with hyperuricemia. Febuxostat works by inhibiting the activity of an enzyme that is responsible for the synthesis of uric acid, thereby reducing serum uric acid levels.[A230548] 

In February 2019, a black box warning for febuxostat was added, based on the findings of a post-market clinical study (the CARES trial) where there was an increased risk of cardiovascular (CV) fatal outcomes in patients with gout and known cardiovascular disease treated with febuxostat, when compared to those treated with allopurinol. The manufacturer and the FDA advise health professionals to limit the use of febuxostat to second-line therapy in patients who have inadequate response or intolerance to allopurinol, and to avoid the use of febuxostat in patients with cardiovascular diseases.[A2742, L13056]', '["M04AA03"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18895, 'Feldene 10mg 20 caps', 'فلدين 10مجم 20 كبسولة', '26', NULL, 'Nsaid.oxicam', 'Piroxicam', 'Pfizer', 'Cap', 'كبسولة', '10mg', '2', NULL, NULL, '6221180000312', NULL, 1060, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.', '["M01AC01", "M02AA07", "S01BC06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18896, 'Feldene 10mg 20 dispersible .tab', 'فلدين 10مجم 20 قرص سريع الذوبان', '29', NULL, 'Nsaid.oxicam', 'Piroxicam', 'Pfizer', 'Tab', 'أقراص', '10mg', '2', NULL, NULL, '6221180000343', NULL, 1149, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.', '["M01AC01", "M02AA07", "S01BC06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18897, 'Aaa', 'ششش', '28', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 657, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18898, 'Feldene 20mg 10 caps.', 'فلدين 20مجم 10 كبسولات', '42', '26.25', 'Nsaid.oxicam', 'Piroxicam', 'Pfizer', 'Cap', 'كبسولة', '20mg', '1', NULL, 'about piroxicam nsaid oxicam derivative analgesic antiinflammatory. mechanism of action of piroxicam drug inhibits the biosynthesis and release of prostaglandins by inhibiting cyclooxygenase enzyme in a reversible manner. in this way it reduces the pg (pr', '6221180000336', NULL, 1217, '2024-02-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.', '["M01AC01", "M02AA07", "S01BC06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18899, 'Feldene 20mg 5 supp.', 'فلدين 20مجم 5 اقماع لبوس', '24', NULL, 'Nsaid.oxicam', 'Piroxicam', 'Pfizer', 'Supp', 'لبوس', '20mg', '1', NULL, 'about piroxicam nsaid oxicam derivative analgesic antiinflammatory. mechanism of action of piroxicam drug inhibits the biosynthesis and release of prostaglandins by inhibiting cyclooxygenase enzyme in a reversible manner. in this way it reduces the pg (pr', '6221180000374', NULL, 943, '2022-12-05', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.', '["M01AC01", "M02AA07", "S01BC06"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18900, 'Aaa', 'ششش', '47', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 630, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18901, 'Aaa', 'ششش', '45', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 640, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18902, 'Aaa', 'ششش', '8', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 716, '2022-10-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18903, 'Aaa', 'ششش', '6', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 892, '2022-10-15', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18905, 'Feloblock 10 mg 20 sr f.c. tabs.', 'فيلوبلوك 10 مجم اس ار 20 قرص', '35', NULL, 'Antihypertensive.selective calcium channel blocker', 'Felodipine', 'Mepaco', 'Tab', 'أقراص', '10 mg', '2', NULL, 'about felodipine a selective calcium channel blocker dihydropyridine derivative anti hypertensive. mechanism of action of felodipine felodipine is a vasoselective long acting dihydropyridine ca channel blocker. it exerts antihypertensive antianginal actio', NULL, NULL, 887, '2022-07-21', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential hypertension.', '["C07FB02", "C08CA02", "C09BB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18906, 'Feloblock 2.5 mg 20 sr f.c. tabs.', 'فيلوبلوك 2.5 مجم اس ار 20 قرص', '22', NULL, 'Antihypertensive.selective calcium channel blocker', 'Felodipine', 'Mepaco', 'Tab', 'أقراص', '2.5 mg', '2', NULL, 'about felodipine a selective calcium channel blocker dihydropyridine derivative anti hypertensive. mechanism of action of felodipine felodipine is a vasoselective long acting dihydropyridine ca channel blocker. it exerts antihypertensive antianginal actio', NULL, NULL, 735, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential hypertension.', '["C07FB02", "C08CA02", "C09BB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18907, 'Feloblock 5 mg 20 sr f.c. tabs.', 'فيلوبلوك 5 مجم اس ار 20 قرص', '28', NULL, 'Antihypertensive.selective calcium channel blocker', 'Felodipine', 'Mepaco', 'Tab', 'أقراص', '5 mg', '2', NULL, 'about felodipine a selective calcium channel blocker dihydropyridine derivative anti hypertensive. mechanism of action of felodipine felodipine is a vasoselective long acting dihydropyridine ca channel blocker. it exerts antihypertensive antianginal actio', NULL, NULL, 782, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential hypertension.', '["C07FB02", "C08CA02", "C09BB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18908, 'Felodipin stada 10 mg 10 mr tabs.', 'فيلوديبين ستادا 10 مجم ام ار 10 اقراص', '24', NULL, 'Antihypertensive.selective calcium channel blocker', 'Felodipine', 'Global napi pharmaceuticals > stada', 'Tab', 'أقراص', '10 mg', '1', NULL, 'about felodipine a selective calcium channel blocker dihydropyridine derivative anti hypertensive. mechanism of action of felodipine felodipine is a vasoselective long acting dihydropyridine ca channel blocker. it exerts antihypertensive antianginal actio', NULL, NULL, 737, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential hypertension.', '["C07FB02", "C08CA02", "C09BB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18909, 'Felodipin stada 2.5 mg 10 mr tabs.', 'فيلوديبين ستادا 2.5 مجم ام ار 10 اقراص', '11', NULL, 'Antihypertensive.selective calcium channel blocker', 'Felodipine', 'Global napi pharmaceuticals > stada', 'Tab', 'أقراص', '2.5 mg', '1', NULL, 'about felodipine a selective calcium channel blocker dihydropyridine derivative anti hypertensive. mechanism of action of felodipine felodipine is a vasoselective long acting dihydropyridine ca channel blocker. it exerts antihypertensive antianginal actio', NULL, NULL, 762, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential hypertension.', '["C07FB02", "C08CA02", "C09BB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18910, 'Felodipin stada 5 mg 10 mr tabs.', 'فيلوديبين ستادا 5 مجم ام ار 10 اقراص', '16', NULL, 'Antihypertensive.selective calcium channel blocker', 'Felodipine', 'Global napi pharmaceuticals > stada', 'Tab', 'أقراص', '5 mg', '1', NULL, 'about felodipine a selective calcium channel blocker dihydropyridine derivative anti hypertensive. mechanism of action of felodipine felodipine is a vasoselective long acting dihydropyridine ca channel blocker. it exerts antihypertensive antianginal actio', NULL, NULL, 964, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Felodipine is a long-acting 1,4-dihydropyridine calcium channel blocker (CCB)b. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, felodipine prevents calcium-dependent myocyte contraction and vasoconstriction. Felodipine is the most potent CCB in use and is unique in that it exhibits fluorescent activity. In addition to binding to L-type calcium channels, felodipine binds to a number of calcium-binding proteins, exhibits competitive antagonism of the mineralcorticoid receptor, inhibits the activity of calmodulin-dependent cyclic nucleotide phosphodiesterase, and blocks calcium influx through voltage-gated T-type calcium channels. Felodipine is used to treat mild to moderate essential hypertension.', '["C07FB02", "C08CA02", "C09BB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18911, 'Felopress 2.5/2.5 mg 21 f.c. tab.', 'فيلوبريس 2.5 / 2.5 مجم 21 قرص', '33', NULL, 'Antihypertensive', 'Felodipine+ramipril', 'Liptis', 'Tab', 'أقراص', '2.5 mg', '3', NULL, 'about felodipine a selective calcium channel blocker dihydropyridine derivative anti hypertensive. mechanism of action of felodipine felodipine is a vasoselective long acting dihydropyridine ca channel blocker. it exerts antihypertensive antianginal actio', NULL, NULL, 1151, '2022-07-11', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18912, 'Felopress 5/5 mg 21 f.c. tab.', 'فيلوبريس 5/5 مجم 21 قرص', '44', NULL, 'Antihypertensive', 'Felodipine+ramipril', 'Liptis', 'Tab', 'أقراص', '5 mg', '3', 'علاج ارتفاع ضغط الدم', 'about felodipine a selective calcium channel blocker dihydropyridine derivative anti hypertensive. mechanism of action of felodipine felodipine is a vasoselective long acting dihydropyridine ca channel blocker. it exerts antihypertensive antianginal actio', NULL, NULL, 1222, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18913, 'Feltado massage cream 80 gm', 'فلتادو كريم مساج 80 جم', '45', NULL, 'Massage cream', 'Eucalyptus oil+capsaicin+peppermint oil+chamomile oil+almond oil', 'Egyptian co. for cosmetics > docare pharm', 'Cream', 'كريم', '80 gm', '1', NULL, 'indications : -rheumatoid arthritis -diabetic neuropathy -muscle sprains and strains -cramps. usage : apply a suitable amount of cream on skin 2 ï¿½ 3 times daily', NULL, NULL, 940, '2022-07-08', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18914, 'Fem 7 - 100 mcg 4 transdermal patches', 'فيم 7-100 ميكروغرام 4 لصقات عبر الجلد', '50', NULL, 'Hormone replacement therapy', 'Estradiol', 'Merck kgaa f.r.germany > merck kgaa f.r-egypt', 'Patch', 'لصقة', '100 mcg', '1', NULL, 'each patch contains 2.25 mg of estradiol hemihydrate in a patch size of 22.5 cm2 releasing 100 micrograms of estradiol per 24 hours. therapeutic indications hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women. preve', NULL, NULL, 846, '2022-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Estradiol is a naturally occurring hormone circulating endogenously in females. It is commercially available in several hormone therapy products for managing conditions associated with reduced estrogen, such as vulvovaginal atrophy and hot flashes. Some available forms of estradiol include oral tablets, injections, vaginal rings, transdermal patches, sprays, gels, and creams.[L11485,L11488,L11491, L11494,L11497,L11500,L11503] 

When used for oral or IM administration, estradiol is commonly synthesized as a pro-drug ester (such as [DB13952], [DB13953], [DB13954], [DB13955], and [DB13956]). Because it has a low oral bioavailability on its own, estradiol is commonly formulated with an ester side-chain. [DB00977] (EE) is a synthetic form of estradiol commonly used as the estrogenic component of most combination oral contraceptive pills (OCPs). Ethinyl estradiol is different from estradiol due to its higher biovailability and increased resistance to metabolism, rendering it more suitable for oral administration.', '["G03FA16", "G03FA06", "G03FA09", "G03FA14", "G03CA53", "G03FA12", "G03FB12", "G03FB03", "G03FA15", "G03FB02", "G03FB10", "G03FA10", "G03EA01", "G03FA04", "G03FB11", "G03FA01", "G03FB09", "G03FB08", "G03EA03", "G03AA14", "G03AB08", "G03FB01", "G03FA03", "H01CC54", "G03FA08", "G03FB06", "G03EA02", "G03AA17", "G03FA11", "G03FB07", "G03FA17", "G03FA07", "G03FA02", "G03HB01", "G03FB04", "G03FA13", "G02BB01", "G03CA03", "G03FA05", "G03FB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18915, 'Fem 7 - 50 mcg 4 transdermal patches', 'فيم 7-50 ميكروغرام 4 لصقات عبر الجلد', '30', NULL, 'Hormone replacement therapy', 'Estradiol', 'Merck kgaa f.r.germany > merck kgaa f.r-egypt', 'Patch', 'لصقة', '50 mcg', '1', NULL, 'each patch contains 2.25 mg of estradiol hemihydrate in a patch size of 22.5 cm2 releasing 50 micrograms of estradiol per 24 hours. therapeutic indications hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women. preven', NULL, NULL, 870, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Estradiol is a naturally occurring hormone circulating endogenously in females. It is commercially available in several hormone therapy products for managing conditions associated with reduced estrogen, such as vulvovaginal atrophy and hot flashes. Some available forms of estradiol include oral tablets, injections, vaginal rings, transdermal patches, sprays, gels, and creams.[L11485,L11488,L11491, L11494,L11497,L11500,L11503] 

When used for oral or IM administration, estradiol is commonly synthesized as a pro-drug ester (such as [DB13952], [DB13953], [DB13954], [DB13955], and [DB13956]). Because it has a low oral bioavailability on its own, estradiol is commonly formulated with an ester side-chain. [DB00977] (EE) is a synthetic form of estradiol commonly used as the estrogenic component of most combination oral contraceptive pills (OCPs). Ethinyl estradiol is different from estradiol due to its higher biovailability and increased resistance to metabolism, rendering it more suitable for oral administration.', '["G03FA16", "G03FA06", "G03FA09", "G03FA14", "G03CA53", "G03FA12", "G03FB12", "G03FB03", "G03FA15", "G03FB02", "G03FB10", "G03FA10", "G03EA01", "G03FA04", "G03FB11", "G03FA01", "G03FB09", "G03FB08", "G03EA03", "G03AA14", "G03AB08", "G03FB01", "G03FA03", "H01CC54", "G03FA08", "G03FB06", "G03EA02", "G03AA17", "G03FA11", "G03FB07", "G03FA17", "G03FA07", "G03FA02", "G03HB01", "G03FB04", "G03FA13", "G02BB01", "G03CA03", "G03FA05", "G03FB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18916, 'Fem 7 - 75 mcg 4 transdermal patches', 'فيم 7-75 ميكروجرام 4 لصقات عبر الجلد', '40', NULL, 'Hormone replacement therapy', 'Estradiol', 'Merck kgaa f.r.germany > merck kgaa f.r-egypt', 'Patch', 'لصقة', '75 mcg', '1', NULL, 'each patch contains 2.25 mg of estradiol hemihydrate in a patch size of 22.5 cm2 releasing 100 micrograms of estradiol per 24 hours. therapeutic indications hormone replacement therapy (hrt) for oestrogen deficiency symptoms in postmenopausal women. preve', NULL, NULL, 980, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Estradiol is a naturally occurring hormone circulating endogenously in females. It is commercially available in several hormone therapy products for managing conditions associated with reduced estrogen, such as vulvovaginal atrophy and hot flashes. Some available forms of estradiol include oral tablets, injections, vaginal rings, transdermal patches, sprays, gels, and creams.[L11485,L11488,L11491, L11494,L11497,L11500,L11503] 

When used for oral or IM administration, estradiol is commonly synthesized as a pro-drug ester (such as [DB13952], [DB13953], [DB13954], [DB13955], and [DB13956]). Because it has a low oral bioavailability on its own, estradiol is commonly formulated with an ester side-chain. [DB00977] (EE) is a synthetic form of estradiol commonly used as the estrogenic component of most combination oral contraceptive pills (OCPs). Ethinyl estradiol is different from estradiol due to its higher biovailability and increased resistance to metabolism, rendering it more suitable for oral administration.', '["G03FA16", "G03FA06", "G03FA09", "G03FA14", "G03CA53", "G03FA12", "G03FB12", "G03FB03", "G03FA15", "G03FB02", "G03FB10", "G03FA10", "G03EA01", "G03FA04", "G03FB11", "G03FA01", "G03FB09", "G03FB08", "G03EA03", "G03AA14", "G03AB08", "G03FB01", "G03FA03", "H01CC54", "G03FA08", "G03FB06", "G03EA02", "G03AA17", "G03FA11", "G03FB07", "G03FA17", "G03FA07", "G03FA02", "G03HB01", "G03FB04", "G03FA13", "G02BB01", "G03CA03", "G03FA05", "G03FB05"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18917, 'Fem cal 20 tabs', 'فيم كال 20 قرص', '30', NULL, 'Calcium with iron supplement', 'Vitamin (a+d)+calcium+ferrous fumarate', 'Debeiky > regal pharma', 'Tab', 'أقراص', NULL, '2', NULL, NULL, NULL, NULL, 594, '2022-08-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18918, 'Femapent 2.5mg 14 f.c. tablets', 'فيمابنت 2.5مجم 14 قرص', '228', '228', 'Non-steroidal aromatase inhibitor. infertitlity', 'Letrozole', 'Penta pharma-egypt', 'Tablet', 'أقراص', '2.5mg', '2', 'لتأخر الحمل والانجاب و علاج العقم', NULL, '6224007738214', NULL, 18629, '2024-08-01', 0, NULL, NULL, NULL, NULL, 0, 0, 0, 'Letrozole, or CGS 20267, is an oral non-steroidal type II aromatase inhibitor first described in the literature in 1990.[A190543,A1559,L11623,L11626] It is a third generation aromatase inhibitor like [exemestane] and [anastrozole], meaning it does not significantly affect cortisol, aldosterone, and thyroxine.[A190546]

Letrozole was granted FDA approval on 25 July 1997.[L11623]', '["L02BG04"]', '[]');
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18921, 'Femgood vaginal douch 250 ml', 'فيمجود غسول مهبلي 250 مل', '70', '40', 'Vaginal care', 'Mallow extract+chamomile extract+tea tree oil+menthol+thymol oil+irgasan', 'Egyptian co. for cosmetics > beam pharma', 'Unknown', 'غير محدد', '250 ml', '1', 'غسول مهبلي', 'intimate wash used without dilution to treat and protect from bacterial infection and to moisturize the affected area suitable for everyday use', NULL, NULL, 863, '2024-03-04', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18923, 'Femiday vaginal wash 160 ml', 'فيميداي غسول مهبلي 160 مل', '28', NULL, 'Vaginal wash', 'Calendula ext.+thyme ext.+chamomile ext.', 'Joyce cosmetics > aug pharma', 'Vaginal wash', 'غسول مهبلي', '160 ml', '1', NULL, NULL, NULL, NULL, 780, '2022-07-26', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18924, 'Femiday vaginal wash 320 ml', 'فيميداي غسول مهبلي 320 مل', '48', NULL, 'Vaginal wash', 'Calendula ext.+thyme ext.+chamomile ext.', 'Joyce cosmetics > aug pharma', 'Vaginal wash', 'غسول مهبلي', '320 ml', '1', NULL, NULL, NULL, NULL, 709, '2022-08-03', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18925, 'Femifly vag. wash 250 ml', 'فيميفلي غسول مهبلي 250 مل', '30', NULL, 'Vaginal wash', 'Menthol crystals+triclosan+aloe vera ext.+glycerin+chamomile ext.', 'Hi-care > pharmazone company', 'Unknown', 'غير محدد', '250 ml', '1', NULL, 'used after dilution only', NULL, NULL, 903, '2022-07-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18926, 'Aaa', 'ششش', '4', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '1', NULL, NULL, NULL, NULL, 738, '2023-04-27', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18928, 'Feminalopram 8 caplets', 'فيمينالوبرام 8 كبسولات', '6', NULL, 'Menstrual pain releif', 'Pamabrom+paracetamol(acetaminophen)', 'Organopharma', 'Cap', 'كبسولة', NULL, '1', NULL, 'pamabrom is typically recommended to women to alleviate symptoms associated with menstrual cycles the medication works as all diuretics do by pulling excessive water from throughout the body and increasing how frequently patients need to urinate. by flush', NULL, NULL, 802, '2022-07-24', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18929, 'Femireem 30 f.c. tabs.', 'فيميريم 30 قرص', '27', NULL, NULL, 'Genistein+vitamin d3', 'Rameda', 'Tab', 'أقراص', NULL, '3', NULL, 'used during menopause. dose: once daily.', NULL, NULL, 1107, '2022-07-09', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18930, 'Femireem plus 30 caps.', 'فيمريم بلس', '33', NULL, NULL, 'Genistein+calcium+vitamin d3+vitamin k', 'Rameda', 'Cap', 'كبسولة', NULL, '3', 'مضاد للاكسدة -- يحافظ علي صحة العظام -- ينشط جهاز المناعة -- يساعد علي امتصاص الكالسيوم', 'used during menopause. dose: once daily.', NULL, NULL, 975, '2022-05-12', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18932, 'Femorex gel 50 gm', 'فيموركس جل 50 جم', '27', '27', 'Massage', 'Glucosamine sulphate+chondroitin sulphate+menthol+camphor+ginko biloba', 'Egyptian company for cosmetics > rand pharm co.', 'Gel', 'جل', '50 gm', '1', NULL, 'massage gel to relieve pain', NULL, NULL, 979, '2024-10-16', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
INSERT OR IGNORE INTO drugs (id, trade_name, arabic_name, price, old_price, category, active, company, dosage_form, dosage_form_ar, concentration, unit, usage, pharmacology, barcode, qr_code, visits, last_price_update, updated_at, indication, mechanism_of_action, pharmacodynamics, data_source_pharmacology, has_drug_interaction, has_food_interaction, has_disease_interaction, description, atc_codes, external_links) VALUES (18933, 'Aaa', 'ششش', '120', NULL, NULL, NULL, NULL, 'Unknown', 'غير محدد', NULL, '0', NULL, NULL, NULL, NULL, 602, '2022-07-13', 0, NULL, NULL, NULL, NULL, 0, 0, 0, NULL, NULL, NULL);
